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ABSTRACT 
Excessive collagen degradation (collagenolysis) has been implicated in a series of 
diseases such as tumor metastasis, atherosclerosis and arthritis. There are still several unresolved 
questions about the mechanism of collagenolysis. First, the prototypical structure of the collagen 
triple helix does not fit into the active site of collagenases, the enzymes responsible of cleaving 
collagen. Moreover, the scissile bond that is degraded during collagenolysis is hidden from 
solvent. Therefore it is widely agreed that collagen unfolding must occur in order for 
collagenolysis to proceed. Some proposed mechanisms suggest that collagenases actively unfold 
collagen in order to expose the cleavage site, but no direct evidence of such mechanisms has 
been provided. Second, while several potential cleavage sites exist in the sequence of collagen, 
only one is cleaved in triple helical collagen. 
The hypothesis of this work is that locally unfolded states exist in collagen in the absence 
of collagenases. They occur as a result of the natural thermal fluctuations in the structure of 
collagen. Collagenolysis occurs when collagenases bind and cleave these unfolded states. In this 
work, a combination of computational and experimental methods is presented in order to test this 
hypothesis. Initially, computational results suggest that locally unfolded states are ubiquitous 
along the structure of collagen. However, it is shown that not all unfolded states are created 
equal, and that the precise sequence in the vicinity of the true collagenase cleavage site in type 
III collagen allows collagen to sample locally unfolded states that are complimentary to the 
collagenase active site. Therefore, it is hypothesized that cleavage site specificity is encoded in 
the nature of the unfolded states. Next, it is shown that types I and III collagen can be bound and 
cleaved at the actual cleavage site by just the catalytic domain of collagenases, a finding in 
apparent contradiction with previous work in this field. These results are interpreted in light of a 
novel conformational selection mechanism in which collagenases only cleave locally unfolded, 
vulnerable states. Finally, based on the new mechanism of collagenolysis presented here, new 
strategies to regulate collagenolysis are proposed.  
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I.1. Collagen 
I.1.1. The collagen triple helix 
Collagen is composed of three polypeptide chains that form a triple helical structure. 
Each of the chains can be quite long, about 1000 amino acids or more in length in some collagen 
types. A repeating sequence of three amino acids (G-X1-X2) forms this structure, in which every 
third amino acid is glycine (Ramachandran and Kartha 1955; Rich and Crick 1955; Rich and 
Crick 1961). The tight internal packing of the triple-helix only allows a residue without a side-
chain to occupy every first position. Many of the remaining positions in the chain are occupied 
by proline (Pro or P) and a post-translational modification of proline, hydroxyproline (Hyp, or O) 
(Brodsky and Ramshaw 1997). The three polypeptide chains, each in an extended left-handed 
polyproline II-helix conformation, are supercoiled in a right-handed manner around a common 
axis, with a stagger of one residue between adjacent chains (Brodsky and Persikov 2005). A 
classic triple helix is shown in Figure I.1, corresponding to the PDB file 1BKV (Kramer, Bella et 
al. 2001).  
 
Figure I.1. Representation of the triple helix of collagen. The figure is based on the crystal 
structure of a type III collagen like peptide containing a biologically relevant sequence, PDB file 
1BKV (Kramer, Bella et al. 2001). A) Lateral view of the collagen triple helix. Each chain is 30 
amino acids in length. The diameter of the triple helix is about 15Å. The backbone is shown in 
cartoon representation, and the side chains in stick representation. B) View down the barrel of 
the collagen triple helix. Both representations were generated with Pymol (DeLano 2002). 
 
B) A) 
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Regions in the collagen sequence that are rich in GPO (glycine-proline-hydroxyproline) 
repeats (imino rich regions) are essential for the overall triple helical structure of collagen, but 
represent only 10% of the total type I collagen sequence (Shoulders and Raines 2009). Imino 
acids are responsible for triple helical stability, while other amino acids can stabilize the triple 
helix to a lesser degree or even destabilize it (Persikov, Ramshaw et al. 2000; Persikov, 
Ramshaw et al. 2005). Indeed, not only imino acids are found in the X1 and X2 positions of the 
G-X1-X2 triplets, but other amino acids can be present. There are several stretches within 
different collagen sequences that are relatively imino poor in that few or no imino acids are 
present. These imino poor regions, rather than playing a structural role, are thought to carry 
biological information, such as cell recognition or protein binding sites (Brodsky and Persikov 
2005). Most importantly, the regions downstream of the cleavage sites in several types of 
collagen have a low content of imino acids and may play an important role in collagen 
degradation (Fields 1991). 
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I.1.2. Collagen types and their role in normal and disease states 
About one third of all of proteins in the human body belong to the class of structural 
proteins known as collagens (Shoulders and Raines 2009). Up to 29 vertebrate collagen types 
have been discovered to this date (Shoulders and Raines 2009). They can be subdivided into 
several subfamilies. Fibrillar collagens, the most abundant, include type I, II, III, V and XI 
(Hulmes 2002; Gelse, Poschl et al. 2003). Other collagens fall under the network-forming, fibril 
associated with interrupted triple helices (FACIT), membrane associated with interrupted triple 
helices (MACIT) and multiple triple-helix domains and interruptions (MULTIPLEXINs) 
categories (Brinckmann 2005; Shoulders and Raines 2009). Interestingly, collagens are also 
present in invertebrates (Boot-Handford and Tuckwell 2003), and triple helical domains 
resembling collagen’s structure have been discovered in bacteria (Xu, Keene et al. 2002; Mohs, 
Silva et al. 2007). 
In humans, fibrillar collagens form fibers that add significant tensile strength to a variety 
of body structures. To mention a few, type I collagen is the most abundant collagen and is 
present in tendon, bone, ligament, type II collagen is the main component of cartilage, and type 
III collagen is present in skin and blood vessels. Type I collagen is a heterotrimer composed of 
two α1(I) chains and one α2(I) chain (Ricard-Blum, Ruggiero et al. 2005). Type II collagen is a 
homotrimer composed of three α1(II) chains (Gelse, Poschl et al. 2003; Shoulders and Raines 
2009). Type III collagen is a homotrimer composed of three α1(III) chains (Gelse, Poschl et al. 
2003). In all three types of collagen, each of the chains is about 1000 amino acids in length. 
Collagen is involved is several disease states that affect the human body. The inefficient 
biosynthesis of collagen or the synthesis of structurally defective collagen, for example, leads to 
disorders such as the family of Ehlers-Danlos syndromes (Parapia and Jackson 2008). In type IV 
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Ehlers-Danlos syndrome, for example, mutations in the type III collagen gene lead to a 
deficiency of type III in the vessel walls, which, in turn, results into debilitated blood vessels that 
can rupture (Germain 2007). Another disorder is osteogenesis imperfecta (OI), also known as 
brittle bone disease, characterized by fragile bones susceptible to breaking (Gajko-Galicka 
2002). Several mutations in the α1(I) and α2(I) chains of type I collagen are responsible for a 
variety of different phenotypes in osteogenesis imperfecta (Gajko-Galicka 2002). The previously 
discussed disorders have in common the fact that mutations in the collagen genes or in the 
enzymes required for collagen biosynthesis are responsible for the disease. This confines these 
disorders to a relatively small number of patients. Ehlers-Danlos syndrome, for example, affects 
an estimated 1 in 10000 to 25000 individuals, 5-10% of which correspond to type IV Ehlers-
Danlos (Germain 2007), while OI occurs in 1 out of 10000 births in the US (Martin and Shapiro 
2007).  
Other collagen-related disorders that affect larger number of individuals have been 
associated with excessive collagen degradation. In these disorders, no mutations in collagen or in 
the enzymes required for its biosynthesis need to occur. Therefore individuals that correctly 
synthesize collagen are susceptible to these disorders. Amongst these disease states we find 
atherosclerosis and tumor metastasis. Atherosclerotic heart disease is the most prevalent of these 
conditions and affects about 80 million people in the US (Lloyd-Jones, Adams et al. 2009). 
Mature atherosclerotic plaques are lipid-laden protrusions from the inner lining of arteries 
(Celentano and Frishman 1997; Barnes and Farndale 1999; McDonnell, Morgan et al. 1999). 
These abnormal evaginations contain an overlying layer of collagen that separates the internal 
lipid-laden contents within the plaque from the blood. When excessive collagen degradation 
occurs at the plaque, the outer layer of collagen debilitates and can rupture. When this protective 
18 
lining of collagen is degraded, the contents of the atherosclerotic plaque are exposed to the 
blood, leading to the formation of a clot in the blood vessel itself; i.e., an event which prevents 
flow through the artery. This sequence of events is the major cause of catastrophic heart attacks 
(Barnes and Farndale 1999).  
Another disorder which has been linked to abnormal collagen metabolism is tumor 
metastasis (McDonnell, Morgan et al. 1999; Nelson, Fingleton et al. 2000; Nerenberg, Salsas-
Escat et al. 2007). For a further details about collagen and cancer metastasis, please refer to a 
review written by the Stultz group (Nerenberg, Salsas-Escat et al. 2007). In light of the clinical 
importance of collagen degradation, methods which provide a deeper understanding of the 
molecular mechanism of collagen degradation may shed light on the events underlying a number 
of important diseases.  
19 
I.1.3. Collagen biosynthesis 
The biosynthesis of collagen is a complex process that requires the participation of many 
enzymes and coenzymes. This process can only be carried out in cells that contain the 
appropriate cellular machinery capable of introducing post-translational modifications (Gelse, 
Poschl et al. 2003; Koide and Nagata 2005; Salsas-Escat and Stultz 2009). The main steps of 
collagen biosynthesis are outlined in Figure I.2. Initially, procollagen α chains are synthesized in 
the endoplasmic reticulum, ER (I). Next, selected prolines and lysines are hydroxylated (II). This 
is followed by O-glycosilation of selected hydroxylysines (III). Then, the 3 procollagen α chains 
are ready for self assembly and the procollagen triple-helix forms (IV). This structure is then 
secreted (V and VI) and the propeptides are then cleaved (VII) to form collagen monomers. 
These monomers self-assemble into fibrils that present a banding pattern of periodicity of about 
70nm, and can covalently crosslink to each other (VIII). Finally, the fibrils aggregate to form a 
collagen fiber (IX).             
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Figure I.2. Collagen biosynthesis. Schematic representation of collagen biosynthesis starting 
from the synthesis of the procollagen chains in the endoplasmic reticulum (ER) and finishing in 
the formation of collagen fibers (Hohenester and Engel 2002; Gelse, Poschl et al. 2003; Salsas-
Escat and Stultz 2009).  
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I.2. Collagen degradation 
I.2.1. Matrix metalloproteinases: general structural and sequence motifs 
Matrix metalloproteinases are a family of Zn2+ and Ca2+ dependent endopeptidases that 
are capable of cleaving components of the extracellular matrix, including collagen, fibronectin 
and laminin (Chakraborti, Mandal et al. 2003).  For example, a number of members of the MMP 
family such as fibroblast collagenase (MMP1), neutrophil collagenase (MMP8), collagenase-3 
(MMP13), collagenase 4 (MMP18, found in frog but not in humans), membrane type I MMP 
(MMP14) and MMP2 (gelatinase A) are the only enzymes that can cleave native triple helical 
fibrillar collagens (Lauer-Fields, Juska et al. 2002; Chakraborti, Mandal et al. 2003; Song, 
Wisithphrom et al. 2006). There are at least 28 members of the MMP family. All but two 
(MMP7 and MMP26) contain at least the two domains shown in Figure I.3. This structure, 
corresponding to MMP1, consists of two domains - a catalytic domain of approximately 160-170 
amino acids, and a hemopexin-like domain of about 200 amino acids – connected by a linker of 
variable length, between 15 and 65 residues (Tallant, Marrero et al. 2009). Some members of the 
MMP family contain additional domains, e.g. the transmembrane domain of MMP14 or the 
fibronectin-like domains of MMP2 (Lauer-Fields, Juska et al. 2002; Overall 2002; Bode and 
Maskos 2003; Tallant, Marrero et al. 2009).   
MMPs are expressed as zymogens and can be activated intra or extracellularly (Pei and 
Weiss 1995; Chakraborti, Mandal et al. 2003). These zymogens include an approximately 80 
residue long propeptide at the N-terminus of the catalytic domain that prevents access to the 
catalytic site (Overall 2002). The propeptide can be cleaved by membrane-type MMPs or other 
proteases, including activated MMPs (Jones, Sane et al. 2003).  The catalytic domain contains a 
conserved sequence motif HEXXHXXGXXH, with glutamate being the catalytic residue and 
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the histidine residues responsible for coordinating the Zn2+ ion. In the absence of the hemopexin-
like domain, some MMPs retain catalytic activity for cleaving gelatin (unfolded collagen), but 
lose efficiency to cleave triple helical collagen. The hemopexin is considered to be necessary for 
collagen binding and it has been hypothesized that it is involved in the active unfolding of the 
collagen triple helix (Overall 2002; Chung, Dinakarpandian et al. 2004). Several structures of 
different MMP domains or some full length MMPs have been previously reported (Maskos 
2005). 
 
Figure I.3. Structure of matrix metalloproteinase-1. The crystal structure of MMP1 (PDB: 
1FBL), which is the MMP archetypal structure (Li, Brick et al. 1995). The catalytic domain is 
shown in red, the linker in blue, the hemopexin-like domain in green, the calcium ions as green 
spheres and the zinc ions as grey sphere. This figure was created with molecular visualization 
package Pymol (DeLano 2002). 
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I.3. The mechanism of collagen degradation by MMPs: an 
unanswered question 
The steps underlying the mechanism of collagen degradation are mysterious. Collagen 
degradation begins with the cleavage of collagen monomers by specific proteases called matrix 
metalloproteinases (MMPs), which cleave collagen at unique cleavage sites that are 
characterized by a covalent bond between a Glycine residue and a Leucine or Isoleucine residue, 
followed by an Alanine or Leucine, G~I/L-A/L, where ~ represents the bond cleaved (Fields 
1991). What is curious about the degradation process itself, is that the collagen triple helix has a 
diameter of approximately 15Å (Figure I.1) while the catalytic domain of MMPs has a catalytic 
site that is only 5Å wide, suggesting that the folded structure of collagen cannot fit into the 
catalytic site, as seen in Figure I.4 (Fields 1991; Chung, Dinakarpandian et al. 2004; Lang, Braun 
et al. 2004).  
 
Figure I.4. Alignment of the collagen triple helix (15Å diameter) with the active site of MMP1 
(5Å opening). The catalytic domain is shown in red and the hemopexin-like domain is shown in 
green. This figure was created with molecular visualization package Pymol (DeLano 2002). 
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Moreover, an analysis of the solvent accessible surface of the structure of collagen 
suggests that the scissile bond which is cleaved by collagenases is buried within the structure of 
collagen (Figure I.5), implying that even if the catalytic site could accommodate collagen, the 
bond that has to be cleaved is still inaccessible (Stultz 2002). As the catalytic site of MMPs 
cannot accommodate the folded structure of collagen, and the collagenase scissile bond is hidden 
within the triple-helical structure (Figure I.5), the precise mechanism of collagen cleavage by 
MMPs remains unclear. 
 
Figure I.5. Solvent accessibility of the scissile bond within the triple helix. Surface representation 
of the collagen triple helix, in transparent grey, with the four atoms forming the scissile bond 
shown in color. This figure was created with molecular visualization package VMD (Humphrey, 
Dalke et al. 1996). 
 
There a number of hypotheses that explain the structural changes that must occur to 
facilitate collagen degradation. For example, it has been proposed that collagen is actively 
unwound by MMPs in a process known as “molecular tectonics” (Overall 2002; Bode and 
Maskos 2003). Figure I.6 shows a possible scenario in which a collagenase may actively unfold 
the collagen triple helix using a clamping mechanism. The problematic issue surrounding such 
mechanisms is that molecular tectonics requires the different MMP domains to undergo 
significant structural rearrangements that, in principle, would require large amounts of energy 
(Overall 2002). However, as collagen degradation does not require energy input in vitro, 
molecular tectonic theories have yet to be validated (Murphy and Knauper 1997; Overall 2002). 
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Figure I.6. Molecular tectonics - a clamping mechanism. Each figure shows a down the barrel 
(left) and longitudinal (right, 90º rotation) view with respect to a collagen monomer. In A), the 
fully folded triple helix (blue) sits near the catalytic domain (red) of MMP. It is apparent that the 
triple helix doesn’t fit in the active site (yellow). In order to unfold collagen, the hemopexin-like 
domain (green) has to move towards the collagen triple helix and ‘clamp’ it; B) The triple helix 
of collagen is locally unfolded as a result of the concerted action of the catalytic and hemopexin-
like domains (coordinated by the linker, in brown). The local unfolding then allows a single 
chain to fit into the active site. All figures were created with the molecular visualization package 
VMD (Humphrey, Dalke et al. 1996).    
B) 
A) 
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I.4. Unfolded states and collagen degradation 
One of the unifying themes of the research carried out in the Stultz lab is an interest in 
unfolded states (Huang and Stultz 2007; Huang and Stultz 2008; Yoon, Venkatachalam et al. 
2009). When the unfolded state is the predominant state of a protein, we refer to them as natively 
unfolded proteins. These proteins take on highly flexible and conformationally heterogeneous 
states that determine function, although the function of many of these natively unfolded proteins 
is unknown. Natively unfolded proteins play a key role in diseases such as Alzheimer’s disease 
(Aβ protein), Parkinson’s disease (α-Synuclein) or tauopathy (tau protein) (Taylor, Hardy et al. 
2002; Dyson and Wright 2005; Vendruscolo 2007). Computational methods are highly suitable 
to study these natively unfolded proteins (Vendruscolo 2007).  
Natively folded proteins can also undergo motions and structural fluctuations that are 
important for enzyme catalysis, ligand binding and formation of protein complexes, amongst 
others (Vendruscolo 2007). This dynamic view of proteins is an important addition to the central 
dogma of modern protein science in which the sequence of a protein determines its structure, 
which in turn, determines its function. Indeed, the repetitive sequence of collagen and the 
presence of imino acids dictate collagen’s triple helical structure (Brodsky and Persikov 2005). 
Consequently, its triple helical structure allows collagen to form fibrils and perform its structural 
function. In this thesis we study the structure of collagen regarded as a mobile, breathing entity. 
Therefore, the protein sequence determines the ensemble of structures that a protein adopts, and 
the dynamic fluctuations within the ensemble (Karplus and Kuriyan 2005). It is this combination 
of ensemble and dynamics that ultimately determines the function of a protein. Indeed, in the 
recent years it has become apparent that collagen itself may not be a rigid, inflexible, molecule. 
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That is, like most proteins, collagen can undergo small fluctuations in its structure at physiologic 
temperatures and unfold locally while maintaining a globally folded triple helix.  
Experimentally, the existence of locally unfolded states has been suggested in studies of 
collagen and collagen like peptides, short peptides that fold into a triple helix. The collagen triple 
helix is typically thought to be resistant to proteases like trypsin or pepsin, a property which is 
used in the purification of acid soluble collagen at cold temperatures (Haralson and Hassell 
1995). Nevertheless, it has been shown that, at temperatures below its melting temperature, type 
III collagen can be degraded by trypsin (Miller, Finch et al. 1976; Birkedal-Hansen, Taylor et al. 
1985) or thermolysin (Wang, Chan et al. 1978) in the imino poor region downstream of the 
collagenase cleavage site. This suggests a disordered or interrupted triple helix.   
Work with collagen-like peptides is also consistent with the existence of locally unfolded 
states in collagen. An NMR study showed that the central glycine residue in the imino poor 
region C-terminal to the type III collagenase cleavage site exchanges proton with solvent faster 
than a pure (POG)10 peptide (a peptide containing imino acids in all X1 and X2 positions), 
suggesting a more labile triple helix at that position for the former peptide (Fan, Li et al. 1993). 
Another NMR study on a type I collagen-like peptide that contained an imino rich region and a 
relative imino poor region including the type I collagen cleavage site, revealed two independent 
structural domains. The imino rich region appeared to be well folded, while the imino poor 
region appeared to lack triple helical structure (Fiori, Sacca et al. 2002). Moreover, dynamical 
simulations on type I collagen and type III collagen-like peptides suggest that partial unfolding at 
room temperature does occur (Stultz 2002; Nerenberg and Stultz 2008; Salsas-Escat and Stultz 
2009).   
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These data support the fact that local unfolding is an inherent property of the collagen 
triple helix and its sequence that occurs naturally without the action of collagenases. Taking this 
concept one step further, we formulate a conformational selection hypothesis for collagen, in 
which the existence of locally unfolded states, independent of collagenases, is necessary for 
collagen degradation. In other words, the interaction of preexisting unfolded states of collagen 
and collagenases is required for collagen degradation to occur. In fact, in a paper published 
during the course of this thesis, a two-state, conformational selection model was developed and 
was used to explain previous experimental observations in which deletion mutants of MMP1, 
containing only the catalytic domain, failed to cleave type I collagen at room temperature. These 
experimental results were interpreted to mean that locally unfolded states in collagen do not exist 
(Chung, Dinakarpandian et al. 2004; Nerenberg, Salsas-Escat et al. 2008). The two-state model is 
shown in Figure I.7. In short, collagen exists in an equilibrium between native (N) and 
vulnerable (V) states. While collagenases can bind to both states, yielding CNE and CVE, 
respectively, degradation can only occur when vulnerable states are bound. For details about this 
work, please refer to Appendix 1.  
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Figure I.7. Conformational selection mechanism for collagen degradation. N denotes the native 
state of collagen (i.e., its triple-helical structure); E denotes a collagenase; CNE is the enzyme-
substrate complex; CVE denotes the complex formed between the enzyme E and the partially 
unfolded state V; and P denotes the products of collagenolysis. The model itself, as outlined 
here, makes no assumption about the form of collagen and therefore is applicable to both 
collagen in its monomeric form as well as in its fibrillar form. The individual rate constants for 
each transition are shown. 
 
Given all the data suggesting the existence of unfolded states in collagen, it may be that 
the classic triple-helical structure of collagen found in many textbooks does not accurately 
represent its structure under physiologic conditions. Collagen degradation in the body occurs at 
37ºC and mainly in the fibrillar state. The detailed study of collagen structure and degradation 
under these conditions is experimentally and computationally complex. However, it has been 
shown that collagen can be cleaved by collagenases in vitro at room temperature (Chung, 
Dinakarpandian et al. 2004). For this reason, we restrict our computational and experimental in 
vitro studies to room temperature, which is well below collagen’s melting temperature (Leikina, 
Mertts et al. 2002). Using computational tools, in Chapters 1 and 2 we intend to develop a deeper 
understanding of the normal thermal fluctuations that the collagen structure experiences. 
However, studying conformational fluctuations in proteins is often a difficult task as the thermal 
fluctuations of interest are often quite small. In this thesis we demonstrate how computational 
tools can be used to probe these small structural changes at an atomistic level of detail. 
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I.5. The problem of cleavage site specificity 
In addition to the aforementioned unfolding question of collagen degradation, there is 
another aspect of collagen degradation that is of much debate. This is the issue of collagenase 
cleavage site specificity. Collagenases cleave triple helical collagen at sites defined by the 
sequence G~I/L-A/L. While several of these sites exist in the sequence of collagen (Figure I.8), 
only one in each chain is cleaved by collagenases in triple helical collagen (Fields 1991).  
Certain proteases have, in general, well defined sequence specificities. For example, 
trypsin cleaves after positively charged residues (Olsen, Ong et al. 2004), pepsin preferentially 
after phenyalanine and leucine residues (Fruton and Bergmann 1938; Baker 1951) and 
chymotrypsin after aromatic residues (Hudaky, Kaslik et al. 1999). Therefore, from the analysis 
of the sequence of a target protein it can be predicted what fragments will result from the 
incubation with any of these proteases, given enough time for the protease to completely process 
its target. Limited proteolysis relies on the short exposure of general proteases to a target protein 
so that only the most accessible peptide bonds that satisfy the specificity requirements of the 
protease in question will be cleaved (Hubbard 1998). For example, limited exposure of trypsin to 
a protein will result in cuts at the most exposed positively charged residues, while arginine or 
lysine residues buried in the structure will not be readily cut. Only when the partially cut protein 
starts unfolding, these otherwise inaccessible residues will be accessed and cleaved by the 
protease. In light of this, it is apparent that accessibility of a peptide bond of interest to the active 
site of a protease is a key to the cleavage of such peptide bond. 
An explanation of the issue of collagenase cleavage site specificity can be formulated 
using the same approach. Only collagen triplets of the sequence G~I/L-A/L that are accessible to 
the collagenase active site will be cleaved. The main difference with the description of limited 
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proteolysis is that, in principle, there are no G~I/L-A/L triplets totally buried in the collagen 
structure, since collagen is a triple helical protein, not a globular one. Due to its triple helical 
structure, all side chains in collagen are solvent exposed, which is not the case in a globular 
protein. Nevertheless, in Section I.3 it has been discussed that the scissile bond in the canonical 
triple helical structure is hidden from solvent, and that the collagen triple helix does not fit into 
the active site of collagenases. The existence of locally unfolded states, discussed in Section I.4, 
may play a key role in allowing certain scissile bonds to become accessible to collagenases. 
While all the potential cleavage sites in collagen share the G~I/L-A/L sequence, they are 
surrounded by different stretches of amino acids. These differences in the surrounding sequences 
may result in different local conformations at each site. It is possible that the locally unfolded 
states at each of the potential cleavage sites are different, and that this helps determine cleavage 
site specificity. 
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Type I collagen α1 chain sequence (UniProtKB-SwissProt accession no. P02452) 
QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKN 
GDDGEAGKPGRPGERGPPGPQGARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAP 
GQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPRGSEGPQ 
GVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEP 
GAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPK 
GPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGAR 
GQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQ 
GLPGPAGPPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDA 
GAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDK 
GESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPP 
GPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRP 
GEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPS 
GASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPV 
GPAGKSGDRGETGPAGPAGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSP 
GEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAG 
FDFSFLPQPPQEKAHDGGRYYRA 
 
Type I collagen α2 chain sequence (UniProtKB-SwissProt accession no. P08123) 
QYDGKGVGLGPGPMGLMGPRGPPGAAGAPGPQGFQGPAGEPGEPGQTGPAGARGPAGPPGKAGEDGHP 
GKPGRPGERGVVGPQGARGFPGTPGLPGFKGIRGHNGLDGLKGQPGAPGVKGEPGAPGENGTPGQTGAR 
GLPGERGRVGAPGPAGARGSDGSVGPVGPAGPIGSAGPPGFPGAPGPKGEIGAVGNAGPAGPAGPRGEV 
GLPGLSGPVGPPGNPGANGLTGAKGAAGLPGVAGAPGLPGPRGIPGPVGAAGATGARGLVGEPGPAGSK 
GESGNKGEPGSAGPQGPPGPSGEEGKRGPNGEAGSAGPPGPPGLRGSPGSRGLPGADGRAGVMGPPGSR 
GASGPAGVRGPNGDAGRPGEPGLMGPRGLPGSPGNIGPAGKEGPVGLPGIDGRPGPIGPAGARGEPGNI 
GFPGPKGPTGDPGKNGDKGHAGLAGARGAPGPDGNNGAQGPPGPQGVQGGKGEQGPAGPPGFQGLPGPS 
GPAGEVGKPGERGLHGEFGLPGPAGPRGERGPPGESGAAGPTGPIGSRGPSGPPGPDGNKGEPGVVGAV 
GTAGPSGPSGLPGERGAAGIPGGKGEKGEPGLRGEIGNPGRDGARGAPGAVGAPGPAGATGDRGEAGAA 
GPAGPAGPRGSPGERGEVGPAGPNGFAGPAGAAGQPGAKGERGAKGPKGENGVVGPTGPVGAAGPAGPN 
GPPGPAGSRGDGGPPGMTGFPGAAGRTGPPGPSGISGPPGPPGPAGKEGLRGPRGDQGPVGRTGEVGAV 
GPPGFAGEKGPSGEAGTAGPPGTPGPQGLLGAPGILGLPGSRGERGLPGVAGAVGEPGPLGIAGPPGAR 
GPPGAVGSPGVNGAPGEAGRDGNPGNDGPPGRDGQPGHKGERGYPGNIGPVGAAGAPGPHGPVGPAGKH 
GNRGETGPSGPVGPAGAVGPRGPSGPQGIRGDKGEPGEKGPRGLPGLKGHNGLQGLPGIAGHHGDQGAP 
GSVGPAGPRGPAGPSGPAGKDGRTGHPGTVGPAGIRGPQGHQGPAGPPGPPGPPGPPG 
Type III collagen sequence (UniProtKB-SwissProt accession no. P02461) 
QYDSYDVKSGVAVGGLAGYPGPAGPPGPPGPPGTSGHPGSPGSPGYQGPPGEPGQAGPSGPPGPPGAI 
GPSGPAGKDGESGRPGRPGERGLPGPPGIKGPAGIPGFPGMKGHRGFDGRNGEKGETGAPGLKGENGLP 
GENGAPGPMGPRGAPGERGRPGLPGAAGARGNDGARGSDGQPGPPGPPGTAGFPGSPGAKGEVGPAGSP 
GSNGAPGQRGEPGPQGHAGAQGPPGPPGINGSPGGKGEMGPAGIPGAPGLMGARGPPGPAGANGAPGLR 
GGAGEPGKNGAKGEPGPRGERGEAGIPGVPGAKGEDGKDGSPGEPGANGLPGAAGERGAPGFRGPAGPN 
GIPGEKGPAGERGAPGPAGPRGAAGEPGRDGVPGGPGMRGMPGSPGGPGSDGKPGPPGSQGESGRPGPP 
GPSGPRGQPGVMGFPGPKGNDGAPGKNGERGGPGGPGPQGPPGKNGETGPQGPPGPTGPGGDKGDTGPP 
GPQGLQGLPGTGGPPGENGKPGEPGPKGDAGAPGAPGGKGDAGAPGERGPPGLAGAPGLRGGAGPPGPE 
GGKGAAGPPGPPGAAGTPGLQGMPGERGGLGSPGPKGDKGEPGGPGADGVPGKDGPRGPTGPIGPPGPA 
GQPGDKGEGGAPGLPGIAGPRGSPGERGETGPPGPAGFPGAPGQNGEPGGKGERGAPGEKGEGGPPGVA 
GPPGGSGPAGPPGPQGVKGERGSPGGPGAAGFPGARGLPGPPGSNGNPGPPGPSGSPGKDGPPGPAGNT 
GAPGSPGVSGPKGDAGQPGEKGSPGAQGPPGAPGPLGIAGITGARGLAGPPGMPGPRGSPGPQGVKGES 
GKPGANGLSGERGPPGPQGLPGLAGTAGEPGRDGNPGSDGLPGRDGSPGGKGDRGENGSPGAPGAPGHP 
GPPGPVGPAGKSGDRGESGPAGPAGAPGPAGSRGAPGPQGPRGDKGETGERGAAGIKGHRGFPGNPGAP 
GSPGPAGQQGAIGSPGPAGPRGPVGPSGPPGKDGTSGHPGPIGPPGPRGNRGERGSEGSPGHPGQPGPP 
GPPGAPGPCCGGVGAAAIAGIGGEKAGGFAPYYG 
Figure I.8. Amino acid sequences of human types I and III collagens. The actual collagenase 
cleavage sites are highlighted in green, while the potential cleavage sites are highlighted in red. 
These sites are not cleaved by collagenases in triple helical collagen. Since these sequences were 
obtained from genomic data, all hydroxyproline residues are being shown as proline.   
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I.6. Hypothesis and aims of this thesis 
The main hypothesis of this thesis is that locally unfolded states in collagen exist in the 
absence of collagenases. Degradation occurs when collagenases cleave these locally unfolded 
states. Also, it is hypothesized that the nature of the locally unfolded states at each cleavage site 
is a determinant of cleavage site specificity.  
In order to test these hypotheses, three main chapters are present in this work. The first 
chapter “Influence of the C-terminal Sequence to a Cleavage Site on Local Unfolding” aims to 
study the relationship between the sequence C-terminal to two potential cleavage sites and the 
existence of unfolded states, using a combination of computational and experimental methods. 
The second chapter “Characterizing the Conformational Ensemble of Collagen Cleavage Sites” 
takes the computational methods used in Chapter 1 one step further, expanding the study to 
multiple cleavage sites and the sequences upstream and downstream to these cleavage sites. In 
particular, it aims to study all the potential cleavage sites in type III collagen using computational 
methods, with hopes to understand the nature of the different locally unfolded states that occur at 
each cleavage site. The third chapter “Investigating the Influence of Unfolded States in Cleavage 
Site Specificity” aims to establish if the existence of unfolded states is a determinant of cleavage 
site specificity, by computational and experimental methods.  
In addition, two appendices are present in this thesis. In Appendix 1, the early 
development of the two-state collagen degradation model and testing of its predictive power 
against earlier experimental data is demonstrated.  Finally, Appendix 2 aims to test the two-state 
collagen degradation model developed in Appendix 1. The goal is to be able to confirm 
experimental predictions of the two-state degradation model and also gain insight into the 
thermodynamics of unfolded states and of the collagen-collagenase interaction. 
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Chapter 1: 
Influence of the C-terminal Sequence to 
a Cleavage Site on Local Unfolding 
 
Chapter 1 is adapted from: Salsas-Escat, R. and Stultz C.M. (2009). "The Molecular Mechanics 
of Collagen Degradation: Implications for Human Desease." Experimental Mechanics
  
 49(1): 65-
77. 
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1.1 Introduction 
Although several G~I/L-A/L triplets can be found in collagen, only one of these triplets 
in native collagen is cleaved by matrix metalloproteinases. That is, peptide bond hydrolysis 
occurs at one unique site despite the fact that several potential cleavage sites exist. A comparison 
of collagen sequences from several species suggests that the amino acid sequence surrounding 
the true collagenase cleavage site has unique sequence characteristics (Fields 1991). Namely, the 
true collagenase cleavage site has: 1) a relatively high imino acid content (4 or more imino acids 
in 12 residues) in the 4 triplets N-terminal (upstream) to the cleavage site; 2) a low imino acid 
content (less than 2 imino acids in 12 residues) in the 4 triplets C-terminal (downstream) to the 
cleavage site; and 3) an arginine residue downstream from the scissile bond (in position 𝑃𝑃5′  or 
𝑃𝑃8′ ). While these observations provide insight into sequence properties that are correlated with 
the true cleavage site, it is not obvious why such sequence differences enable the actual cleavage 
site to be recognized and cleaved by MMPs. Since it has been established that the presence of 
imino acids stabilizes the triple helix (Persikov, Ramshaw et al. 2000), we focus on the second 
sequence rule presented. We hypothesize that a low content of imino acids in the 4 triplets C-
terminal to the cleavage site is necessary to allow the existence of locally unfolded states. In 
Chapter 1 we investigate the influence of the C-terminal sequence to a cleavage site on the nature 
of the locally unfolded states existing next to such cleavage site.  
Most biochemical experiments measure average properties from a large collection of 
molecules. Spectroscopic measurements, for example, are performed on solutions containing 
micromolar concentrations of protein, which have on the order of 1020 molecules. Single 
molecule experiments can be more informative but even so, they can be difficult to perform and 
rarely yield information at an atomistic level of detail. By contrast, molecular dynamics (MD) 
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simulations have the advantage of generating detailed pictures of molecular phenomena at an 
arbitrary level of detail (Schlick 2000). These characteristics make MD simulations well-suited 
to study the small conformational fluctuations that may occur in collagen. These fluctuations are 
of particular interest as they may facilitate the recognition of collagen by proteases. To gain 
insight into the conformational fluctuations of collagen, we could compute trajectories using a 
model of the collagen molecule. As collagen itself contains over 3000 amino acids and well over 
30,000 atoms, detailed molecular simulations on a system of this size would require extensive 
computational resources. Consequently, we use a reduced representation that focuses on the 
amino acids near the true collagenase cleavage site. In order to achieve that, we simulate 
collagen-like peptides, short peptides that contain a biologically relevant sequence surrounded by 
proline-hydroxyproline-glycine (POG) repeats to ensure that the peptides fold in solution. This 
also allows us to perform experiments on the same peptides that are being simulated. 
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1.2 Results  
The peptide T3-785 (IP1 in this work) models an imino-poor segment from type III 
collagen which is downstream from the unique collagenase cleavage site (Figure 1.1). T3-785 
has been shown to adopt a triple helical structure at temperatures well below body temperature 
(Kramer, Bella et al. 1999). The other peptide studied in this work, IP2, models a region of 
collagen that is adjacent to a bond that is not cleaved in native collagen, but is cleaved in 
denatured (i.e., unfolded) collagen (Fields 1991) (Figure 1.1) - a finding which suggests that the 
conformation of this region is not partially unfolded in solution. We demonstrate how data 
obtained from MD simulations can be used to make useful inferences into the relative stability of 
these two peptides and that such observations ultimately lead to insights regarding the 
mechanism of collagenolysis.  
 
Figure 1.1. Sequences of peptides IP1 and IP2. A) Alignment of residues 776-805 in type III 
collagen (C3) and IP1 (T3-785) peptide. The symbol O denotes the residue hydroxyproline. The 
underlined residues correspond to the imino-poor region. The covalent bond cleaved by 
collagenases in type III collagen is denoted by a ~. The corresponding position in IP1 is denoted 
by a *. B) Alignment of residues 515-544 in type III collagen and IP2 peptide. In this case, the 
potential cleavage site is denoted by a ^. This site is not cleaved in native collagen. The 
corresponding position in IP2 is denoted by a *. 
 
MD simulations use a potential function to generate molecular trajectories. While the 
potential energy of the system is an important parameter in this regard, it is the free energy of the 
system that is most important for understanding physical properties. Potential energies tell us 
B) 
A) 
39 
 
about the energy of an individual conformation - a parameter that is inaccessible experimentally. 
By contrast, free energies tell us about the behavior of large collections of molecules. As typical 
laboratory experiments are performed on solutions containing molecules at nano-to-micromolar 
concentrations, methods that compute free energies allow us to directly correlate calculated 
quantities with experiment. In this regard, the potential of mean force plots (pmfs, also known as 
free-energy profiles) of IP1 and IP2 are of particular interest. From the free energy profiles, we 
can estimate the relative stability of different conformers, including partially unfolded states. 
Figure 1.2 shows the calculated free energy profiles of both peptides. The x-axis displays 
the radius of gyration, γ, - a convenient measure which indicates the extent in which a protein is 
unfolded - and the y-axis corresponds to the free energy. The pmf for IP1 has two minima, one at 
γ=18.5Å, close to that of the crystal structure of T3-785, and another at γ=18.9Å. The pmf for 
IP2 only has one minimum at γ=18.2Å - a value suggesting that the structure of this peptide in 
solution is more compact than the crystallographic structure. Qualitatively these data suggest that 
IP1 is conformationally labile relative to IP2. However, an added advantage of these calculations 
is that the pmf itself is a rigorous description of the conformational landscape of each peptide. 
Once the pmf is known, all properties that depend on the peptide’s conformation can be 
calculated. To quantify the conformational flexibility of each sequence, we compute the 
conformational entropy of each pmf; i.e., a quantity that describes the number of accessible 
states the peptide can have (see Methods). We find that 𝑇𝑇∆𝑆𝑆 =200 cal/mol higher for IP1, 
confirming that the conformational landscape of IP1 has higher entropy than the conformational 
landscape of IP2. However, the overall value of this entropy difference is quite small. To put this 
value into perspective, we note that estimates of the entropy changes associated with complete 
unfolding of globular proteins is on the order of 1500 to 1800 cal/mol/residue at 300K (Privalov 
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and Dragan 2007). Therefore the entropic difference between the conformational landscape of 
IP1 and IP2 is less than the entropic change associated with the complete unfolding of a single 
residue. These findings suggest that while the IP1 can adopt two distinct states, neither of these 
states is completely unfolded and the structural differences between the two conformers are 
likely to be quite localized.  
 
 
Figure 1.2. Comparison of potential of mean force for IP1 (blue) and IP2 (magenta). The pmf for 
IP1 is obtained from a previous work (Stultz 2002). IP1 presents 2 minima, one near the radius 
of gyration of the crystal structure (18.5Å) and a second near 18.9Å. IP2 presents only one 
minimum, near 18.2Å. 
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An analysis of representative structures from the simulations confirms this observation. 
While the structure of IP1 at the minimum corresponding to γ=18.5Å is quite similar to the 
crystallographic structure, the structure corresponding to γ=18.9Å has a relatively localized 
region that is unfolded (Figure 1.3 A and B) (Kramer, Bella et al. 1999; Stultz 2002). 
Interestingly, this region is adjacent to the collagenase cleavage site. Given this, we refer to 
conformers, like that shown in Figure 1.3 B, as vulnerable because these structures are, in 
principle, more vulnerable to cleavage by collagenases. To quantify structural differences 
between these conformers we compute the change in solvent accessibility surface (SAS) for 
backbone residues of the unfolded chain in each structure with respect to the well folded triple 
helix (Figure 1.3 D). To calculate the solvent accessibility, we use the Lee and Richards 
algorithm (Lee and Richards 1971), with a sphere radius of 1.4Å. Positive peaks indicate that the 
structure of a given residue in the conformation of interest is more exposed relative to the 
conformation of that residue in the crystal structure. These data corroborate the qualitative 
observations noted in Figure 1.3 A and B. That is, regions near the true collagenase cleavage site 
are relatively solvent exposed and accessible.  
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Figure 1.3. Comparison of the structural ensembles of each energy minima in Figure 1.2. A) 
Crystal structure of T3-785. The chain which is unfolded in the molecular simulations is shown 
in red. The green arrow points to the location where the scissile bond would be in type III 
collagen. B) Representative structure for IP1 at the minimum corresponding to radius of gyration 
18.9Å. C) Representative structure for IP2 at the minimum corresponding to radius of gyration 
18.2Å. D) Solvent accessibility surface (SAS) differences for the vulnerable state of IP1 (black) 
and for the structure lowest energy state of IP2 (green). Positive peaks indicate higher solvent 
accessibility than in the crystal structure. Figures A, B and C have been created with the 
molecular visualization package VMD (Humphrey, Dalke et al. 1996).  
 
  
B) 
A) 
C) 
D) 
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The simulations predict that peptide IP1 can sample compact as wells as unfolded 
conformations near room temperature while IP2 samples mainly compact confromations in 
solution. To determine whether these observations are consistent with the structure of these 
peptides in vitro, we obtain experimental estimates of the relative stability of both peptides. We 
begin by noting that the melting point of a solution containing a specific protein is the 
temperature in which half of the protein molecules in solution become unfolded. The more stable 
a given protein, the higher its melting temperature. Our data suggest that at temperatures near 
room temperature, IP1 starts to unfold, while IP2 retains much native like character. 
Consequently, we would expect IP2 to have a higher melting temperature than IP1.  
Melting curves for IP1 and IP2 are obtained at variable heating rates (Figure 1.4 A and 
B). From each melting curve, one can estimate the melting temperature (Figure 1.4 C). These 
data demonstrate that the melting curve is highly dependent on the heating rate (Privalov 1982). 
Ideally, the quantity that is of most interest is the melting temperature obtained by heating the 
peptide at an infinitely slow rate. Consequently, we use the various melting curves to extrapolate 
a melting curve corresponding to a heating rate of 0ºC/h (Figure 1.4 C). The resulting melting 
temperatures for IP1 and IP2 (Table 1.1) demonstrate that IP1 does, in fact, have a slightly lower 
melting temperature, suggesting that it unfolds first as the temperature is raised. 
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Figure 1.4. Melting curves at different heating rates for A) IP1 and B) IP2. C) Melting point 
extrapolation for IP1 and IP2. 
 
 
Table 1.1 Melting temperature for peptides  
     IP1 and IP2 
 Melting temperature (ºC) 
IP1 18.9±0.2 
IP2 21.4±0.1 
 
 
    
  
B) A) 
C) 
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1.3 Discussion 
Proteins are truly fascinating. They are complex molecules that are responsible for a 
myriad of diverse functions. To perform their prescribed functions, they often need to exhibit 
some degree of flexibility during their biological lifetime (Bahar and Rader 2005). Such 
structural fluctuations range from small thermal vibrations, where protein atoms oscillate about 
some average position, to large conformational changes, like the structural alterations associated 
with the myosin ‘molecular motor’ (Sellers and Veigel 2006). In practice, it is often quite 
difficult to visualize and/or quantify the degree of structural flexibility that is available to any 
given protein. Protein structures are usually determined by well-established experimental 
techniques such as x-ray crystallography and NMR spectroscopy (Voet and Voet 2004; Nelson 
and Cox 2005). X-ray crystallography uses x-ray radiation to obtain a diffraction pattern of a 
crystal which contains a large number of protein structures that are oriented in an orderly and 
recurring pattern. As protein crystals may contain a relatively heterogeneous population of 
conformations, meaningful x-ray crystal structures are only obtained when the different 
structures within the crystal are all quite similar. Fortunately, this is the case for most proteins. 
That is, under physiologic conditions most proteins only make small deviations from their 
average structure. To quantify the degree of thermal fluctuations within the crystal, x-ray 
crystallographers often report a measure of the thermal motion of atoms within the structure; i.e., 
B factors. The average structure, together with these B-factors, contains a wealth of information 
as they encode the magnitude of the structural fluctuations that each atom in a protein undergoes 
in the environment of a protein crystal. Nevertheless, decoding their information content can be 
quite problematic. Artifacts caused by disorder within a protein crystal can lead to erroneous 
conclusions that are based on analyses of B-factors. NMR experiments, by contrast, can 
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sometimes give insights into the degree of structural flexibility that is inherent to specific regions 
of a protein. However, due to technical limitations it is not always feasible to perform these 
experiments on an entire protein. Consequently, it is not always possible to make detailed 
conclusions about conformational flexibility in proteins from experimental data alone (Brooks 
III, Karplus et al. 1988; Voet and Voet 2004; Nelson and Cox 2005). 
Given these observations, it is likely that crystallographic structures of collagen-like 
peptides within the structural database do not fully capture the extent of conformational 
flexibility in the vicinity of the collagenases cleavage site. This is especially poignant given that 
crystal structures of collagen like-peptides are obtained under conditions that dramatically differ 
from physiologic states (Kramer, Bella et al. 1999). A number of experimental studies suggest 
that this may in fact be the case (Fiori, Sacca et al. 2002; Sacca, Fiori et al. 2003; Brodsky and 
Persikov 2005). While NMR and gross structural experiments have implied that collagen may be 
flexible in some areas, they provide only limited information on the detailed conformational 
changes that are involved. 
In this chapter, detailed molecular simulations on collagen-like peptides that model two 
distinct regions of collagen reveal the necessary structural characteristics that a sequence must 
have to enable degradation to occur. In particular, our data suggest that the amino acid sequence 
near the true collagenase cleavage site is conformationally labile relative to another sequence 
next to a potential cleavage site that is not degraded. Experimentally, the melting temperature for 
IP1 is significantly lower than IP2, a finding which agrees with our observations; i.e., the pmfs 
imply that unfolded states of IP1 are relatively prevalent at temperatures near room temperature 
while IP2 retains a more compact structure at such temperatures. Analyzing the most important 
sequence differences between both peptides, both IP1 and IP2 are relatively imino-poor in 
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content but IP2 has a hydroxyproline residue in its 11th position (Figure 1.1). This likely confers 
extra stability, preventing unfolding near the collagenase cleavage site. These results suggest that 
small variations in sequence next to a cleavage site, especially in the imino acid context, can lead 
to significant differences in stability and conformational dynamics in the neighborhood of the 
cleavage site.   
48 
 
1.4 Methods 
1.4.1 Molecular dynamics simulations 
Dynamical simulations of molecules have a long history. Early atomistic simulations 
were used to calculate scattering trajectories associated with simple chemical reactions 
(Hirschfelder, Eyring et al. 1936). Further applications were focused on hard sphere liquids and 
near ideal gasses (Alder and Wainwright 1959; Rahman 1964). Simulations of protein systems 
first appeared in the early 1970s and demonstrated that previously unappreciated insights into 
protein dynamics could be obtained from detailed simulations of modest length (Levitt and 
Warshel 1975; McCammon, Gelin et al. 1977). Today, molecular dynamics (MD) simulations 
are broadly applied to different proteins to make observations that would otherwise not have 
been possible with standard biochemical experiments (Hansson, Oostenbrink et al. 2002; Karplus 
and McCammon 2002). Next, we briefly outline the main features of a MD simulation and the 
type of data that is needed to generate molecular trajectories. 
1.4.1.1 The initial model 
The first step in simulating a molecular system is to obtain an appropriate model of the 
system of interest. Many types of models exist to represent a biomolecular system, ranging from 
the very detailed, which model subatomic particles, to the very simplified which represent 
groups of atoms as single spheres. In the present case, we model atoms in the molecule as points 
in space. Each atom has an associated mass and an associated partial charge. As the 
computational cost of the simulation is directly related to the number of atoms that are explicitly 
modeled, we only model heavy atoms (e.g., C, N, O, and S) and atoms which are covalently 
bonded to the electronegative atoms N, O and S. In other words, hydrogen atoms that are bound 
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to carbon atoms (also known as non-polar hydrogens) are not explicitly represented. Instead, 
hydrogen-carbon clusters are represented by a single point. The mass and van der Waals radius 
of these points is adjusted to include both the mass and van der Waals radius of a carbon atom 
and the bonded hydrogen atoms. This representation is referred to as a polar hydrogen set. Its 
main advantage is that it reduces the number of atoms that need to be explicitly simulated, 
thereby reducing the computational cost.  Nevertheless, the model explicitly represents hydrogen 
atoms that can engage in non-covalent hydrogen bonds.   
In order to perform a molecular dynamics simulation, the three dimensional coordinates 
of the atoms of the system must be known. They are usually obtained from structures determined 
by x-ray crystallography, and less often by nuclear magnetic resonance (NMR), and can be found 
in the Protein Data Bank repository (www.pdb.org). As hydrogen atoms are typically not seen in 
x-ray crystallographic structures, the position of polar hydrogens must be inferred from the 
coordinates of the heavy atoms that they are bound to. Once the positions of all relevant atoms 
are known, the system can be solvated to model the surrounding environment of the protein. In 
this work, we use an explicit model of water where each water molecule contains an oxygen 
atom bonded to two hydrogen atoms.    
1.4.1.2 The potential energy function 
At the heart of all molecular dynamics simulations is the potential energy function. Once 
a potential energy function is defined for any given protein conformation, then trajectories can be 
calculated using the corresponding Euler-Lagrange equation. 
  The potential energy function can be divided into interactions between atoms that are 
connected through covalent bonds and interactions between atoms that are separated by 4 or 
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more covalent bonds. The latter set of interactions is often referred to as non-bonded 
interactions:  
 𝑉𝑉 = 𝑉𝑉𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 + 𝑉𝑉𝐵𝐵𝐵𝐵𝐵𝐵−𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵  (1.1)  
 
Figure 1.5. Potential energy interactions. A) Interactions between atoms connected by covalent 
bonds in a Glutamate-Alanine-Lysine tripeptide which are included in typical potential energy 
models. In glutamate (red), two atoms represented by red dots are connected by a bond. In 
alanine (blue), three atoms represented by blue dots form an angle.  In lysine (green), four atoms 
represented by green dots define a dihedral angle. Also, non-bonded interactions between circled 
atoms, separated by more than 3 covalent bonds, are shown. B) Schematic representation of a 
dihedral angle. It is defined by the angle between the plane formed by atoms 1, 2 and 3 (red 
plane), and the plane formed by atoms 2, 3 and 4 (blue plane). 
 
Bonded interactions are associated with atoms that are connected through covalent bonds 
(
Bonded interactions 
Figure 1.5).  They can be subdivided as follows:  
 𝑉𝑉𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 (𝑟𝑟1, . . . , 𝑟𝑟𝐵𝐵−1,𝜃𝜃1, . . . ,𝜃𝜃𝐵𝐵−2,𝜑𝜑1, . . . ,𝜑𝜑𝐵𝐵−3)= 𝑉𝑉𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵      (𝑟𝑟1, . . . , 𝑟𝑟𝐵𝐵−1) + 𝑉𝑉𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝐵𝐵      (𝜃𝜃1, . . . ,𝜃𝜃𝐵𝐵−2)+ 𝑉𝑉𝐵𝐵𝐷𝐷𝐷𝐷𝐵𝐵𝐵𝐵𝐷𝐷𝐴𝐴𝐴𝐴 (𝜙𝜙1, . . . ,𝜙𝜙𝐵𝐵−3) 
(1.2)  
B) A) 
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where 𝑟𝑟1, . . . , 𝑟𝑟𝐵𝐵−1 denotes the distances corresponding to the N-1 bonds in the system (where N 
is the number of atoms in the protein), respectively. Similarly, 𝜃𝜃1, . . . , 𝜃𝜃𝐵𝐵−2 and 𝜙𝜙1, . . . ,𝜙𝜙𝐵𝐵−3  
denote the N-2 bond angles and N-3 dihedral angles in the system, respectively. For simplicity 
we express the potential energy as a function of the internal coordinates of the system (e.g., atom 
distances, bond angle measurements, etc.) instead of the Cartesian coordinates. We recognize, 
however, that all of these equations could be written in terms of the more traditional Cartesian 
coordinates without loss of generality.  
The bond stretching term models the energy associated with small vibrations about 
covalent bonds.  Typically this term is modeled with a harmonic function of the form:  
  𝑉𝑉𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵(𝑟𝑟𝑖𝑖) = �𝐾𝐾𝑏𝑏 ,𝑖𝑖�𝑟𝑟𝑖𝑖 − 𝑟𝑟𝑖𝑖𝑒𝑒𝑒𝑒 �2
𝑖𝑖
 (1.3)  
where 𝑟𝑟𝑖𝑖
𝑒𝑒𝑒𝑒  is the equilibrium bond length of the ith bond and 𝐾𝐾𝑏𝑏 ,𝑖𝑖  is the force constant for the ith 
bond. Force constants and equilibrium bond lengths are chosen to agree with data obtained from 
x-ray crystallography and infra-red spectroscopy.   
The energetic contribution associated with bending the bond angle is also expressed as a 
simple harmonic function:   
  𝑉𝑉𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝐵𝐵 (𝜃𝜃𝑖𝑖) = � 𝐾𝐾𝜃𝜃 ,𝑖𝑖�𝜃𝜃𝑖𝑖 − 𝜃𝜃𝑖𝑖𝑒𝑒𝑒𝑒 �2
𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝐵𝐵𝑆𝑆
 (1.4)  
where 𝜃𝜃𝑖𝑖
𝑒𝑒𝑒𝑒  is the equilibrium angle of the ith angle and 𝐾𝐾𝜃𝜃 ,𝑖𝑖  is the force constant for the ith angle. 
Rotation about dihedral angles is the only bonded term that is not modeled by a harmonic 
function:  
  𝑉𝑉𝐵𝐵𝐷𝐷𝐷𝐷𝐵𝐵𝐵𝐵𝐷𝐷𝐴𝐴𝐴𝐴 (𝜑𝜑𝑖𝑖) = � 𝐾𝐾𝜑𝜑 ,𝑖𝑖�1 + 𝑐𝑐𝑐𝑐𝑐𝑐(𝑛𝑛𝜙𝜙𝑖𝑖 − 𝛿𝛿)�
𝐵𝐵𝐷𝐷𝐷𝐷𝐵𝐵𝐵𝐵𝐷𝐷𝐴𝐴𝐴𝐴𝑆𝑆
 (1.5)  
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where 𝐾𝐾𝜑𝜑 ,𝑖𝑖  is force constant, n the multiplicity of that function, and 𝛿𝛿 is the phase shift. A 
sinusoidal function is appropriate here because the dihedral energy can have several local energy 
minima. 
 
The energetic contribution for non-bonded interactions (
Non-bonded interactions 
Figure 1.5 A) can be subdivided 
into an electrostatic contribution and a van der Waals (vdW) contribution, Equation (1.6):  
 
  
𝑉𝑉𝐵𝐵𝐵𝐵𝐵𝐵−𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 �𝑟𝑟𝑖𝑖𝑖𝑖 � = 𝑉𝑉𝑣𝑣𝑣𝑣𝑣𝑣�𝑟𝑟𝑖𝑖𝑖𝑖 � + 𝑉𝑉𝐵𝐵𝐴𝐴𝐵𝐵𝐸𝐸�𝑟𝑟𝑖𝑖𝑖𝑖 � (1.6)  
where 𝑟𝑟𝑖𝑖𝑖𝑖  is the distance between non-bonded atoms i and j.    
The electrostatic contribution is the familiar Coulombic interaction term: 
  
𝑉𝑉𝐵𝐵𝐴𝐴𝐵𝐵𝐸𝐸�𝑟𝑟𝑖𝑖𝑖𝑖 � = �𝑄𝑄𝑖𝑖𝑄𝑄𝑖𝑖𝐵𝐵𝑟𝑟𝑖𝑖𝑖𝑖𝑖𝑖 ,𝑖𝑖  (1.7)  
where 𝑄𝑄𝑖𝑖  and 𝑄𝑄𝑖𝑖  are the charges on atoms i and j, respectively, and D is the dielectric constant of 
the surrounding medium (typically set to 1 when explicit solvent is used in the simulations). At 
the beginning of the simulations, each atom in the protein of interest is assigned a partial atomic 
charge based on detailed quantum mechanical calculations on model systems, which is used for 
all subsequent electrostatic calculations.  
The vdW term models the interaction that arises from dispersion forces associated with 
all atomic interactions. The equation follows the so-called 6-12 potential, describing the Lenard-
Jones potential energy:  
  
𝑉𝑉𝑣𝑣𝑣𝑣𝑣𝑣�𝑟𝑟𝑖𝑖𝑖𝑖 � = �𝜀𝜀𝑖𝑖𝑖𝑖 ��𝐴𝐴𝑖𝑖𝑖𝑖𝑟𝑟𝑖𝑖𝑖𝑖 �12 − �𝐴𝐴𝑖𝑖𝑖𝑖𝑟𝑟𝑖𝑖𝑖𝑖 �6�𝑖𝑖 ,𝑖𝑖  (1.8)  
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where 𝜀𝜀𝑖𝑖𝑖𝑖  determines the well depth and 𝐴𝐴𝑖𝑖𝑖𝑖  determines the “vdW radius”; i.e., the distance 
where the vdW energy starts to precipitously increase. In the absence of any other outside forces, 
two atoms generally do not get closer than their vdW radii. 
1.4.1.3 Integrating the Equations of Motion 
Once the potential energy of the system is specified, Newton’s equations of motion are 
obtained by applying the Euler-Lagrange equation.  The result is that the force on any atom is a 
function of the derivative of the potential energy:  
 
  
−
𝑣𝑣𝑉𝑉
𝑣𝑣𝑒𝑒𝑖𝑖
= 𝑚𝑚𝑖𝑖?̈?𝑒𝑖𝑖 = 𝐹𝐹𝑖𝑖  (1.9)  
where 𝑒𝑒𝑖𝑖  denotes the Cartesian coordinates of the system, ?̈?𝑒𝑖𝑖  denotes the 3N accelerations, and 
𝐹𝐹𝑖𝑖  is the force associated with the ith degree of freedom.  At any given time, the force can be 
calculated from the derivative of the potential. Once the force is known, the velocity, ?̇?𝑒𝑖𝑖 , of each 
atom can be obtained after some small time step: 
  ?̇?𝑒𝑖𝑖(𝑡𝑡 + ∆𝑡𝑡) = ?̇?𝑒𝑖𝑖(𝑡𝑡) + ?̈?𝑒𝑖𝑖(𝑡𝑡)∆𝑡𝑡 + 𝐵𝐵∆𝑡𝑡2 (1.10)  
Similarly, once the velocity is known, the positions can be calculated as follows: 
 
  
𝑒𝑒𝑖𝑖(𝑡𝑡 + ∆𝑡𝑡) = 𝑒𝑒𝑖𝑖(𝑡𝑡) + ?̇?𝑒𝑖𝑖(𝑡𝑡)∆𝑡𝑡 + 12 ?̈?𝑒𝑖𝑖(𝑡𝑡)∆𝑡𝑡2 + 𝐵𝐵∆𝑡𝑡3 (1.11)  
In order to use Equations (1.10) and (1.11), one must have an initial set of Cartesian 
coordinates for all atoms in the system and an initial set of atomic velocities. The initial 
Cartesian coordinates can be obtained from the x-ray crystal structure and the initial velocities 
are assigned to the protein to ensure that the system is at some pre-specified temperature. 
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1.4.2 Potential of mean force calculations 
All molecular dynamics simulations are performed with potential energy function within 
the program CHARMM (Chemistry at HARvard Molecular Mechanics) (Brooks III, Bruccoleri 
et al. 1983). All peptides are constructed using the polar hydrogen set, as previously described. 
Molecular dynamics for IP1 are performed in a previous work (Stultz 2002) and in this work the 
data is just reanalyzed. Molecular dynamics simulations for IP2 are carried out using the same 
reported methodology (Stultz 2002), with a few modifications. As a crystallographically 
determined structure of IP2 is not available, we model the mutant structure by substituting key 
amino acids in the T3-785 structure with residues found in IP2. This approach is appropriate 
because crystallographic structures of collagen-like peptides with distinct sequences have been 
shown to adopt triple-helical structures. Subtle variations arise in the side-chain packing and the 
helical twist - variations that, in principle, can be captured using the molecular modeling 
techniques mentioned below. For both IP1 and IP2, the system is solvated using a sphere of 20Å 
of diameter of explicit water molecules. Simulations are performed at radius of gyration (γ) 
values ranging from 17.7 to 19.5Å, with increments of 0.1Å, starting at the value for the initial 
structure (18.5Å), and proceeding in the forward and reverse directions. The radius of gyration γ 
is calculated for the backbone atoms of chain A of each peptide within the reaction region, and 
corresponds to: 
 
𝛾𝛾 = �∑ 𝑚𝑚𝑖𝑖𝐷𝐷𝑖𝑖2𝐵𝐵𝑖𝑖=1
∑ 𝑚𝑚𝑖𝑖
𝐵𝐵
𝑖𝑖=1  (1.12)  
where  𝑚𝑚𝑖𝑖  is the mass of a given atom and 𝐷𝐷𝑖𝑖  is the distance of such atom to the center of mass. 
 
55 
 
Each simulation is 50ps in length, with a time step of 1 femtosecond, where the first 20ps 
are considered equilibration and the last 30ps are the production time. During the production 
time, 3000 values of the radius of gyration are collected in order to create a histogram of values 
of γ at that simulation window. From the histogram, the biased probability for a given window 
can be calculated, by dividing the number of occurrences of a certain bin of the histogram over 
the 3000 values collected. This local biased probability distribution can be unbiased following 
the procedure explained in the next section. 
Simulations are performed using a stochastic boundary approach as previously described 
(Stultz 2002). Stochastic boundary methods limit the computational requirements of the system 
by only simulating a relatively small region within the protein of interest (Figure 1.6) (Brooks III 
and Karplus 1983; Brooks III, Brunger et al. 1985). Regions that fall outside of the simulated 
area are retained in the computation but do not undergo full molecular dynamics. Instead they are 
restrained to adopt conformations that are near the crystallographic coordinates. 
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Figure 1.6. The stochastic boundary method (Brooks III and Karplus 1983; Brooks III, Brunger 
et al. 1985) applied to a collagen-like peptide. The reaction region undergoes full molecular 
dynamics. The portion of the protein that falls within this sphere is exposed to water molecules at 
a density near that found in physiologic systems. Waters are kept within the reaction region using 
a stochastic boundary potential. The two restrained regions do not undergo molecular dynamics 
and are not solvated. This figure has been created with the molecular visualization package 
VMD (Humphrey, Dalke et al. 1996). 
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1.4.3 Obtaining an unbiased potential of mean force from a biased simulation 
We start by defining the probability distribution for a given window as a function of the 
reaction coordinate γ, in this case the radius of gyration of the chain A within the reaction region. 
 
𝑝𝑝𝑖𝑖(𝛾𝛾) = ∫ 𝑒𝑒−𝛽𝛽𝑈𝑈𝑖𝑖(𝛾𝛾 ,𝜉𝜉)𝑣𝑣𝜉𝜉𝑧𝑧  (1.13)  
where 𝛽𝛽 = 1
𝑘𝑘𝐵𝐵𝑇𝑇
 and kB is the Boltzmann’s constant, T is the temperature in degrees Kelvin, z is 
the partition function of the system and 𝑈𝑈𝑖𝑖(𝛾𝛾, 𝜉𝜉) is the potential energy as a function of the radius 
of gyration and the Cartesian coordinates 𝜉𝜉. 
The sampling of different values of radius of gyration is ensured by introducing a biasing 
energy term that forces the system to sample conformation around a given value of radius of 
gyration. Starting at the equilibrated value of radius of gyration, this is increased or decreased by 
increments of 0.1Å, using the following expression: 
 𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾) = 𝐴𝐴(𝛾𝛾 − 𝛾𝛾𝑖𝑖)2 (1.14)  
where γ is the value of radius of gyration that the system takes at a given time of the simulation, 
γi is the reference value to which the a given window is biased and A is the force constant of the 
bias, in this case 500 kcal/Å2. Therefore, the effective potential energy for that is used to simulate 
a window is given by the sum: 
 𝑈𝑈𝑖𝑖(𝛾𝛾, 𝜉𝜉) + 𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾) (1.15)  
From each window, we obtain the biased probability distribution as a function of γ: 
 
𝑝𝑝𝑖𝑖
∗(𝛾𝛾) = ∫ 𝑒𝑒−𝛽𝛽�𝑈𝑈𝑖𝑖(𝛾𝛾 ,𝜉𝜉)+𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾)�𝑣𝑣𝜉𝜉
𝑧𝑧∗
 (1.16)  
where z* is the biased partition function. If we now multiply and divide by the partition function 
z (multiplying by 1) we obtain: 
58 
 
 
𝑝𝑝𝑖𝑖
∗(𝛾𝛾) = ∫ 𝑒𝑒−𝛽𝛽�𝑈𝑈𝑖𝑖(𝛾𝛾 ,𝜉𝜉)+𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾)�𝑣𝑣𝜉𝜉
𝑧𝑧∗
∙
𝑧𝑧
𝑧𝑧
 (1.17)  
 
Rearranging terms we obtain: 
 
𝑝𝑝𝑖𝑖
∗(𝛾𝛾) = ∫ 𝑒𝑒−𝛽𝛽�𝑈𝑈𝑖𝑖(𝛾𝛾 ,𝜉𝜉)+𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾)�𝑣𝑣𝜉𝜉
𝑧𝑧∗
∙
𝑧𝑧
𝑧𝑧
= ∫ 𝑒𝑒−𝛽𝛽�𝑈𝑈𝑖𝑖(𝛾𝛾 ,𝜉𝜉)�𝑣𝑣𝜉𝜉 ∙ 𝑒𝑒−𝛽𝛽�𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾)�
𝑧𝑧∗
∙
𝑧𝑧
𝑧𝑧
= ∫ 𝑒𝑒−𝛽𝛽�𝑈𝑈𝑖𝑖(𝛾𝛾 ,𝜉𝜉)�𝑣𝑣𝜉𝜉
𝑧𝑧
∙
𝑧𝑧
𝑧𝑧∗
∙ 𝑒𝑒−𝛽𝛽𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾)
= 𝑝𝑝𝑖𝑖(𝛾𝛾) ∙ 𝑧𝑧𝑧𝑧∗ ∙ 𝑒𝑒−𝛽𝛽𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾) = 𝑝𝑝𝑖𝑖∗(𝛾𝛾) 
(1.18)  
Isolating the unbiased probability we obtain: 
 
𝑝𝑝𝑖𝑖(𝛾𝛾) = 𝑝𝑝𝑖𝑖∗(𝛾𝛾) ∙ 𝑧𝑧∗𝑧𝑧 ∙ 𝑒𝑒𝛽𝛽𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾) (1.19)  
which relates the unbiased probability with the biased probability. The ratio of partition functions 
is just a number that can be adjusted to allow the data from different simulations to match, and 
can be expressed as 𝑧𝑧
∗
𝑧𝑧
= 𝑒𝑒−𝛽𝛽𝐹𝐹𝑖𝑖 , where the 𝐹𝐹𝑖𝑖  constants can be determined using the SPLICE 
method (Stultz 2002), or the weighted histogram analysis method in Chapter 2. If we take 
logarithms on both sides of the previous relation, we obtain the free energy Wi as a function of γ. 
 𝑣𝑣𝑖𝑖(𝛾𝛾) = −𝑘𝑘𝐵𝐵𝑇𝑇𝑇𝑇𝑛𝑛�𝑝𝑝𝑖𝑖(𝛾𝛾)�𝑖𝑖  (1.20)  
 𝑣𝑣𝑖𝑖(𝛾𝛾) = −𝑘𝑘𝐵𝐵𝑇𝑇𝑇𝑇𝑛𝑛�𝑝𝑝𝑖𝑖∗(𝛾𝛾) ∙ 𝑒𝑒−𝛽𝛽𝐹𝐹𝑖𝑖 ∙ 𝑒𝑒𝛽𝛽𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾)�= −𝑘𝑘𝐵𝐵𝑇𝑇𝑇𝑇𝑛𝑛�𝑝𝑝𝑖𝑖∗(𝛾𝛾)� − 𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑐𝑐 ,𝑖𝑖(𝛾𝛾) + 𝐹𝐹𝑖𝑖  (1.21)  
In short, in the SPLICE method, the overlap between the unbiased probability distribution 
of two contiguous windows is found. Next, the slopes in the overlap region are compared, and 
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the two distributions are pieced together where the slopes match the best. In order to piece the 
two fragments of pmf together, one of the pieces is arbitrarily shifted in order to bring it close to 
the other piece. This is equivalent to adjusting the constant 𝐹𝐹𝑖𝑖 . This method is repeated until all 
the windows have been matched together. 
1.4.4 Flexibility calculations 
The conformational flexibility of sequence in solution, is related to the configurational 
entropy of the peptide as follows (McQuarrie 2000):  
 
𝑆𝑆 = −𝑘𝑘𝐵𝐵𝑇𝑇� 𝑝𝑝(𝛾𝛾)𝑇𝑇𝑐𝑐𝑙𝑙�𝑝𝑝(𝛾𝛾)�𝑣𝑣𝛾𝛾𝛾𝛾𝑚𝑚𝑏𝑏𝑚𝑚
𝛾𝛾𝑚𝑚𝑖𝑖𝑛𝑛
 (1.22)  
where kB is the Boltzmann constant, T the temperature and p the probability density described in 
Equation (1.23).  
 
  
𝑝𝑝(𝛾𝛾) = 𝑒𝑒−𝛽𝛽𝑣𝑣(𝛾𝛾)
∫ 𝑒𝑒−𝛽𝛽𝑣𝑣 (𝛾𝛾′)𝑣𝑣𝛾𝛾𝛾𝛾𝑚𝑚𝑏𝑏𝑚𝑚𝛾𝛾𝑚𝑚𝑖𝑖𝑛𝑛 ′ (1.23)  
where β is 1/kBT, 𝑣𝑣(𝛾𝛾) is the pmf for a given sequence and γmin and γmax denote values of the 
reaction coordinate where the overall probability falls below 10-6.  
1.4.5 Peptide preparation 
Two collagen-like peptides are studied in this work: A) T3-785, which models the imino-
poor segment next to the actual cleavage site in type III collagen, which we refer to as peptide 
IP1, and B) an imino-poor segment next to a potential cleavage site in type III collagen, with 
similar sequence to IP1. We refer to the latter as peptide IP2. The sequences for the two peptides 
are shown in Figure 1.1. Both peptides contain multiple POG repeats to ensure that they will fold 
into a triple helix. 
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All peptides are obtained to >95% purity from Genemed Synthesis. Peptides are received 
as a lyophilized powder and are then resuspended in phosphate buffered saline (PBS) to a final 
concentration of 10mg/ml and allowed to sit for at least 24 hours at 4ºC prior to any experiments. 
Samples are then stored at -80ºC until experiments could be performed. 
1.4.6 Circular dichroism 
Circular dichroism (CD) spectroscopy is based on the differential absorption of circularly 
polarized light by the peptide bonds in a protein. CD experiments have been successfully used to 
gain insights into the overall conformation of proteins (Kelly, Jess et al. 2005). As the CD 
spectrum of fully folded collagen has a unique shape, CD spectroscopy of collagen and collagen-
like peptides can be used to screen proteins and peptides for the presence of triple-helical 
structure (Bhatnagar and Cough 1996). All CD spectroscopic measurements are obtained with a 
Jasco J-810 spectropolarimeter. Compressed nitrogen is used to minimize the amount of air in 
the sample chamber during the experiments, as air interferes with spectral readings at low 
wavelengths (Venyaminov and Yang 1996).  
1.4.7 Peptide melting point and melting curve determination 
Peptide samples are thawed by storing them at 4ºC for 24h. Melting curves and melting 
temperatures are obtained by heating the peptide of interest at distinct heating rates (3, 4, 10, and 
15ºC/h). Heating begins with the sample at a temperature of 4ºC and ends at a temperature of 
50ºC, with two repetitions in each case. The ellipticity value at the wavelength of 225nm is 
chosen to monitor the structural change in the peptide during the melting experiment. This value 
corresponds to the maximum in CD spectra of a triple helical structure (in the range 190-240nm 
(Bhatnagar and Cough 1996)). Measurements are made using a peptide concentration of 1mg/ml. 
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The raw output measures the ellipticity in mili-degrees at a given wavelength, which is then 
converted to the standard circular dichroism units of molar ellipticity per residue - a function of 
sample concentration, peptide molecular weight, cell cuvette length, peptide residue length, and 
the ellipticity in milli-degrees (Venyaminov and Yang 1996). To obtain the melting point as a 
function of the heating rate, we fit each melting curve to the sigmoidal function:  
  
 
𝑓𝑓(𝑇𝑇) = 𝐴𝐴 � 11 + 𝑒𝑒𝐵𝐵(𝑇𝑇−𝑇𝑇𝑚𝑚 )� (1.24)  
 
where Tm is the melting temperature and A, B and C are constants.  
We would ideally like to obtain the melting temperature of the protein at a heating rate 
near 0ºC/h; i.e., when the protein is heated infinitely slowly. Consequently, the different melting 
curves, obtained at distinct heating rates, are used to estimate the melting curve at a heating rate 
of 0ºC/h. Data at each temperature interval (separated by 0.1ºC increments) for the different 
melting curves (recorded at different heating rates) is extrapolated as well to a heating rate of 
0ºC/h.  
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Chapter 2: 
Characterizing the Conformational 
Ensemble of Collagen Cleavage Sites 
 
Chapter 2 is adapted from: Salsas-Escat, R. and Stultz C.M. (2010). "Conformational selection 
and collagenolysis in type III collagen." Proteins
 
 78(2): 325-35. 
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2.1 Introduction 
In collagen degradation, in order for peptide bond hydrolysis to occur at one unique site, 
MMPs must: 1) localize to a region in the vicinity of the unique scissile bond; 2) bind residues 
that comprise the scissile bond at the catalytic site; and 3) hydrolyze the corresponding peptide 
bond. Recent studies suggest that for some collagen types, localization to the unique cleavage 
site is mediated by the binding of non-catalytic MMP domains (e.g., the hemopexin-like domain) 
to specific amino acid sequences near the actual cleavage site (Perumal, Antipova et al. 2008; 
Erat, Slatter et al. 2009). For example, in type I collagen, a short stretch of 4 residues (RGER) 
downstream from the actual cleavage site has been implicated as a true binding site for such non-
catalytic domains (Perumal, Antipova et al. 2008; Erat, Slatter et al. 2009).  
Once the enzyme is localized to a region near the scissile bond, the catalytic domain must 
then bind the residues that contain the peptide bond to be hydrolyzed. Even if the localization 
step was the sole responsible for cleavage specificity, there is still the problem that the triple 
helix does not fit in to the active site of the collagenase. Here, we focus on the second step in the 
degradation process. In particular, we wish to determine whether unfolded states exist at the 
collagenase cleavage site and if binding of the catalytic domain to these states plays any role in 
determining MMP cleavage site specificity. The precise question we address is: if one could 
localize an MMP near each potential cleavage site, could the catalytic domain then bind the 
corresponding scissile bond without the need of active unwinding of the collagen triple helix?  
In this thesis we hypothesize that naturally occurring locally unfolded allow collagen 
degradation to occur. The nature of such locally unfolded states may be a function of the 
sequence surrounding each potential cleavage site, making some of them suitable for binding and 
degradation, while others not. In Chapter 1, we demonstrate that the sequence C-terminal to two 
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cleavage sites has an influence on the structural characteristics of the locally unfolded states 
occurring next to such cleavage sites. While these results are interesting, they present several 
limitations. Mainly, the studied sequences do not include the actual cleavage site. This is due to 
the fact that IP1 (T3-785) was designed without the cleavage site (Kramer, Bella et al. 2001). 
Second, they ignore the effect of the sequence N-terminal to the cleavage site. An third, only two 
sequences are compared. In favor of those sequences though, they can easily be studied 
experimentally since they are embedded between POG repeats that allow them to fold in 
solution. Adding the cleavage site itself and the sequence N-terminal to it may complicate 
possible experiments, i.e., the longer the peptide is the harder it will be to fold and more POG 
repeats will be needed at both ends of the peptide. However, from a computational point of view, 
adding more amino acids to the system only results in longer simulation times, which can be 
assumed by using more computer time. For this reason, a more complete computational study of 
the influence of sequence on the nature of locally unfolded states is presented here in Chapter 2. 
In particular, several potential cleavage sites are studied in peptides that include the cleavage 
sites themselves surrounded by their upstream and downstream amino acid sequences. 
To assess the ability of different potential cleavage sites to adopt locally unfolded states 
that are amenable to binding by the MMP catalytic domain, we compute the conformational free 
energy surface of amino acid sequences near each potential cleavage site in type III collagen 
using detailed molecular simulations. The goal in Chapter 2 is to characterize the conformational 
states that the different potential cleavage sites sample, as a function of their surrounding 
sequence. The goal in Chapter 3 is to determine whether the binding of the catalytic domain of 
collagenases to these unfolded states is sufficient to explain cleavage site specificity. 
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2.2 Results 
2.2.1 Free energy profiles of potential cleavage sites in type III collagen 
We begin by mapping the free energy landscape of regions that contain potential 
cleavage sites in type III collagen. As type III collagen only contains a relatively small number 
(5) of potential cleavage sites (type I has 8 and type II has 6) this helps to ensure that we are able 
to fully map the free energy landscape of all potential cleavage sites in a reasonable amount of 
CPU time (Seyer and Kang 1981; Cheah, Stoker et al. 1985; Kuivaniemi, Tromp et al. 1988; 
Tromp, Kuivaniemi et al. 1988; Su, Lee et al. 1989; Peri, Navarro et al. 2003; Mishra, Suresh et 
al. 2006). 
Each of the type III collagen potential cleavage sites, together with their N- and C-
terminal flanking triplets, is shown in Figure 2.1. One sequence is centered about the true 
collagenase cleavage site (S1) while the other sequences (S2-S5) are centered about potential 
cleavage sites that are not degraded. We note that since the true collagenase cleavage site is near 
another potential cleavage site, peptides S1 and S2 contain both the true cleavage site in addition 
to a non-cleaved potential site (Figure 2.1).  
 
Figure 2.1. Sequences corresponding to the 5 potential cleavage sites in type III collagen. The 
true collagenase cleavage site (defined by the triplet GIA) is colored in green, while potential 
cleavage sites (three GLA triplets and one GIA triplet), that are not cleaved, are colored in red. 
The actual scissile bond is depicted with a ~ sign, while the scissile bonds corresponding to 
triplets that are not cleaved are depicted with a * sign. The numbering in parenthesis corresponds 
to the position of the first and last amino acids in the sequence of type III collagen. 
 
S1(757-807):GDA-GQO-GEK-GSO-GAQ-GPO-GAO-GPL-G~IA-GIT-GAR-GLA-GPO-GMO-GPR-GSO-GPQ
S2(766-816):GSO-GAQ-GPO-GAO-GPL-GIA-GIT-GAR-G*LA-GPO-GMO-GPR-GSP-GPQ-GVK-GES-GKO
S3(496-546):GDA-GAO-GAO-GGK-GDA-GAO-GER-GPO-G*LA-GAO-GLR-GGA-GPO-GPE-GGK-GAA-GPO
S4(598-648):GPI-GPO-GPA-GQO-GDK-GEG-GAO-GLO-G*IA-GPR-GSO-GER-GET-GPO-GPA-GFO-GAO
S5(811-861):GES-GKO-GAN-GLS-GER-GPO-GPQ-GLO-G*LA-GTA-GEO-GRD-GNP-GSD-GLO-GRD-GSO
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We compute free energy profiles (also known as potentials of mean force or pmf) for 
unfolding homotrimeric triple-helical structures of peptides S1-S5 at 300K with explicit solvent 
using the radius of gyration as a reaction coordinate (Figure 2.2 A-E). Representative structures 
from local energy minima in each pmf are also shown. The pmf for peptide S1, the true cleavage 
site, contains two minima that have similar energies and representative structures from each 
minimum are partially unfolded in the region that contains the scissile bond (Figure 2.2 A). The 
pmf for peptide S2 is similar to the S1 pmf in that it also has two minima with comparable 
energies (Figure 2.2 B). This result is not surprising since peptides S1 and S2 share 50% of their 
sequence, in particular an imino poor stretch of sequence GIA-GIT-GAR-GLA that is expected 
to form a more labile and mobile triple helix due to the lack of imino acids. This increased 
mobility may allow collagen to sample more states, as reflected in the two energy minima of 
both pmf plots. The rest of potential cleavage sites S3-S5 have pmf plots with only one energy 
minimum (Figure 2.2 C-E). Interestingly, while there is some degree of unfolding in all the 
representative structures from each minimum, the scissile bond itself seems to be relatively 
hidden from solvent in sequences S2-S5 (Figure 2.2 B-E). Moreover, these results differ from the 
pmfs in Chapter 1 in that no well folded triple helices are present in the pmfs of sequences S1-
S5. This may be due to the presence of POG repeats in the peptides from Chapter 1, while the 
peptides studied here only contain their wild type sequences, which contain a smaller number of 
imino acids. 
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Figure 2.2. Potential of mean force (pmf) plots for the five potential cleavage sites in type III 
collagen (sequences listed in Figure 2.1). Representative structures from each energy minima are 
shown. The four atoms comprising the scissile bond (H, N, C and O) are shown in green for the 
true cleavage site and in red for the four potential cleavage sites. 
A) 
B) 
C) 
D) 
E) 
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While these data suggest that each of the potential cleavage sites is locally unfolded in 
the vicinity of the cleavage site, an analysis of representative structures from the low energy 
states of each pmf suggest that the different sequences correspond to distinct unfolded 
ensembles. As the goal of Chapter 2 is to compare and contrast the different structural ensembles 
for each of the potential cleavage sites, it is desirable to develop simple metrics that facilitate the 
comparison of unfolded ensembles at each potential cleavage site. In this regard, for each 
sequence we compute: 1) a Vulnerability Score that quantifies the average scissile bond exposure 
and 2) a Flexibility Score that quantifies the conformational entropy of each sequence. Large 
Vulnerability Scores suggest that the scissile bond is, on average, solvent exposed and 
consequently relatively accessible to collagenases. Similarly, large Flexibility Scores suggest that 
the chain can adopt a relatively large number of conformational states at 300K. It is important to 
note that flexibility and vulnerability are, in principle, distinct concepts. If a sequence adopts 
many different conformations during its biological lifetime, it is by definition flexible, however 
if none of these conformations have solvent exposed scissile bonds, then the sequence will have 
a low Vulnerability Score. Conversely, a sequence that adopts only one state in solution may be 
very vulnerable if this state has an exposed scissile bond. Such a sequence, however, is clearly 
not flexible. Together, the Vulnerability Score and the Flexibility Score constitute a rigorous set 
of metrics that we use to compare different free energy profiles. 
Computed Vulnerability Scores for sequences S1-S5 confirm that the scissile bond site in 
the sequence corresponding to the true collagenase cleavage site has the highest vulnerability 
(Figure 2.3). By contrast, sequences S2-S5 have lower Vulnerability Scores. Taking into account 
that sequences S2-S5 are not cleaved in triple helical collagen, we suggest that vulnerability, i.e. 
the existence of vulnerable locally unfolded states, is a metric that describes whether a cleavage 
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site can be cleaved or not. Calculated Flexibility Scores are listed in Table 2.1. The listed values 
are relative to the Flexibility Score of sequence S1. Sequences S2-S5 all have negative Flexibility 
Scores and are therefore less flexible than sequence S1, which contains the true collagenase 
cleavage site. To put these values into context, we note that a previous estimate of the average 
entropy gain associated with complete unfolding of one amino acid to be 1500 to 1800 
cal/mol/residue at 300K (D'Aquino, Gomez et al. 1996; Privalov and Dragan 2007). Therefore 
the conformational entropy changes listed in Table 2.1 are smaller than the entropy of complete 
unfolding of a single residue; i.e., differences in flexibility between sequences S1-S5 are all quite 
small. This is consistent with the representative structures from the different pmfs in Figure 2.2 
in that the structural differences between sequences are localized to relatively small regions.  
 
Figure 2.3. Vulnerability Score plots for the 5 cleavage sites in type III collagen. Vulnerability 
values are expressed as a percentage, with 100% being the vulnerability of the scissile bond of a 
G-I or G-L dipeptide free in solution. 
 
71 
 
 
 
 
 
 
 
 
 
 
Table 2.1. Entropy values for sequences S1-S5 and mutants S1M1, S1M1e and I785P  
  
Sequence (S)  [F(S) – F(S1)]  
cal/mol at 300K 
S1 0 
S2 -114 
S3 -573 
S4 -363 
S5 -78 
S1M1 -153 
S1M1e -222 
I785P -132 
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2.2.2 The effect of imino acids C-terminal to the S1 cleavage site on sequence 
vulnerability and flexibility 
  It has been previously hypothesized that one of the requirements for a collagenase 
cleavage site to be cleaved is that its C-terminal region must be mostly imino acid free (Fields 
1991). This hypothesis was drawn from the comparison of the C-terminal sequences of true 
cleavage sites versus non degraded cleavage sites, amongst several collagen types and species. 
While these results yielded an interesting insight into the sequence requirements for a cleavage 
site to be amenable to collagenolysis, they didn’t explain the mechanism by which the presence 
of imino acids C-terminal to a cleavage site would abrogate collagenolysis. The results from 
Chapter 1 show that the presence of a hydroxyproline residue in the imino poor sequence C-
terminal to a potential cleavage site, corresponding to sequence S3, limits local unfolding. Since 
the cleavage site is not included in that sequence, it is not clear what the effect would the 
presence of an imino acid have. 
 Interestingly, it has been reported that a type III collagen mutant containing the mutation 
I785P is resistant to collagenolysis when compared to wild type collagen (Williams and Olsen 
2009). This mutation substitutes an isoleucine residue in the adjacent triplet C-terminal to the 
true collagenase cleavage site in sequence S1 for a proline (Figure 2.4 A). When introducing a 
proline residue, type III collagen becomes resistant to cleavage by MMP1 at a 10:1 
collagen:enzyme ratio (Figure 2.4 B). At lower values of collagen:enzyme ratio, like 5:1, some 
degradation of the I785P mutant occurs, while all wild type collagen is degraded (data not 
shown).   
 In order to investigate the cause for the marked resistance to cleavage of the I785P 
mutant, we also perform a potential of mean force simulation of the mutant and compute its 
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Vulnerability Score. The introduction of the proline residue results in a pmf with only one energy 
minimum, as opposed to the two energy minima for sequence S1 (Figure 2.4 C), suggesting that 
the I785P can sample less states than S1. In addition, the Vulnerability Score for the I785P 
mutant is much lower, about 5%, compared to the S1 score, which is above 80% (Figure 2.4 D). 
The mutant I785P is also less flexible than sequence S1 (Table 1). Therefore it is possible to 
explain, under the hypothesis of locally unfolded, vulnerable states, why the I785P mutant is 
cleaved with less efficiency by MMP1. The results suggest that the scissile bond is hindered 
from solvent in the I785P mutant, hence the low Vulnerability Score, which does not allow 
degradation to occur. Together with the previous result in which sequence S1 is the most 
vulnerable of all the wild type sequences, our results on the I785P mutant allow us to draw a 
connection between vulnerability and the possibility of a cleavage site to be degraded. Under the 
hypothesis that locally unfolded states are necessary for collagen degradation to occur, if a 
cleavage site is not vulnerable enough, binding of the catalytic domain will not occur and 
degradation will not proceed. This ultimately implies that vulnerability can be used as a marker 
of degradability at a cleavage site.  
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Figure 2.4. Effect of introducing the I785P mutation in type III collagen. A) Sequence 
corresponding to the S1 cleavage site and its I785P mutant in type III collagen. The true 
collagenase cleavage site (defined by the triplet GIA) is colored in green. The introduced proline 
residue is shown in magenta. B) Degradation of type III collagen, wild type, versus the 
degradation of the I785P mutant by MMP1, 10:1 collagen:enzyme ratio (Williams and Olsen 
2009). In the wild type lane three bands can be seen. The intact α1(III) chain, top band, and the 
characteristic ¾ and ¼ fragments of the α1(III) chain, middle and bottom bands. In the I785P 
lane, only the intact α1(III) chain can be seen. C) Potential of mean force (pmf) plots for the S1 
cleavage site (blue) and its I785P mutant (red). D) Vulnerability Score plots for the S1 cleavage 
site and its I785P mutant. Vulnerability values are expressed as a percentage, with 100% being 
the vulnerability of the scissile bond of a G-I dipeptide free in solution. 
 
  
C) B) D) 
A) 
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2.2.3 The effect of arginine on sequence vulnerability and flexibility 
An early analysis of collagen sequences from different species identified sequence 
properties that are associated with the true collagenase cleavage site. Two important properties 
along these lines include a relatively paucity of imino acids downstream from the cleavage site 
and an arginine residue downstream from the cleavage site (usually in the 5P′  or 8P′  position) 
(Fields 1991). A number of previous studies have demonstrated that the presence of imino acids 
has an influence on the conformational stability of collagen (Li, Fan et al. 1993; Fiori, Sacca et 
al. 2002; Stultz 2002; Nerenberg and Stultz 2008) and in the previous section it has been shown 
to have an effect on the capability of a cleavage site to be degraded. On the other hand, while 
there are data to suggest that arginine residues also confer added stability to the triple-helical 
structure (Persikov, Ramshaw et al. 2000; Persikov, Ramshaw et al. 2000), the structural basis 
underlying any stabilizing effects of arginine has not been fully explored.  
In crystallographic structures of collagen-like peptides, the downstream arginine side 
chain forms a hydrogen bond with a backbone carbonyl from a neighboring chain (Kramer, Bella 
et al. 2001). We hypothesize that this interaction may help to stabilize the downstream triple-
helical structure. To test this, we design a mutant of sequence S1, called S1M1, which contains 
an arginine residue immediately N-terminal to the scissile bond containing triplet (Figure 2.5 A). 
The resulting pmf contains only one energy minimum (Figure 2.5 B). More importantly, the 
calculated Vulnerability Score of the resulting sequence is significantly less than the wild-type 
sequence (Figure 2.5 C), suggesting that arginine residues prevent significant unfolding at the 
cleavage site. Based on the previously proposed predictive power of the Vulnerability Score, we 
hypothesize that mutant S1M1 will be resistant to cleavage. Moreover, the flexibility of the 
mutant sequence is also significantly reduced (Table 2.1).  
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To test whether the formation of a hydrogen bond between this arginine side chain and 
other moieties on adjacent collagen chains is responsible for this change in vulnerability and 
flexibility, we rerun the unfolding simulations for S1M1 with the electrostatic interactions 
between the introduced arginine and the rest of the system turned off (sequence S1M1e, Figure 
2.5 A). The goal is to understand whether electrostatic interactions between the arginine side 
chain and the rest of the protein play an important role in decreasing the vulnerability and 
flexibility of the sequence. While the resulting pmf still contains only one energy minimum 
(Figure 2.5 B), the Vulnerability Score is increased (almost to the value seen in the wild-type 
sequence) when these electrostatic interactions are excluded (Figure 2.5 C). The Flexibility 
Score, however, remains significantly below the corresponding wild-type value (Table 2.1). 
 
Figure 2.5. Effect of introducing an arginine residue N-terminal to the actual cleavage site in S1. 
A) Sequence alignment of the S1 and the S1M1/S1M1e corresponding mutants. The actual type 
III collagen cleavage site is shown in green. The nearby potential cleavage site is shown in red. 
Mutant residue positions are shown in magenta. S1M1 replaces a leucine with an arginine. 
S1M1e has the same mutation, but the electrostatic interactions between the side chain of the 
mutant arginine and other collagen chains are turned off. B) Comparison of the potential of mean 
force plots for S1 and its two mutant sequences. C) Vulnerability Score plot for S1 and its two 
mutant sequences. 
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2.3  Discussion 
Although there are several potential cleavage sites in the sequence of type III collagen, 
only one is cleaved at temperatures below collagen’s melting temperature. Prior attempts to 
understand this phenomenon were based on a comparison of sequences across different species 
and collagen types. While these studies yielded a number of important sequence rules that are 
correlated with the true collagenase cleavage site, they do not immediately make clear how these 
sequence variations translate into the experimentally observed specificity of MMPs (Fields 
1991). The goals of Chapter 2 are to determine whether locally unfolded states exist in collagen, 
to characterize such unfolded states, and to establish whether the nature of these unfolded states 
contributes to MMP cleavage site specificity.  
We begin with an analysis of the conformational free energy landscape of collagen-like 
sequences corresponding to the different potential cleavage sites in type III collagen. Low energy 
states from all five sequences exhibit some degree of partial unfolding. This is to be contrasted 
with prior simulations of imino rich homotrimeric triple-helical peptides that suggest that such 
sequences retain their folded triple-helical structure at 300K (Stultz 2002). Each of the sequences 
under consideration contains a stretch of 2-4 triplets that lack any imino acids. Consequently, the 
finding that these regions adopt structures that differ from the classic triple-helical fold is not 
surprising in light of the fact that each of the 19 imino poor naturally occurring amino acids 
contribute differently to triple-helical stability, where many amino acids can lead to 
destabilization of the helical structure when placed in positions X1 or X2 of G-X1-X2 triplets 
(Persikov, Ramshaw et al. 2000). Moreover, the fact that relatively imino poor regions of 
collagen adopt structures that differ from the prototypical collagen-like fold is consistent with 
other data that imply that there is considerably heterogeneity in triple helix structure and stability 
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along the collagen chain and that this heterogeneity may be important for the interaction of 
collagen with other proteins (Kramer, Bella et al. 1999; Persikov, Ramshaw et al. 2000; Kramer, 
Bella et al. 2001; Sacca, Fiori et al. 2003; Orgel, Irving et al. 2006; Makareeva, Mertz et al. 
2008; Perumal, Antipova et al. 2008; Erat, Slatter et al. 2009). Our results show that, while 
unfolded conformations are present in low energy states of each potential cleavage site, stable 
states of the true cleavage site have the scissile bond in conformations that are the most 
vulnerable and the most flexible. Overall, our data suggest, at least for type III collagen, that 
differences in unfolded ensembles of potential cleavage sites may contribute to MMP specificity. 
In particular, we hypothesize that vulnerability is a marker of degradability at a cleavage site. 
Also, we propose an explanation based on the lack of vulnerable states to account for the 
experimental observation in which a type III mutant incorporating a I785P mutation next to the 
collagenase cleavage site is resistant to cleavage by MMP1 (Williams and Olsen 2009). Imino 
acids like Proline in the X1 position and Hydroxyproline in the X2 position of G-X1-X2 triplets 
have been shown to stabilize the triple helix the most (Persikov, Ramshaw et al. 2000). Since the 
proline residue in I785P is placed in the X1 position two residues C-terminal to the scissile bond, 
it is possible that it stabilizes the triple helix locally, impeding the local unfolding required for 
vulnerable states to occur.  
A limitation of our results is that we focus on a small region of collagen in isolation, as 
opposed to in the fibrillar state. In a recent study, a relatively low resolution fiber diffraction 
structure of a type I collagen fibril was obtained at room temperature (Orgel, Wess et al. 2000; 
Orgel, Miller et al. 2001; Orgel, Irving et al. 2006; Perumal, Antipova et al. 2008). Full length 
porcine MMP1 was then manually docked at the cleavage site of type I collagen (Perumal, 
Antipova et al. 2008). However, chain exposure/dissociation in the fibrillar structure – which is 
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an average x-ray structure – was insufficient to allow the scissile bond to access the active site of 
MMP1 (Perumal, Antipova et al. 2008). This suggests that the region including the true scissile 
bond does not, on average, adopt states that are compatible with the catalytic site. In the same 
study it was also demonstrated that a number of potential cleavage sites in type I collagen, which 
are not cleaved, have similar degrees of chain dissociation from the helix center relative to the 
true cleavage site. 
Unlike type III collagen, type I collagen (the focus of the fibrillar study) contains a 
hydroxyproline residue in the triplet immediately downstream from the scissile bond, which is 
known to stabilize the triple-helical structure (Persikov, Ramshaw et al. 2000; Vitagliano, 
Berisio et al. 2001; Mizuno, Hayashi et al. 2004; Nerenberg and Stultz 2008). Hence our 
observations regarding the accessible states of potential cleavage sites in type III collagen may 
not be directly applicable to other types of collagen. Moreover, the applicability of our results to 
collagen in the fibrillar state remains to be determined. Nevertheless, it is important to note that 
in order to determine whether a potential cleavage site is complementary to a given enzyme 
active site, one must consider all of the thermally accessible states of the system. This is 
particularly true for regions of the protein that are known to be partially unfolded, as such 
regions typically have a wide range of accessible states. For such sequences, an average structure 
may not provide an accurate representation of whether the protein can adopt complementary 
states for any given target (Lange, Lakomek et al. 2008). While our data suggest that all potential 
cleavage sites in type III collagen are similar in that they sample unfolded states, the exact nature 
of the corresponding unfolded ensembles significantly differs in that the true cleavage site 
samples conformations that are more vulnerable and flexible. These findings are in accord with 
other studies on intrinsically disordered proteins that suggest that unfolded states of proteins 
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have their own taxonomy, which is determined by their precise amino acid sequences (Tran, 
Wang et al. 2005; Dunker, Silman et al. 2008; Huang and Stultz 2008; Tran, Mao et al. 2008; 
Huang and Stultz 2009). In other words, not all unfolded states are created equal. 
Lastly we note that the role of arginine residues in collagen degradation has recently been 
a subject of some interest (Perumal, Antipova et al. 2008; Erat, Slatter et al. 2009). Both α1 and 
α2 chains in type I collagen contain a RGER motif 14 residues downstream to the cleavage site. 
NMR and X-Ray crystallography studies have shown that this motif interacts with the 8 and 9 
repeats of fibronectin I (Erat, Slatter et al. 2009). Moreover, docking studies involving MMP1 
and fibrillar type I collagen suggest that this motif interacts with the MMP hemopexin-like 
domain (Perumal, Antipova et al. 2008). An analysis of the docked MMP1 structure points to the 
interaction between the RGER motif and a pocket between modules 3 and 4 of the hemopexin-
like domain and it has been suggested that this interaction may lead to further destabilization of 
the triple helix (Perumal, Antipova et al. 2008). Our data suggest that electrostatic interactions 
between the arginine side chain and backbone moieties on adjacent collagen chains stabilize the 
triple-helical structure. Consequently, interactions between non-catalytic MMP domains and 
arginine residues that disrupt this interaction may lead to further destabilization of the triple-
helical structure, thereby allowing nearby residues to sample non triple-helical states that are 
more compatible with the catalytic site (Perumal, Antipova et al. 2008). In addition, our data 
suggest that the placement of arginine residues themselves may influence stability at the 
cleavage site. The introduction of an arginine residue immediately upstream from the scissile 
bond containing triplet leads to a significant reduction in sequence vulnerability. Our 
calculations suggest that this is due to direct electrostatic interactions between the arginine side 
chain and backbone moieties on adjacent chains. The fact that the flexibility of the chain remains 
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unchanged when these electrostatic interactions are turned off argues that the intrinsic 
conformational preference of the arginine residue restricts collagen’s flexibility.  
In summary, in Chapter 2 we use molecular dynamics simulations to determine that 
locally unfolded states are present at all of the potential cleavage sites in type III collagen. These 
unfolded states are not created equal and differ in terms of vulnerability and flexibility, being the 
actual cleavage site the most vulnerable and flexible. We hypothesize that this combination is 
partly responsible for cleavage specificity at the actual cleavage site. Since it has been 
hypothesized that cleavage site specificity is mediated by binding sites in the hemopexin-like 
domain, Chapter 3 aims to test whether cleavage site specificity can be achieved by the selective 
interaction of the catalytic domain of a collagenase alone and the locally unfolded states 
described here in Chapter 2.  
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2.4 Methods 
2.4.1 Model construction 
The sequences S1 to S5 (Figure 2.1) are obtained from the Human Protein Reference 
Database (Peri, Navarro et al. 2003; Mishra, Suresh et al. 2006). As there are no existing 
structures for most regions of the type III collagen sequence, the triple helical structure of each 
sequence is generated using the THeBuScr (Triple Helical collagen Building Script) tool (Rainey 
and Goh 2004). This approach is appropriate because crystallographic structures of collagen-like 
peptides with distinct sequences have been shown to adopt similar triple-helical structures 
(Brodsky and Persikov 2005). Subtle variations arise in the side-chain orientation and the helical 
twist - variations that, in principle, can be captured using molecular dynamics. Each sequence is 
17 triplets long, centered about the potential cleavage site.  
2.4.1.1 Details of the molecular dynamics simulations 
All molecular dynamics simulations are performed with CHARMM (Brooks III, 
Bruccoleri et al. 1983). The initial structures generated with THeBuScr are imported into 
CHARMM, and the positions of polar hydrogens are determined as previously described 
(Brunger and Karplus 1988). The resulting structure is then energy minimized with 100 steps of 
steepest descent minimization. Each structure is then solvated with a sphere of TIP3P water 
molecules of 30Å radius (for a total of 3245 water molecules). Simulations are performed at 
300K using a stochastic boundary approach (Salsas-Escat and Stultz 2009). The 30Å radius 
contains 7 triplets, centered at the cleavage site. Stochastic boundary methods explicitly simulate 
a relatively small region within the protein of interest (Brooks III and Karplus 1983; Brooks III, 
Brunger et al. 1985). Regions that fall outside of the simulated region (reaction region) are 
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retained in the computation but do not undergo full molecular dynamics. Instead they are 
restrained to adopt conformations that are near their initial coordinates. 
 
Figure 2.6. The stochastic boundary method (Brooks III and Karplus 1983; Brooks III, Brunger 
et al. 1985) applied to a collagen-like peptide from Chapter 2. The reaction region undergoes full 
molecular dynamics. The portion of the protein that falls within this sphere is exposed to water 
molecules at a density near that found in physiologic systems. Waters are kept within the 
reaction region using a stochastic boundary potential. The two restrained regions do not undergo 
molecular dynamics and are not solvated. This figure has been created with molecular 
visualization package VMD (Humphrey, Dalke et al. 1996). 
 
Since we are interested in studying the conformational free energy landscape of regions 
nearby potential scissile bonds as they appear in the full sequence of type III collagen, a 
stochastic boundary method is appropriate. Simulations that do not employ a stochastic boundary 
would explore the conformational free energy landscape of these sequences in isolation. 
However, the isolated S1-S5 sequences likely do not adopt a triple helical fold in isolation at 
300K. Using an online Collagen Peptide Tm Calculator (Persikov, Ramshaw et al. 2005), all of 
these sequences have a negative predicted melting temperature. Since these sequences are 
globally folded in the context of full triple helical collagen, the stochastic boundary method 
allows us to model the local structure of these sequences as they appear within full length 
collagen.  
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The solvated system is equilibrated for 150ps prior to the potential of mean force 
calculations. The potential of mean force is the free energy as a function of a reaction coordinate 
and in this work, the reaction coordinate, γ, corresponds to the radius of gyration of chain A of 
the tripeptide within the reaction region. This radius of gyration has been used as a reaction 
coordinate for unfolding for a number of systems, including collagen, and useful results have 
been obtained (Boczko and Brooks 1995; Brooks 1998; Stultz 2002; Salsas-Escat and Stultz 
2009). The radius of gyration γ corresponds to: 
 
𝛾𝛾 = �∑ 𝑚𝑚𝑖𝑖𝑅𝑅𝑖𝑖2𝑁𝑁𝑖𝑖=1
∑ 𝑚𝑚𝑖𝑖
𝑁𝑁
𝑖𝑖=1  (2.1)  
where  𝑚𝑚𝑖𝑖  is the mass of a given atom and 𝑅𝑅𝑖𝑖  is the distance of such atom to the center of mass. 
The starting γ value for each sequence is determined from the average backbone radius of 
gyration of the non restrained central 7 triplets of each peptide from the last 100ps of 
equilibration. The reaction coordinate is sampled by increments and decrements of 0.1Å, for a 
total of 20 windows for each sequence. Each window is simulated for a total of 50ps long, with 
the last 30ps used for the production dynamics. During production dynamics, radius of gyration 
data is saved each 0.01ps, for a total of 3000 data points per window. Free energy profiles ae 
computed from these data using WHAM (Kumar, Rosenberg et al. 1992; Kumar, Rosenberg et 
al. 1995).  
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2.4.2 Essentials of the WHAM method 
For a description on how to obtain an unbiased potential of mean force from a biased 
simulation, refer to section 1.4.3 in Chapter 1. From the simulations at each window we can 
calculate the biased 𝑝𝑝𝑖𝑖∗(𝛾𝛾) probability and the bias potential 𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑏𝑏 ,𝑖𝑖(𝛾𝛾) is known. The weighted 
histogram analysis method (WHAM) allows to determine the best set of values for 𝐹𝐹𝑖𝑖  (Kumar, 
Rosenberg et al. 1992; Kumar, Rosenberg et al. 1995). 
The two equations of the WHAM method are: 
 
𝑝𝑝(𝛾𝛾) = � 𝑛𝑛𝑖𝑖𝑝𝑝𝑖𝑖∗(𝛾𝛾)
∑ 𝑛𝑛𝑗𝑗 𝑒𝑒
−𝛽𝛽�𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑏𝑏 ,𝑗𝑗 (𝛾𝛾)−𝐹𝐹𝑗𝑗 �𝑁𝑁𝑊𝑊
𝑗𝑗=1
𝑁𝑁𝑊𝑊
𝑖𝑖=1  (2.2)  
 
𝑒𝑒−𝛽𝛽𝐹𝐹𝑖𝑖 = �𝑒𝑒−𝛽𝛽�𝑈𝑈𝑏𝑏𝑖𝑖𝑏𝑏𝑏𝑏 ,𝑗𝑗 (𝛾𝛾)�𝑝𝑝(𝛾𝛾)𝑑𝑑𝛾𝛾 (2.3)  
where 𝑁𝑁𝑊𝑊  is the number of biased simulations and 𝑛𝑛𝑖𝑖  the number of data points for simulation i.  
The WHAM method starts by making a guess for all the 𝐹𝐹𝑖𝑖  in Equation (2.2) and calculate a new 
set of 𝐹𝐹𝑖𝑖  in Equation (2.3). This method is iterated until the root mean square difference between 
successive sets of  𝐹𝐹𝑖𝑖  is less than 10
-6. 
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2.4.3 Vulnerability calculations 
The Vulnerability Score, V, of a given sequence is defined as the average solvent 
accessible surface (SAS) of atoms (H, N, C and O) that form the potential scissile bond in 
question, Equation (2.4), normalized by the maximum value possible of SAS, Equation (2.5): 
  
〈𝑆𝑆𝑆𝑆𝑆𝑆〉 = � 𝑆𝑆𝑆𝑆𝑆𝑆(𝛾𝛾)𝑝𝑝(𝛾𝛾)𝑑𝑑𝛾𝛾𝛾𝛾𝑚𝑚𝑏𝑏𝑚𝑚
𝛾𝛾𝑚𝑚𝑖𝑖𝑛𝑛
 (2.4)  
 
  
𝑉𝑉 ≡
〈𝑆𝑆𝑆𝑆𝑆𝑆〉𝛾𝛾
𝑆𝑆𝑆𝑆𝑆𝑆𝑚𝑚𝑏𝑏𝑚𝑚
∙ 100 (2.5)  
where 𝑆𝑆𝑆𝑆𝑆𝑆(𝛾𝛾) is the solvent accessible surface of the atoms that form the scissile bond in 
structures having a radius of gyration equal to γ , and 𝑝𝑝(𝛾𝛾) is the probability density function 
over γ: 
  
𝑝𝑝(𝛾𝛾) = 𝑒𝑒−𝛽𝛽𝑊𝑊(𝛾𝛾)
∫ 𝑒𝑒−𝛽𝛽𝑊𝑊 (𝛾𝛾′)𝑑𝑑𝛾𝛾𝛾𝛾𝑚𝑚𝑏𝑏𝑚𝑚𝛾𝛾𝑚𝑚𝑖𝑖𝑛𝑛 ′ (2.6)  
where β is 1/kBT, kB is the Boltzmann constant, T is the temperature, 𝑊𝑊(𝛾𝛾) is the pmf for a given 
sequence and γmin and γmax denote values of the reaction coordinate where the overall probability 
falls below 10-6.  
  Calculating a Vulnerability Score entails first calculating the solvent accessible surface 
area for conformations with different radii of gyration. Vulnerability Scores are expressed as a 
percentage of the maximum SAS that a G-I or G-L dipeptide can have in solution. Hence to 
determine the maximum possible vulnerability, we simulate G-I and G-L dipeptides for 150ps at 
300K (50ps equilibration, 100ps production) in a 20Å sphere of water (approximately 1000 
TIP3P water molecules). The N-terminal nitrogen atom is fixed to avoid drifting of the dipeptide 
outside of the water sphere during the simulation. To calculate 𝑆𝑆𝑆𝑆𝑆𝑆𝑚𝑚𝑏𝑏𝑚𝑚  for the reference 
dipeptides, the same algorithm is applied to individual structures resulting from the production 
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dynamics (1000 structures) and computing its average. We ensure that the calculated 
Vulnerability Scores are well converged in a given simulation window (Figure 2.7). 
 
Figure 2.7. Average Vulnerability Score for the windows closest to the energy minima of each 
sequence. 
2.4.4 Flexibility calculations 
The Flexibility Score, F, which quantifies the number of conformational states that the 
sequence can adopt in solution, is related to the configurational entropy of the peptide as follows 
(McQuarrie 2000):  
 
𝐹𝐹 ≡ −𝑘𝑘𝐵𝐵𝑇𝑇� 𝑝𝑝(𝛾𝛾)𝑙𝑙𝑙𝑙𝑙𝑙�𝑝𝑝(𝛾𝛾)�𝑑𝑑𝛾𝛾𝛾𝛾𝑚𝑚𝑏𝑏𝑚𝑚
𝛾𝛾𝑚𝑚𝑖𝑖𝑛𝑛
 (2.7)  
where kB is the Boltzmann constant, T the temperature and p the probability density described in 
Equation (2.6). The limits of integration are the same as those outlined in the Vulnerability 
Score.
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Chapter 3: 
Investigating the Influence of Unfolded 
States on Cleavage Site Specificity  
Chapter 3 is adapted in part from:  
Salsas-Escat, R. and Stultz C.M. (2010). "Conformational selection and collagenolysis in type III 
collagen." Proteins 78(2): 325-35. 
and 
Salsas-Escat, R., Nerenberg, P.S., and Stultz C.M. (2010). "Cleavage Site Specificity and 
Conformational Selection in Type I Collagen Degradation." Biochemistry. Accepted.  
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3.1 Introduction  
In Chapter 2 we determined that locally unfolded states are ubiquitous in type III 
collagen, and that the conformational ensemble at the actual collagenase cleavage site is the most 
vulnerable and flexible. In this section, we want to study whether the binding of the catalytic 
domain to these unfolded states is sufficient to determine cleavage site specificity. That is, even 
in the absence of the hemopexin-like domain, which is believed to encode cleavage site 
specificity (Perumal, Antipova et al. 2008; Erat, Slatter et al. 2009), can we still observe a single 
site cleavage at the actual cleavage site in triple helical collagen?  
In order to investigate this, we first develop a novel rigid body docking method in which 
we dock 300 unfolded structures of each energy minima from Figure 2.2 into the catalytic 
domain of MMP8. The question we try to answer here is very simple. That is, since we have a 
heterogeneous population of unfolded states across the 5 potential cleavage sites, do any of them 
fit well into the active site of a collagenase? In short, we find that the locally unfolded states in 
sequence S1, the actual cleavage site, fit best into the active site of a collagenase. We then 
validate the docking results with the experimental degradation of type III collagen by the 
catalytic domain of MMP8 or MMP1 and observe that single cleavage at the true collagenase 
cleavage site can be obtained by the catalytic domain of MMP8 or MMP1 alone.  
Furthermore, we look to generalize our experimental results for type III collagen to other 
collagen types. As stated in the Introduction chapter of this thesis, a number of experiments have 
explored whether collagen can adopt conformations at low temperatures that could, in principle, 
be recognized and cleaved by proteases. While type III collagen can be cleaved by general 
proteases at temperatures below its melting temperature (Miller, Finch et al. 1976; Wang, Chan 
et al. 1978; Birkedal-Hansen, Taylor et al. 1985), this is not the case for type I collagen. Early 
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experiments incubated type I collagen with trypsin at 25ºC and no collagen degradation was 
observed (Miller, Finch et al. 1976). More recent experiments incubated type I collagen with 
high concentrations of the catalytic domain of MMP8 (CMMP8) at room temperature and, again, 
no degradation was found (Schnierer, Kleine et al. 1993). Similar results have been reported with 
the catalytic domain of MMP1 (CMMP1) (Chung, Dinakarpandian et al. 2004). If the region 
near the collagenase cleavage site is able to spontaneously adopt partially unfolded states in 
solution that can be bound by the collagenase cleavage site, then one would expect incubation of 
the catalytic domain of MMPs with collagen to result in collagenolysis. Since this is not the case, 
it is difficult to reconcile these latter experimental observations with other studies (mentioned in 
the Introduction chapter) that suggest that type I collagen adopts partially unfolded states in the 
vicinity of the cleavage site in solution (Kadler, Hojima et al. 1988; Fiori, Sacca et al. 2002; 
Nerenberg and Stultz 2008). Consequently, these latter degradation experiments support a theory 
where the collagenase cleavage site does not spontaneously adopt partially unfolded states in 
solution (at temperatures below collagen’s melting temperature), and that collagenolysis involves 
active unfolding of the collagen triple helix by MMPs. In this formalism the coordinated action 
of both the catalytic and hemopexin-like MMP domains leads to active unwinding of the triple-
helical structure (Overall 2002; Chung, Dinakarpandian et al. 2004; Tam, Moore et al. 2004; 
Gioia, Monaco et al. 2007). In addition, recent data argues that the hemopexin-like domain may 
also play a role in determining cleavage site specificity by binding to specific secondary sites 
located near the unique collagenase cleavage site (Perumal, Antipova et al. 2008). Hence it has 
been argued that the hemopexin-like domain plays an essential role in both exposing the scissile 
bond and in ensuring that only one potential cleavage site is recognized by the collagenase.  
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In Chapter 3 we demonstrate for the first time that the degradation of type I collagen at 
room temperature - a temperature well below type I collagen’s melting temperature - does not 
require the presence of the MMP hemopexin-like domain. Moreover, peptide bond hydrolysis 
with MMP mutants that contain only the catalytic domain occurs at the unique collagenase 
cleavage site and not at other potential cleavage sites. Thus both peptide bond hydrolysis and 
enzyme specificity are achieved with the catalytic domain alone at room temperature. As full 
length enzyme is thought to be necessary for collagenase-mediated unwinding, our data imply 
that enzyme-mediated unwinding is not required for collagenolysis in vitro. In Appendix 2, we 
analyze our data in light of a conformational selection model where thermal fluctuations at the 
cleavage site cause collagen to adopt unfolded conformations that are complementary to the 
collagenase active site. Overall, our findings suggest that both types I and III collagen can adopt 
locally unfolded states at room temperature and that collagenolysis occurs when collagenases 
cleave these locally unfolded states.  
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3.2 Results  
3.2.1 Binding of potential cleavage sites to the MMP catalytic domain 
To further explore whether the locally unfolded states sampled in the molecular dynamics 
simulations from Chapter 2 are consistent with the MMP catalytic site, we dock representative 
structures from each minimum arising from the various pmfs into the crystallographic structure 
of the MMP catalytic domain. Since there is considerable homology between the catalytic 
domains of different collagenases, we choose the catalytic domain from the crystallographic 
structure in the pdb that is solved to the highest resolution; i.e., MMP8 (PDB ID 2OY4) (Li, 
Brick et al. 1995; Berman, Westbrook et al. 2000; Bertini, Calderone et al. 2006).  
Structures arising from simulations that restrain the triple-helical peptide to adopt a radius 
of gyration consistent with a local energy minimum are individually docked into the MMP8 
binding site. Docking simulations are performed using a harmonic restraining potential that 
biases the rigid backbone of each partially unfolded structure to adopt the backbone position of a 
single stranded collagen-like peptide found in the binding site of a related MMP (Bertini, 
Calderone et al. 2006). Docked structures that have a low rms between the collagen-triple helix 
and the corresponding residues in a bound collagen-like peptide are most complementary to the 
active site (see Methods). 
Figure 3.1 shows the results of the docking simulations. Structures belonging to minima 
S1min1 and S1min2 have the lowest rms differences, suggesting that these structures fit best 
within the MMP8 catalytic site. The complex with the lowest rms deviation arises from 
minimum S1min2 and is shown in Figure 3.2 A. The scissile bond involving the glycine and 
isoleucine residues from the partially unfolded chain fits within the catalytic site and is in close 
proximity to the catalytically essential Zn+2 metal of the active site (Figure 3.2 B); i.e., the 
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carbonyl oxygen from the scissile bond is 2.7Å from the catalytically important Zn+2 ion (Grams, 
Reinemer et al. 1995). Moreover, the side chain of the isoleucine residue in position 1P′  enters 
the hydrophobic 1S ′  site (Bertini, Calderone et al. 2006), and the alanine residue sits in the 
hydrophobic 2S ′  site (Brandstetter, Grams et al. 2001). Finally, the side chain of the leucine 
residue in position P2 is solvent exposed, as is the side chain of an asparagine residue in the 
corresponding position, P2, of the original single stranded peptide used as a reference for docking 
(Bertini, Calderone et al. 2006). This suggests that the identity of the residue in position P2 is not 
critical for binding to CMMP8. These results show that the unfolded states that are most 
vulnerable, corresponding to S1, also fit best into the active site of an MMP. 
 
Figure 3.1. Results of docking studies. RMS values are computed between the backbone atoms 
of the collagen-like peptide in the co-crystal structure of MMP8 and the corresponding backbone 
atoms in the chain A of the triple helical peptide. All 300 structures from each energy minimum 
shown in Figure 2.2 are individually docked into CMMP8. 
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Figure 3.2. Molecular view of the best docking result. A) Overview of the best docked structure 
of S1 into the catalytic site of CMMP8. Chain A, which is unfolded in our simulations, is shown 
in stick representation and carbon atoms colored in green, while chains B and C are colored in 
red. The structure of CMMP8 is transparent. B) The catalytic site of the bound complex with 
chain A present (chains B and C deleted). The catalytically important E198 is shown, together 
with the 3 histidine residues that coordinate the Zn+2 ion. The isoleucine side chain sits in the S1’ 
site, while the alanine side chain sits in the S2’ site. 
 
  
A) 
B) 
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3.2.2 Collagenolysis without a hemopexin-like domain 
In the previous section we show that the catalytic domain of a collagenase binds type III 
collagen at its actual cleavage site forming a complex that fulfills the putative interactions 
necessary for collagen degradation. While these computational results indicate that the local 
unfolding at the S1 site in type III collagen may help select for cleavage at that site and 
determine cleavage site specificity, it is not clear if such complex does occur experimentally. For 
this reason, we want to test, using collagen degradation experiments, whether the interaction 
between the catalytic domain of two collagenases (CMMP8 and CMMP1) and type III collagen 
results in cleavage at a single site like the docking results would suggest. Furthermore we want 
to generalize these results to other collagen types. Since locally unfolded states at the true 
collagenase cleavage site of type I collagen have been described (Nerenberg and Stultz 2008), 
the same type of experiments are carried out with type I collagen against CMMP8 and CMMP1. 
Moreover, these experiments will help us test the predictive power of the two state 
collagen degradation model developed in Appendix 1. In this conformational selection model, 
collagen is able to adopt either a well-folded native triple-helical state or a vulnerable state where 
the region near the collagenase cleavage site is unfolded and solvent exposed (Nerenberg, Salsas-
Escat et al. 2008). MMPs can bind to either state, but collagenolysis only occurs when MMPs 
bind to vulnerable states. The model is based on the premise that collagen adopts different 
conformations in solution and that collagenolysis occurs when the appropriate conformers are 
selected by the enzyme. A re-examination of collagen degradation experiments suggests that the 
failure to observe collagenolysis with MMP deletion mutants, which contain only the catalytic 
domain, is due to the fact that these mutant enzymes bind partially unfolded states of collagen 
with reduced affinity relative to the full length enzyme. A corollary of this result is that 
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collagenolysis could occur if collagen is exposed to relatively high concentrations of mutant 
enzymes and relatively long incubation times are used (Nerenberg, Salsas-Escat et al. 2008). To 
test this, we expose types I and III collagen to both the catalytic domains of MMP8 and MMP1 
(denoted as CMMP8 and CMMP1, respectively) at high concentrations and for relative long 
incubation times. 
3.2.2.1 Type III collagen degradation by CMMP8 and CMMP1 
Human type III collagen expressed in pichia Pastoris, is incubated with high 
concentrations of CMMP1 at room temperature, a temperature below the melting temperature of 
type III collagen (Engel and Bachinger 2000). Figure 3.3 shows the degradation profile of type 
III collagen against the catalytic domain of MMP8 (CMMP8). Similar results are obtained with 
CMMP1 (Figure 3.4). In both figures, degradation of type III collagen by the catalytic domains 
of MMP1 and MMP8 result in the familiar ¾α1(III) and ¼α1(III) fragments that are obtained 
when type III collagen is degraded by a full length collagenase. This shows that type III collagen 
can be cleaved by the catalytic domain of a collagenase alone, validating the results of our 
docking simulation. Moreover, cleavage occurs at the cleavage site S1, suggesting that the 
hemopexin domain is not necessary for cleavage site specificity in vitro at room temperature.  
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Figure 3.3. Degradation profiles of type III collagen at room temperature with CMMP8. Intact 
type III collagen bands α1(III) and α1(III) ¾ and ¼ degradation bands are shown. Lane 1: Type 
III collagen (200µg/ml, 0.66µM). Lanes 2 to 9: Type III collagen (200µg/ml, 0.66µM) incubated 
with the catalytic domain of MMP8 (CMMP8) (33µg/ml, 1.6µM) for 3, 6, 10, 20, 26, 33, 44 and 
48h, respectively.  
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Figure 3.4. Degradation profiles of type III collagen at room temperature with CMMP1. Intact 
type III collagen bands α1(III) and α1(III) ¾ and ¼ degradation bands are shown. Lane 1: Type 
III collagen (200µg/ml, 0.66µM). Lanes 2 to 9: Type III collagen (200µg/ml, 0.66µM) incubated 
with the catalytic domain of MMP8 (CMMP1) (33.3µg/ml, 1.6µM) for 3, 6, 10, 20, 26, 33, 44 
and 48h, respectively. Lane 10: Type III collagen (200µg/ml, 0.66µM) incubated with full length 
MMP1 (FMMP1) (1.7µg/ml, 30nM) for 24h. 
 
3.2.2.2 Type I collagen degradation by CMMP8 and CMMP1 
Bovine type I collagen is incubated with high concentrations of CMMP8 at room 
temperature - a temperature well below the melting temperature of type I collagen (Privalov 
1982; Leikina, Mertts et al. 2002). After 48h type I collagen degradation is observed in solutions 
containing CMMP8 (Figure 3.5 A lanes 1-7). Degradation bands exhibit the familiar the ¾ and ¼ 
fragments that are associated with cleavage at the unique collagenase cleavage site by the wild 
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type collagenase MMP1 (FMMP1, Figure 3.5 A lane 9). N-terminal amino acid sequencing of 
the ¼α1 and ¼α2 bands confirms that the CMMP8 deletion mutant cleaves at the unique 
cleavage site recognized by wild-type enzyme (data not shown). To demonstrate that our results 
are not specific to MMP8, we expose type I collagen to a deletion mutant containing only the 
catalytic domain of MMP1 (Figure 3.5 B lanes 1-5). Despite the fact that higher concentrations 
of enzyme and longer incubation times are used, type I collagen degradation with CMMP1 is 
significantly less efficient than that observed with CMMP8. The ¼ α1 and α2 bands from the 
CMMP1 reaction cannot be sequenced due to the low amount of collagen that is degraded by 
CMMP1. However, the resulting cleavage pattern is the same as that observed with FMMP1 and 
CMMP8. In bovine type I collagen, the closest potential cleavage sites of sequence G-[I/L]-
[A/L] are 48 and 30 residues away from the true cleavage site in the α1 and α2 chains, 
respectively (Fietzek, Rexrodt et al. 1972; Fietzek, Wendt et al. 1972; Rauterberg, Fietzek et al. 
1972; Wendt, von der Mark et al. 1972; Fietzek, Rexrodt et al. 1973; Fietzek and Kuhn 1975; 
Shirai, Hattori et al. 1998). If these potential sites were cleaved, the pattern of fragments 
observed would be significantly different from the FMMP1 control, suggesting that CMMP1 
mediated cleavage, as is the case with CMMP8, occurs at the same site. 
To confirm that our findings are not due to contamination of our collagen samples with 
unfolded type I collagen chains (gelatin), we incubated CMMP8 and CMMP1 with gelatin. Both 
CMMP8 and CMMP1 cleave gelatin at several sites yielding multiple degradation bands on 
SDS-PAGE (Figure 3.5 A lane 8, Figure 3.5 B lane 6) (Welgus, Jeffrey et al. 1982; Chung, 
Dinakarpandian et al. 2004). Since these bands are not seen when CMMP8 and CMMP1 are 
incubated with collagen, contamination of our collagen sample with unfolded collagen chains 
does not explain our results.  
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To further demonstrate that our results cannot be explained by contamination of the 
original collagen sample with low concentrations of full length MMPs, we incubated solutions of 
type I collagen containing 4-aminophenyl mercuric acetate (APMA), to activate any latent 
enzyme, but without any added collagenases. SDS-PAGE of the solutions after 6 days of 
incubation did not exhibit any degradation bands, thereby arguing that contamination with latent 
enzyme does not explain our findings (Figure 3.6 A). Similarly, to rule out the presence of other 
contaminating proteases in our CMMP1 and CMMP8 preparations, we incubated type I collagen 
and gelatin with CMMP1/8 in presence of 50mM EDTA (Figure 3.6 B and C). While EDTA is a 
known inhibitor of collagenases, it does not affect the activity of non-metal-dependent proteases, 
many of which can readily cleave gelatin (Courts 1955; Gendron, Grenier et al. 1999). Figure 3.6 
B shows the result of incubating collagen and CMMP8 or CMMP1 in the presence of 50mM 
EDTA. In both cases, collagen degradation cannot be observed. Similarly, incubations of 
CMMP1 and CMMP8 with gelatin and EDTA did not reveal any evidence of degradation as 
shown by SDS-PAGE (Figure 3.6 C). Both results suggest that there are no proteases 
contaminating the CMMP1 and CMMP8 samples. For this reason, we can conclude that the 
degradation profiles obtained in Figure 3.5 are the result of collagen and gelatin degradation by 
CMMP1 and CMP8. Interestingly, Figure 3.6 C shows that CMMP8 completely cleaves gelatin 
after 3 hours but that CMMP1 preferentially cleaves the α2 chain. This is expected since, at 37C, 
the reported kcat of α1 gelatin chains cleavage by MMP1 is 0.064s-1, while it is 0.208s-1 for α2 
chains (Welgus, Jeffrey et al. 1982).  
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Figure 3.5. Degradation profiles of type I collagen at room temperature with CMMP8 and 
CMMP1. Intact type I collagen (CI) bands include monomeric α1(I) and α2(I) bands, dimeric β 
bands and trimeric γ bands. The β and γ aggregates correspond to N-terminally crosslinked 
collagen molecules (Veis and Anesey 1965; French, Mookhtiar et al. 1987; Shigemura, Ando et 
al. 2004; Morimoto, Kawabata et al. 2009). Type I collagen degradation bands include α1(I) and 
α2(I) ¾ and ¼ fragments, and degradation of crosslinked chains, βdeg and γdeg. A) Type I 
collagen incubated with CMMP8. Lane 1: Type I collagen (150µg/ml, 0.5µM). Lanes 2 to 7: 
Type I collagen (150µg/ml, 0.5µM) incubated with the catalytic domain of MMP8 (CMMP8) 
(25µg/ml, 1.2µM) for 8, 16, 24, 32, 40 and 48h, respectively. Lane 8: Type I collagen gelatin 
(GI, 150µg/ml, 1.5µM) incubated with CMMP8 (13.8µg/ml, 0.67µM) for 3 h. Lane 9: Type I 
collagen (150µg/ml, 0.5µM) incubated with full length MMP1 (FMMP1) (1.7µg/ml, 30nM) for 
24h. This lane contains a bovine serum albumin (BSA) band since FMMP1 is supplied in a 
buffer containing 1mg/ml BSA. B) Type I collagen incubated with CMMP1. Lane 1: Type I 
collagen (150µg/ml, 0.5µM); Lanes 2 to 5: Type I collagen (150µg/ml, 0.5µM) incubated with 
the catalytic domain of MMP1 (CMMP1) (40µg/ml, 2.0µM) for 24, 48, 96 and 144 h, 
respectively. Lane 6: Type I collagen gelatin (GI 150µg/ml, 1.5µM) incubated with CMMP1 
(16.6µg/ml, 0.83µM) for 3 h. Lane 7: Type I collagen (150µg/ml, 0.5µM) incubated with full 
length MMP1 (FMMP1) (1.7µg/ml, 30nM) for 24h. As with lane 9 in A), this lane contains a 
BSA band since FMMP1 is supplied in a buffer containing 1mg/ml BSA. 
 
A) B) 
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Figure 3.6. Testing for the presence of contaminating MMPs and other proteases. A) Type I 
collagen (150µg/ml, 0.5µM) incubated in the presence of APMA without the addition of any 
collagenases, for 0, 48 and 144h. No degradation bands can be observed, which argues that no 
contaminating MMPs are present. B) Testing for the presence of contaminating proteases in the 
CMMP1/8 solutions with collagen. Lane 1: Type I collagen (150µg/ml, 0.5µM) in 
reaction/EDTA buffer in the absence of collagenases incubated for 48h. Lane 2: Type I collagen 
(150µg/ml, 0.5µM) incubated against CMMP8 (25µg/ml, 1.2µM) in reaction/EDTA buffer. 
Degradation of gelatin cannot be observed. Lane 3: Type I collagen (150µg/ml, 0.5µM) 
incubated against CMMP1 (40µg/ml, 2.0µM) in reaction/EDTA buffer. Degradation of collagen 
cannot be observed. C) Testing for the presence of contaminating proteases in the CMMP1/8 
solutions with gelatin. Lane 1: Type I collagen gelatin (GI 150µg/ml, 1.5µM) in reaction buffer 
in the absence of collagenases incubated for 3h. Lane 2: Type I collagen gelatin (GI 150µg/ml, 
1.5µM) incubated against CMMP8 (1.4µg/ml, 67nM) in reaction buffer. Degradation of gelatin 
can be observed. Lane 3: Type I collagen gelatin (GI 150µg/ml, 1.5µM) incubated against 
CMMP1 (1.4µg/ml, 69nM) in reaction buffer. Degradation of gelatin can be observed. Lane 4: 
Type I collagen gelatin (GI 150µg/ml, 1.5µM) in reaction/EDTA buffer in the absence of 
collagenases incubated for 3h. Lane 5: Type I collagen gelatin (GI 150µg/ml, 1.5µM) incubated 
against CMMP8 (1.4µg/ml, 67nM) in reaction/EDTA buffer. Degradation of gelatin cannot be 
observed. Lane 6: Type I collagen gelatin (GI 150µg/ml, 1.5µM) incubated against CMMP1 
(1.4µg/ml, 69nM) in reaction/EDTA buffer. Degradation of gelatin cannot be observed. 
 
  
A) B) C)  
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3.3 Discussion  
In Chapter 2 we characterized the conformational ensemble of locally unfolded states in 
the different cleavage sites in type III collagen. Since the unfolded states at the actual cleavage 
site S1 are more vulnerable, we hypothesize that collagenases will preferentially bind and cleave 
these states. To test that, we develop a novel rigid docking method in which locally unfolded 
states in the context of triple helical collagen are bound by the catalytic domain of a collagenase. 
The docking studies suggest that the locally unfolded structures for sequence S1 (corresponding 
to the true collagenase cleavage site) are most complementary to the MMP catalytic site. The 
partially unfolded triple helical peptide fits within the catalytic site, placing hydrophobic residues 
into the known hydrophobic pockets in the enzyme (Grams, Reinemer et al. 1995). In addition it 
has been proposed that for catalysis to occur the carbonyl oxygen of the glycine residue, which 
forms part of the scissile bond, must be in close proximity to the Zn2+ ion; i.e., this metal is 
believed to be important in the binding of the substrate and to stabilize the transition state of the 
reaction (Browner, Smith et al. 1995; Pelmenschikov and Siegbahn 2002). Our complex places 
the carbonyl carbon of the glycine residue in the GIA triplet within 2.7Å of this ion and therefore 
is consistent with the notion that binding preformed, and complementary, unfolded states of 
sequence S1 would lead to peptide bond hydrolysis. 
To test whether the interaction described by the docking simulations would actually result 
into collagen degradation, we incubate type III collagen with the catalytic domain of MMP1 and 
MMP8. The resulting degradation pattern suggests that CMMP1 and CMMP8 bind and cleave 
type III collagen at the actual cleavage site, even in the absence of the hemopexin-like domain. 
This suggests that only the locally unfolded states at the true collagenase cleavage site are being 
bound and cleaved by the catalytic domain of MMP1 and MMP8, which correlates with the 
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simulation results shown in Chapter 2. The same results are obtained with type I collagen. These 
results confirm the predictions of a two-state collagen degradation model in which collagenases 
bind to preexisting locally unfolded states, see Appendix 1 (Nerenberg, Salsas-Escat et al. 2008).  
Previous data suggested that non-catalytic domains have binding sites for collagen and 
degradation experiments using only the catalytic domain of MMPs confirmed the importance of 
these domains in hydrolyzing the unique scissile bond (Clark and Cawston 1989; Windsor, 
Birkedal-Hansen et al. 1991; Hirose, Patterson et al. 1993; Nerenberg, Salsas-Escat et al. 2008). 
More recent studies proposed that non-catalytic domains can bind specific amino acid sequences 
near the collagenase cleavage site in some collagen types, and that this serves as a mechanism to 
localize the enzyme to a region near the true cleavage site (Perumal, Antipova et al. 2008; Erat, 
Slatter et al. 2009). However, our computational results suggest that unfolded states of collagen 
exist in the absence of collagenases. Moreover, we show computationally and experimentally 
that these states can be bound and cleaved by collagenases containing only the catalytic domain, 
achieving cleavage site specificity in the absence of the hemopexin-like domain. Therefore, we 
propose that the hemopexin-like domain is not required for either collagenolysis or cleavage site 
specificity in vitro at room temperature. This can be explained in light of the presence of locally 
unfolded states at the actual cleavage site of collagenases that are more vulnerable and 
complimentary to the catalytic domain of collagenases than other unfolded states at other 
potential cleavage sites. While our results seem to contradict previous data that suggest that the 
hemopexin-like domain is required for collagenolysis, we still believe that this domain plays a 
key role in collagen degradation. In both collagen degradation experiments presented in Chapter 
3, very high concentrations of CMMP1 and CMMP8 are required in order to observe 
degradation. This suggests that, while degradation occurs, CMMP1 and CMMP8 are very 
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inefficient enzymes when cleaving triple helical collagen at room temperature. For this reason, 
we propose that the hemopexin-like domain is required to increase the efficiency of these 
enzymes. A more detailed discussion to this end is presented in the Conclusions section of this 
thesis.  
Our data are explained by the fact that the unique scissile bond locally unfolds at low 
temperatures. However, as the temperature increases, microunfolding of collagen leads to the 
exposure of other potential cleavage sites that can be recognized by MMP deletion mutants 
(Taddese, Jung et al. 2009). Indeed, recent data suggest that collagen is thermally unstable at 
body temperature and it has been postulated that microunfolding of distinct collagen regions 
facilitates fibril formation and collagen catabolism (Leikina, Mertts et al. 2002). As the MMP 
hemopexin-like domain has binding sites near the collagenase cleavage site, it may help to 
localize the enzyme to a specific scissile bond, thereby ensuring that the correct site is cleaved at 
body temperature (Perumal, Antipova et al. 2008). Therefore while our data argue that the 
hemopexin-like domain is not needed for cleavage site specificity at low temperatures, it may 
play an important role in determining specificity at body temperature. 
Conformational changes in proteins that are associated with binding reactions are 
typically grouped into two large categories: induced fit and conformational selection. Unlike 
induced fit, where folding and binding occur concomitantly, conformational selection dictates 
that a protein’s binding partner preferentially recognizes pre-formed complementary structures 
(Shoemaker, Portman et al. 2000; Tsai, Ma et al. 2001; Sugase, Dyson et al. 2007; Dobbins, Lesk 
et al. 2008; Lange, Lakomek et al. 2008). One difference between conformational selection and 
induced fit is that conformational selection presupposes that the protein conformation, which is 
complementary to a given binding partner, exists in solution even when the binding partner is 
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absent (Sugase, Dyson et al. 2007; Yoon, Venkatachalam et al. 2009). Hence information as to 
what mechanism is at play for any given protein may be obtained from an analysis of the 
conformational thermodynamics of the protein of interest in the absence of its binding partner. 
The results presented in Chapter 2 and Chapter 3 suggest that at temperatures below the melting 
temperature of type III collagen, the unique cleavage site adopts conformations that are 
complementary to the catalytic site while sequences corresponding to other potential cleavage 
sites do not. Hence, in addition to localization by non-catalytic domains, the subsequent binding 
of the catalytic domain to residues that contain the scissile bond may also help to ensure that the 
true cleavage site in types III collagen is recognized and cleaved. 
 The degradation data of type I collagen by CMMP1 and CMMP8 obtained in Chapter 3 
serve as the basis for testing the conformational selection model presented in Appendix 1. In 
Appendix 2, the model is used to fit the degradation data and obtain information about the 
equilibrium constant between native and vulnerable states, as well as the binding constants of 
CMMP1 and CMMP8 to the vulnerable states. In short, the results show that, at room 
temperature, the native states at the true cleavage site in type I collagen are more stable than the 
vulnerable states, and that CMMP8 binds collagen ~2.5kcal/mol more favorably than CMMP1.  
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3.4 Methods 
3.4.1 Docking simulations 
A co-crystal structure of a cleaved hexapeptide (electron density is seen for only 5 
residues in the active site) corresponding to the consensus sequence of types I and III collagen in 
the active site of the catalytic domain of MMP12 (PDB ID 2OXZ (Berman, Westbrook et al. 
2000; Bertini, Calderone et al. 2006) solved at 1.8Å resolution) is used as the starting structure 
for the docking simulations (Bertini, Calderone et al. 2006). Given the structural similarity 
between the catalytic domains of MMP12 and MMP8 (PDB ID 2OY2 (Berman, Westbrook et al. 
2000; Bertini, Calderone et al. 2006) solved at 1.5Å resolution), with a backbone RMSD of only 
0.67Å, the two structures are aligned and the two peptide fragments are positioned in the active 
site of MMP8. Selected residues are mutated in the peptide fragment in silico in order to obtain 
the corresponding amino acid sequence of the type III collagen cleavage site. The two fragments 
are covalently linked together and the final structure is energy minimized for 100 steps using the 
steepest descent algorithm. This structure, consisting of the catalytic domain of MMP8 and a 
docked 5 residue peptide containing the collagenase scissile bond, serves as our reference 
structure for docking simulations. 
Each collagen structure corresponding to a given stable state from the pmf is docked into 
the active site of MMP8 using the bound 5mer as a reference. A total of 300 structures are 
docked for each energy minimum from the following pmf windows: S1min1, γ=17.3Å; S1min2, 
γ=17.5Å; S2min1, γ=17.3Å; S2min2, γ=17.5Å; S3, γ=17.2Å; S4, γ=17.2Å; S5, γ=17.1Å. We fix 
the internal coordinates of the triple helical peptides, and the position of the MMP8 and 5mer 
atoms. We then use a harmonic biasing potential that minimizes the rms between the backbone 
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(nitrogen, α-carbon and carbonyl carbon) atoms of the bound 5mer and those same atoms in 
chain A of the triple helical peptide. Molecular dynamics are run for 20ps in vacuum with the 
fixed CMMP8 and reference peptide, and a rigid triple helical peptide, with the biasing potential 
turned on with a force constant of 5kcal/mol/Å2. When the triple helical peptide collides with the 
fixed MMP8, due to the predominant van der Waals clashes, the rms stops decreasing and 
fluctuates around a given value. Figure 3.8 shows the evolution of the docking rms from a typical 
docking run. In the early stages, collagen is far from CMMP8 and the rms is therefore large. 
When collagen approaches CMMP8 in order to align with the reference peptide, the rms lowers, 
and the vdW contacts become relevant, preventing collagen from fully aligning with the 
reference peptide. The structure with the lowest rms of all docks, (1.86Å) corresponding to 
S1min2, is energy minimized using the EEF1 (Lazaridis and Karplus 1999) implicit solvent 
model for 200 steps of steepest descent followed by 200 steps of conjugate gradient, while fixing 
CMMP8 and chains B and C. 
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Figure 3.7. Detail of the catalytic domain of MMP8 with the 5 residue peptide bound in the 
catalytic site cleft. Inside the dotted white oval, the scissile bond between G~I is circled. The 
green sphere corresponds to the catalytically essential Zn2+ ion. This figure has been created with 
molecular visualization package VMD (Humphrey, Dalke et al. 1996). 
 
Figure 3.8. Evolution of rms during the docking trajectory for a typical docking run. 
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3.4.2 Collagen degradation experiments 
3.4.2.1 Enzyme preparation and characterization 
MMP mutants that only contain the catalytic domains of MMP1 (CMMP1) and MMP8 
(CMMP8) are purchased from Enzo Life Sciences. Full length MMP1 (FMMP1) is purchased 
from Anaspec, and is provided in a preserving solution containing 1mg/ml of BSA. The specific 
activities of CMMP8 and CMMP1 are determined by the manufacturer at 37ºC to be 356U/µg 
and 1050U/µg, respectively. To verify that the mutant enzymes retained activity under our 
experimental conditions we measure the specific activities of CMMP1 and CMMP8 at 24ºC in 
our reaction buffer. Specific activities are determined using an assay based on the MMP1 
Colorimetric Drug Discovery Kit from Enzo Lifesciences (BML-AK404-0001) (Weingarten and 
Feder 1985). In short, a 1mM solution of 5,5’-dithiobis(2-nitrobenzoic) acid Ellman’s reagent, is 
prepared in reaction buffer. The enzyme (10nM CMMP1 or 13nM CMMP8, a 2500X dilution of 
the supplied enzyme) is then incubated in the latter buffer with 100µM of a colorimetric 
thiopeptolide of sequence Acetil-Proline-Leucine-Glycine-[2-mercapto-4-methyl-pentanoyl]-
Leucine-Glycine-OEthyl (Weingarten, Martin et al. 1985) (Enzo Lifesciences BML-P125). This 
substrate is the same that is used by the manufacturer to measure the enzyme activity at 37ºC. 
The initial velocity is determined using the slope of the absorbance increase at 412nm after 3 
minutes (Figure 3.9), yielding specific activities 289U/µg for CMMP8 and 766U/µg for CMMP1 
(1U = 100pmol/min degradation of the thiopeptolide). The formula used to obtain the specific 
activity is based in the Beer-Lambert law, as follows: 
 𝐴𝐴 = 𝑙𝑙 ∙ 𝜀𝜀 ∙ 𝑐𝑐 (3.1)  
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where A is the Absorbance, l is the path length in cm, ε is the molar absortivity (13600M-1cm-1 
for 2-nitro-5-thiobenzoic acid, the product of the reaction) and c is the molar concentration. If we 
take derivatives with respect to time in both sides of the expression (3.1) and separate c as the 
ratio of moles over volume (V in L), we obtain: 
 𝑑𝑑𝐴𝐴
𝑑𝑑𝑑𝑑
= 𝑙𝑙 ∙ 𝜀𝜀
𝑉𝑉
∙
𝑑𝑑(𝑚𝑚𝑚𝑚𝑙𝑙𝑚𝑚𝑚𝑚)
𝑑𝑑𝑑𝑑
 (3.2)  
since the activity is defined as the number of moles of substrate consumed in a period of time, 
isolating this quantity yields: 
 𝑑𝑑(𝑚𝑚𝑚𝑚𝑙𝑙𝑚𝑚𝑚𝑚)
𝑑𝑑𝑑𝑑
= 𝑉𝑉
𝑙𝑙 ∙ 𝜀𝜀
∙
𝑑𝑑𝐴𝐴
𝑑𝑑𝑑𝑑
 (3.3)  
where 𝑑𝑑𝐴𝐴
𝑑𝑑𝑑𝑑
 (in units of absorbance per minute) is the slope in Figure 3.9. To obtain the specific 
activity, we only have to divide the activity value by the amount of enzyme used in the reaction, 
in µg. 
 
 
Figure 3.9. Determination of the specific activity of CMMP1 and CMMP8. Initial velocity 
measurement of the degradation of a thiopeptolide by A) CMMP1 and B) CMMP8. 
  
B) A) 
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3.4.2.2 Type III collagen degradation experiments 
All experiments are carried out in a reaction buffer containing 100mM Tris HCl (VWR 
International), 10mM CaCl2 (Sigma-Aldrich Co), pH 7.6. Human sequence type III collagen, 
expressed in Pichia Pastoris (Abcam), is obtained at 3.3mg/ml in 0.5M AcOH. Degradation 
experiments are performed at a collagen concentration of 200μg/ml (0.66μM) of type III 
collagen, by diluting the concentrated type III collagen into reaction buffer. Type III collagen 
expressed in yeast does not contain other collagen impurities. For this reason, collagen 
repurification is not needed. 
3.4.2.3 Preparation of type I collagen 
All experiments are carried out in a reaction buffer containing 100mM Tris HCl (VWR 
International), 10mM CaCl2 (Sigma-Aldrich Co), pH 7.6. Bovine type I collagen, (BD 
Biosciences), is obtained at 3mg/ml in 0.012M HCl.  
As purification of type I collagen often results in protein that is contaminated with type 
III collagen, purchased collagen samples are repurified using differential salt precipitation 
(Epstein 1974; Trelstad, Catanese et al. 1976; Miller and Rhodes 1982). First, type I collagen is 
diluted to a concentration of 0.5mg/ml (1.67µM) in 0.5M AcOH. The solution is then dialyzed 
against low salt buffer (0.1M NaCl, 50mM Tris, pH 7.5, at 4ºC) followed by dialysis against a 
high salt buffer (1.8M NaCl, 50mM Tris, pH 7.5, at 4ºC), in which type III collagen 
preferentially precipitates (Trelstad, Catanese et al. 1976). At this point the sample is centrifuged 
at 4ºC for 30min at 16000g and the supernatant, containing purified type I collagen, is then 
dialyzed against reaction buffer. Purity of the final type I solution is confirmed by running 
degradation experiments with full length MMP1 and no type III collagen degradation products 
are observed (Figure 3.10).  
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Figure 3.10. Purification profile of type I collagen. Lane 1: Unpurified type I collagen. α1(I), 
α2(I) and aggregation bands can be seen along an impurity of type III collagen, α1(III) band. 
Lane 2: Degradation of unpurified type I collagen. The degradation bands of type I collagen, ¾ 
and ¼ α1(I) and α2(I) bands can be seen. A small ¾ α1(III) band can also be observed. Lane 3: 
Purified type I collagen. Only α1(I), α2(I) and aggregation bands can be seen. Lane 4: 
Degradation of purified type I collagen. Only the degradation bands of type I collagen, ¾ and ¼ 
α1(I) and α2(I) bands can be seen. 
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3.4.2.4 Type I collagen degradation experiments 
Degradation experiments are performed at a collagen concentration of 150μg/ml 
(0.5μM). Prior studies suggest that the critical concentration for fibril formation was determined 
to be around 4μg/ml at relatively low temperatures and under different experimental conditions 
(T=29ºC, buffer consisting of 20mM NaHCO3, 117mM NaCl, 5.4mM KCl, 1.8mM CaCl2, 0.81 
mM MgSO4, 1.03mM NaH2PO4, 0.01% NaN3.) (Kadler, Hojima et al. 1987). To determine 
whether collagen at 150μg/ml (0.5µM) would remain soluble under our experimental conditions 
(T=24ºC, reaction buffer), we assess the extent of collagen aggregation as a function of time.  
The aggregation of type I collagen at room temperature is followed by allowing samples 
to sit at 150μg/ml (0.5µM) for specified periods of time at room temperature, followed by 
centrifugation (at 16000g for 4min). The supernatant is then run in an SDS gel and stained using 
Coomassie colloidal blue. A similar procedure is followed in a prior work to assess the extent of 
collagen aggregation as a function of time (Kadler, Hojima et al. 1987). Figure 3.11 depicts the 
amount of collagen in the supernatant as a function of time. As the intensity of the collagen 
bands is constant, type I collagen remains soluble under our experimental conditions. 
All degradation reactions are performed at room temperature. The temperature is verified 
using a calibrated thermometer and all recorded temperatures are 24ºC. Degradation experiments 
employed purified type I collagen at a concentration of 150µg/ml (0.5µM). All enzymes are 
incubated with 4-aminophenyl mercuric acetate, APMA, (Sigma-Aldrich Co) as previously 
described (Knäuper and Murphy 2001) and mixed with type I collagen to a final concentration of 
25µg/ml (1.2µM) for CMMP8, 40µg/ml (2.0µM) for CMMP1, and 1.7µg/ml (30nM) for 
FMMP1. Reactions are stopped by the addition of SDS-Laemmli buffer (BioRad Laboratories) 
with β-Mercaptho Ethanol (Sigma-Aldrich Co) and boiled for 10 minutes. The degradation 
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products are run in 4-12% gradient gels and stained with Coomassie colloidal blue. Gelatin is 
generated by boiling type I collagen in reaction buffer for 10 minutes. Gelatin at 150µg/ml (3 
chains X 0.5µM = 1.5µM) is then incubated with 13.8µg/ml (0.67µM) CMMP8 and 16.6µg/ml 
(0.83µM) CMMP1.  
An unstained CMMP8 gel is transferred to a PVDF membrane, which is stained with 
Coomassie blue. The ¼ α1(I) and ¼ α2(I) bands are cut from the gels corresponding to the 
CMMP8 experiments and sent for sequencing to the Tufts University Core Facility, using an 
ABI 494 Protein Sequencer. The ¼ α1(I) and α2(I) bands from the CMMP1 reaction cannot be 
sequenced due to the low amount of collagen that is degraded by CMMP1.  
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Figure 3.11. Control for the fibrillogenesis of collagen. Type I collagen (150µg/ml, 0.5µM) is 
allowed to sit at room temperature for up to 6 days, spun down and the supernatant run on SDS-
PAGE. The intensity of the bands remains constant, suggesting that precipitation does not occur 
under the experimental conditions. 
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Conclusions  
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Collagen degradation is involved in a series of disorders that debilitate millions of 
individuals. In our quest to understand how this process works, we have encountered two 
scientifically challenging questions. First, how does collagen degradation occur given that the 
triple helix does not fit in the active site of a collagenase and the scissile bond in collagen is 
hidden from solvent? Second, how do collagenases cleave only at one site, leaving other 
potential cleavage sites untouched? We hypothesize that the answer to these questions can be 
found in the existence of locally unfolded states in collagen.  
In order to test this hypothesis, we design a path that starts by characterizing the nature of 
locally unfolded states in collagen. In Chapter 1, we show that the nature of the unfolded states 
in type III collagen is dependent on the surrounding sequence of a given cleavage site. These 
results are interesting since they suggest that small sequence variations can lead to significant 
differences in the stability and structure of the conformational ensemble of the triple helix. 
In Chapter 2, we extend the methodology from Chapter 1 to study all potential cleavage 
sites in type III collagen. Our results show that the locally unfolded states at the actual cleavage 
site are more vulnerable and flexible than at other potential cleavage sites. This suggests that 
active unfolding of the triple helix is not required for the existence of vulnerable states at the true 
cleavage site. Moreover, since not all the cleavage sites are as vulnerable, cleavage site 
specificity may be encoded in the conformation at each cleavage site and ultimately in the 
sequence surrounding each cleavage site. Type III collagen is not the only collagen type that 
contains more than one potential cleavage site. Future work in this direction would entail 
simulations of other collagen types to study if high vulnerability at the actual cleavage site is a 
conserved theme amongst collagen types. As a first step in this direction, other work from the 
Stultz lab has shown that locally unfolded states also exist at the true collagenase cleavage site in 
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type I collagen (Nerenberg and Stultz 2008). Also, it would be interesting to extend the 
methodology of the simulations presented here to the fibrillar state of collagen. Since this is the 
natural state of collagen in the body, we wish to study the influence of neighboring collagen 
molecules on the existence of vulnerable states. Structures of the fibrillar state of full length type 
I collagen have been made available (Perumal, Antipova et al. 2008). Although they are not of 
great resolution, they could be used as a scaffold on which to build a more detailed model of type 
I collagen to study the occurrence of vulnerable states in the fibrillar context. While fibrillar 
collagen is more stable than collagen in solution, we still expect that vulnerable states will exist 
in this scenario and that conformational selection will play a prominent role in the mechanism of 
collagenolysis.   
In Chapter 3, we test whether the locally unfolded states described in Chapter 2 can be 
bound by the catalytic site of a collagenase. We also want to determine whether cleavage site 
specificity can be achieved in the absence of the hemopexin-like domain. To this end, we 
develop a novel rigid body docking method. Our results show that the locally unfolded states at 
the actual type III collagen cleavage site fit best inside of the catalytic domain of a collagenase. 
The docking results suggest that incubation of type III collagen with the catalytic domain of 
collagenases would result in degradation at a unique site. Indeed, our experimental results show 
that this is the case. Type III collagen in solution can be cleaved at the true cleavage site by using 
only the catalytic domain of MMP1 or MMP8 at room temperature. We also extend these 
experiments to type I collagen, the most abundant collagen type, to show that, against previous 
literature, locally unfolded states at the actual cleavage site can also be cleaved by the catalytic 
domain of a collagenase. Since the hemopexin-like domain is believed to be necessary to 
actively unfold the collagen triple helix, the results obtained in Chapter 3 strongly suggest that 
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unfolded states exist in the absence of collagenases. Moreover, cleavage site specificity is 
achieved in the absence of the hemopexin-like domain at room temperature. For this reason, we 
propose that cleavage site specificity at room temperature may be encoded in the nature of the 
unfolded states at each cleave site, as the results from Chapter 2 suggest. At higher temperatures, 
we expect vulnerable states to occur at other sites along the triple helix (Taddese, Jung et al. 
2009). Therefore it is possible that the binding hemopexin-like domain in the vicinity of the true 
cleavage site contributes to specificity in vivo. 
Future work related to Chapter 3 would include follow up on the structures obtained from 
the docking simulations. These docked structures of type III collagen are the only available 
snapshots of the interaction between collagen and a collagenase. These structures could serve as 
the starting point of more detailed molecular dynamics simulations to characterize the interaction 
between collagen and collagenases. Moreover, other simulations could be designed in which the 
hemopexin domain of MMPs could be added to the system in order to study the interaction of 
such domain with the triple helix.   
In Appendix 1 we present a conformational selection model of collagenolysis in which 
collagen exists in an equilibrium between native and vulnerable states, and degradation occurs 
when collagenases bind and cleave the vulnerable states. In Appendix 2 we explain the 
degradation results of type I collagen by CMMP1 and CMMP8 from Chapter 3 using the two-
state degradation model presented in Appendix 1. This type of analysis allows us to characterize 
the equilibrium between native (well folded) and vulnerable (locally unfolded) conformers in 
type I collagen in solution at room temperature. It also points to the binding affinity to the 
vulnerable state as the cause behind the marked difference in efficiency of CMMP1 and CMMP8 
at cleaving type I collagen.  
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However, we recognize that collagen is typically degraded by full length collagenases in 
the body. For this reason, here we present a model for collagenolysis by full length MMP based 
in the existence of an equilibrium between native and vulnerable states in collagen. We expand 
the reaction scheme for the catalytic domain alone (Appendix 1 and 2) to consider the effects of 
the hemopexin-like domain on collagenolysis in vitro (Figure C.1). In this reaction scheme, 
collagen exists in an equilibrium between native (N) and vulnerable (V) states, and either state 
can be bound by collagenases via the hemopexin-like domain, which contains binding sites for 
collagen (Murphy, Allan et al. 1992; Overall 2002; Tam, Moore et al. 2004; Perumal, Antipova 
et al. 2008; Lauer-Fields, Chalmers et al. 2009). When the native state is bound, an N·H complex 
is formed that cannot be cleaved since the scissile bond in this structure is not accessible to the 
MMP active site. Since the catalytic domain of the enzyme is not bound to the scissile bond in 
the N·H complex, and the putative binding site for the hemopexin-like domain in type I collagen 
is removed from the cleavage site (Perumal, Antipova et al. 2008; Erat, Slatter et al. 2009), the 
N·H complex can transition to a vulnerable state (V·H complex) via a conformational change 
similar to the one experienced by unbound collagen. Once the V·H complex is formed, the 
catalytic domain can then bind the accessible scissile bond, yielding the V·F complex, which 
then goes on to form degraded protein.  
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Figure C.1. A conformational selection mechanism for collagenolysis with full length 
collagenases. Collagen exists in an equilibrium between native (N) and vulnerable (V) states 
determined by the equilibrium constant 𝐾𝐾𝑒𝑒𝑒𝑒 . Full length MMP (F) can bind to the native state of 
collagen via the hemopexin-like domain (H) with binding constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 , forming the N·H 
complex. The N·H complex can transition to the V·H complex via the equilibrium between native 
and vulnerable states, 𝐾𝐾𝑒𝑒𝑒𝑒 . The full length enzyme, F, can bind directly to the vulnerable state, V, 
via the hemopexin domain (H) forming the V·H complex, again determined by the binding 
constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 . Once a V·H complex is formed, the catalytic domain of the full length MMP can 
bind to the vulnerable state with a binding constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝐶𝐶 , forming the V·F complex. The V·F 
complex is then degraded with catalytic rate kcat. 
Chapter 3 and Appendix 2 analyze the degradation of type I collagen in solution by 
means of both experimental and numerical studies, but in vivo, collagen typically exists in a 
fibrillar state (Gelse, Poschl et al. 2003). Since previous studies suggest that type I collagen is 
thermally stabilized in a fibrillar context relative to the solution state, it is an open question as to 
whether the conformational ensemble of the collagenase cleavage site is the same in the fibril as 
it is in solution (Birkedal-Hansen, Taylor et al. 1985). Interestingly, however, recent fiber 
diffraction studies suggest that the α2(I) chain is relatively dissociated from the central axis of 
the helix at the collagenase cleavage site in situ; i.e. in the fibrillar state, the triple helix is 
disrupted near the cleavage site (Perumal, Antipova et al. 2008). While the fiber diffraction study 
is of insufficient resolution to provide reliable details on the atomic structure of the fibrillar state, 
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these data do suggest that the structure of the triple helix can vary considerably along its length 
and especially near the collagenase cleavage site. Thus, while in vivo collagen degradation 
clearly differs from the solution state degradation studies presented in this work, the mechanism 
outlined in Figure C.1 and the preceding discussion may still be a fair representation of the 
important aspects of in vivo collagen degradation, albeit the value of 𝐾𝐾𝑒𝑒𝑒𝑒  is likely much smaller 
in the fibrillar context. 
To understand how the presence of enzyme might affect the relative concentration of 
vulnerable states, we consider an equilibrium in which the enzyme is catalytically inactive (i.e., 
the degradation step does not occur), and solve for the effective ratio of all vulnerable states to 
all native states, 𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑒𝑒𝑒𝑒 = ([𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻] + [𝑉𝑉 ∙ 𝐹𝐹])/([𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻]). In this scenario, there is a 
closed form solution for 𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑒𝑒𝑒𝑒 (see Methods in Appendix 2): 
 
𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑒𝑒𝑒𝑒 = 𝐾𝐾𝑒𝑒𝑒𝑒 �1 + � 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 [𝐸𝐸]𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 [𝐸𝐸] + 1�𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝐶𝐶�  
 
where [E] is the concentration of free enzyme, which itself is a function of the enzyme-to-
substrate ratio, and the binding constants 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻  and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝐶𝐶 . We can better understand the behavior 
of 𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑒𝑒𝑒𝑒  by evaluating it at two limiting conditions. In the first, no enzyme is present ([E] = [E]tot 
= 0) and/or the enzyme does not bind collagen (𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 = 0); in either case 𝐾𝐾𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 = 𝐾𝐾𝑒𝑒𝑒𝑒  . The 
second limiting condition is when the concentration of enzyme is in relative excess and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻  is 
non-zero; in this case, 𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑒𝑒𝑒𝑒 ≈ 𝐾𝐾𝑒𝑒𝑒𝑒𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝐶𝐶 . Given that the catalytic domain is restricted to reside in 
the vicinity of the cleavage site when the hemopexin-like domain is bound, the entropic loss 
upon binding of the catalytic domain is relatively small when the enzyme is anchored to the 
protein by the hemopexin-like domain. Consequently, we expect that 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝐶𝐶 ≫ 1 and therefore 
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that 𝐾𝐾𝑒𝑒𝑒𝑒 ≪ 𝐾𝐾𝑒𝑒𝑒𝑒𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝐶𝐶 . Accordingly, this suggests that as long as there is a non-zero total 
concentration of enzyme, we will have 𝐾𝐾𝑒𝑒𝑒𝑒 < 𝐾𝐾𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 < 𝐾𝐾𝑒𝑒𝑒𝑒𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝐶𝐶 , as demonstrated in Figure C.2. 
In other words, the ratio of vulnerable states to native states,  𝐾𝐾𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 , will always be greater than 
eqK when enzyme is present simply due to the principle of mass action. In this way the presence 
of enzyme leads to an effective increase in the concentration of vulnerable, “unwound”, 
conformers without requiring energy input or active enzyme-mediated unwinding. 
 
Figure C.2. Change in the effective conformational equilibrium of collagen in the presence of 
full length collagenase. Computed values for the effective equilibrium constant,  𝐾𝐾𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 , as a 
function of total enzyme-to-collagen ratio for three possible values of the hemopexin-like 
domain binding constant, 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 , ranging from sub-millimolar to micromolar affinity. For these 
calculations, [collagen]tot= 10-6 M, 𝐾𝐾𝑒𝑒𝑒𝑒  = 10
-3, and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝐶𝐶  = 106. At low enzyme-to-collagen 
ratios,  𝐾𝐾𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒  is approximately equal to 𝐾𝐾𝑒𝑒𝑒𝑒 , whereas at high enzyme-to-collagen ratios,  𝐾𝐾𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒  
approaches 𝐾𝐾𝑒𝑒𝑒𝑒𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝐶𝐶 .   
 
This analysis of the collagenolysis model by full length collagenases reconciles the 
concept of “active unfolding” with the natural occurrence of vulnerable states. Since the 
hemopexin-like domain preferentially binds in the vicinity of the cleavage site (Perumal, 
Antipova et al. 2008), the catalytic domain is ideally oriented to bind the rarely occurring 
vulnerable states. When such binding happens, the vulnerable states are stabilized in comparison 
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to when they occur freely in solution and no enzyme is around to bind them. Without the 
localization effect due to the binding of the hemopexin-like domain, the probability of productive 
encounter between a vulnerable state and a catalytic domain would be very low. Indeed, this is 
reflected in the very high concentrations of CMMP1 and CMMP8 that are required to observe 
type I collagen degradation, as opposed to the lower concentration of full length collagenases 
needed to observe the same result (Chapter 3 and Chung, Dinakarpandian et al. 2004). In 
summary, this model allows us to redefine the role of the hemopexin-like domain of 
collagenases. This domain was originally thought to be necessary for collagenolysis since it 
would play a key role in the active unfolding of the triple helix (Overall 2002; Chung, 
Dinakarpandian et al. 2004). However, the work presented in this thesis allows explaining 
collagenolysis without having to resort to active unwinding. Therefore we propose that the 
presence of the hemopexin-like domain makes collagenases much more efficient enzymes, as the 
probability of binding vulnerable states increases. Lastly, the hemopexin-like domain may be 
also involved in determining cleavage site specificity in vivo.   
More importantly, the new degradation model based on the existence of an equilibrium 
between native and vulnerable states allows us to propose new avenues of regulating collagen 
degradation, which is the long term goal in the field. Historically, methods designed to prevent 
excessive collagen degradation in disorders of collagen metabolism have mainly focused on 
designing small molecule inhibitors of the MMP active site that would prevent binding and 
hydrolysis of the scissile bond (Folgueras, Pendas et al. 2004; Georgiadis and Yiotakis 2008). 
This corresponds to disrupting the reaction step involving the transition between the V·H and V·F 
complexes in Figure C.1. Although great effort has been directed towards the design of such 
inhibitors, poor clinical results have been obtained. Since the catalytic domains of many 
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collagenases are quite similar, selectivity issues and secondary side effects in clinical trials have 
been encountered and therefore only few inhibitors have been made available commercially 
(Abbenante and Fairlie 2005; Ganea, Trifan et al. 2007; Georgiadis and Yiotakis 2008; Tallant, 
Marrero et al. 2009). The reaction scheme in Figure C.1 highlights additional and potentially 
fruitful avenues for abrogating disease-associated collagenolysis. As others have noted, 
disruption of hemopexin-like domain binding to secondary sites on collagen could prove to be an 
effective mechanism to modulate collagenolysis (e.g., decreasing 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 ) (Folgueras, Pendas et al. 
2004; Nerenberg, Salsas-Escat et al. 2007; Lauer-Fields, Chalmers et al. 2009). Our data suggest 
that mechanisms that lead to stabilization of the native state relative to the vulnerable state (i.e., 
decreasing 𝐾𝐾𝑒𝑒𝑒𝑒 ) may have a similar desirable effect. One possible avenue of research is the study 
of small molecules that have the ability to bind to the native state of collagen at its actual 
cleavage site, preventing unfolding and reducing the number of vulnerable conformers. By 
utilizing these additional steps in the reaction mechanism, collagen degradation could potentially 
be inhibited in a specific and efficient manner. 
To conclude, in this thesis we have used a combination of experimental and 
computational tools to study a biophysical problem of great complexity. By using only one of 
these approaches in isolation it would have probably been very difficult to achieve the level of 
understanding obtained in this thesis. The details provided by the molecular dynamics 
simulations would have been hard to observe using any other experimental technique alone. 
Since MD simulations rely on the accuracy of the underlying potential energy function, which is 
approximate, it is important to verify the observations arising from these simulations with 
experiment. Our collagen degradation studies confirmed the predictions from the MD 
simulations. Then, taking a step back to the computer world, numerical simulations of the 
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experimental data allow us to characterize the interaction between collagen and collagenases, as 
well as the conformational equilibrium at the collagen cleavage site. The synergy between 
simulation and experiment is one of the core values of the Computational and Systems Biology 
program. Here, applied to a biophysical problem, it proved a valuable approach to contribute to 
the current understanding of the mechanism of collagenolysis. 
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Appendix 1: 
A Conformational Selection Mechanism 
of Collagen Degradation 
 
Appendix 1 is adapted from: Nerenberg, P.S., Salsas-Escat, R., and Stultz, C.M. (2008). "Do 
collagenases unwind triple-helical collagen before peptide bond hydrolysis? Reinterpreting 
experimental observations with mathematical models." Proteins
 
 70(4): 1154-61. 
 
Acknowledgment: The Matlab simulations of the differential equations in this section were 
performed by my former labmate Paul Nerenberg  
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A1.1 Introduction 
Collagenolysis is an enigmatic process. Collagenases have catalytic sites that are too 
narrow to accommodate the triple-helical structure of collagen, and the scissile bond within the 
triple helix is not solvent accessible (Fields 1991; Overall 2002; Stultz 2002).  Consequently, the 
precise mechanism of collagenolysis is unclear. It has been suggested that collagenases gain 
access to their cleavage sites by actively unwinding triple-helical collagen before peptide bond 
cleavage (Overall 2002; Chung, Dinakarpandian et al. 2004). According to this theory, 
collagenases not only hydrolyze scissile bonds in collagen, but they also function as triple-
helicases; that is, enzymes that locally unwind collagen’s triple-helical structure. Matrix 
metalloproteases (MMPs) are zinc-dependent proteases that cleave extracellular matrix 
components at specific sites (Fields 1991; Overall 2002). MMP1, in particular, contains a 
catalytic domain and a hemopexin-like domain that are connected through a short linker region 
(Murphy and Knauper 1997). Although the catalytic domain alone can cleave denatured 
collagen, it cannot degrade collagen in its triple-helical form (Clark and Cawston 1989; Overall 
2002; Chung, Dinakarpandian et al. 2004). When type I collagen is incubated with an excess of 
MMP1’s catalytic domain, no significant collagen degradation products are formed - an 
observation that has been viewed as inconsistent with the notion that spontaneous unwinding of 
collagen occurs in the vicinity of the collagenase-cleavage site (Chung, Dinakarpandian et al. 
2004). In addition, while the catalytically inactive form of MMP1 (E200A) cannot hydrolyze 
collagen, it can facilitate collagenolysis by enzymes that only cleave denatured collagen (Chung, 
Dinakarpandian et al. 2004). These observations lend credence to the conjecture that 
collagenases locally unwind triple helical collagen before collagenolysis. Most theories that 
support a triple-helicase function for MMPs require (i) collagen to at least bind both the catalytic 
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and hemopexin-like domains; and (ii) coordinated domain motions that produce lateral tension, 
axial compression, or bending of the collagen triple helix (Overall 2002).  
In principle, these domain motions would have large energetic requirements; however, 
collagenolysis does not require energy input (Fields 1991; Murphy and Knauper 1997; Overall 
2002; Chung, Dinakarpandian et al. 2004). Using a standard kinetic scheme coupled with 
transition state theory, we estimate the energetic barrier associated with this enzyme-mediated 
reaction to be ~20 kcal/mol (see Methods). This significant barrier exists when the enzyme is 
present. However, barriers of this magnitude are characteristic of processes that typically do not 
occur on biological time scales (Dugave and Demange 2003; Hollowell, Younvanich et al. 
2007). 
Although the aforementioned experimental studies imply that partially unfolded states of 
collagen do not occur spontaneously (Clark and Cawston 1989; Chung, Dinakarpandian et al. 
2004), other studies suggest that collagen is conformationally labile in the vicinity of the 
collagenase cleavage site (Fan, Li et al. 1993; Fiori, Sacca et al. 2002; Leikina, Mertts et al. 
2002; Stultz 2002; Sacca, Fiori et al. 2003). Accordingly, one alternate theory is that collagen 
exists as an equilibrium distribution of conformational states, where some states are partially 
unfolded in the vicinity of the collagenase cleavage site. Collagenolysis then occurs when 
collagenases bind to, stabilize, and cleave these partially unfolded conformers. Dynamical 
simulations of collagen-like model peptides suggest that collagen can adopt two distinct 
conformational states near its scissile bond (Stultz 2002). One state corresponds to the native 
triple-helical structure (N), and the other corresponds to a partially unfolded conformation that 
contains a relatively exposed scissile bond. We refer to this latter conformation as vulnerable 
(V), because collagen structures that adopt this conformation are relatively vulnerable to 
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collagenolysis (Stultz and Edelman 2003). In light of these observations, we reexamined prior 
experimental data on the interaction between MMP1 and type I collagen to determine whether 
these data are consistent with the aforementioned experimental observations on the kinetics of 
collagenolysis. 
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A1.2 Results 
Collagenolysis is typically described by the standard kinetic scheme: 
 
  on
off
k
NEk
N E C→+ ←  (A1.1)  
 
  NEcatk
NEC P E→ +  (A1.2)  
 
 
where N denotes the native state of collagen (i.e., its triple-helical structure), E denotes full 
length MMP1, 𝐶𝐶𝑁𝑁𝑁𝑁  is the enzyme-substrate complex, P denotes the products of collagenolysis, 
and the associated rate constants are explicitly shown. The rate at which collagen degradation 
products is formed is given by: 
  𝑑𝑑[𝑃𝑃]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁]  (A1.3)  
 
 
where 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁  is the experimentally observed turnover rate for type I collagen. In general, 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁  is 
quite small, in the order of 0.015s–1 for type I collagen (Welgus, Jeffrey et al. 1981). This slow 
turnover rate is rationalized using the argument that 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁  measures both peptide bond hydrolysis 
and collagenase-mediated triple-helical unwinding, where the latter is an energetically costly 
reaction (Overall 2002; Chung, Dinakarpandian et al. 2004) (see Methods). Given that 
collagenolysis does not require energy input, we explored a reaction scheme that does not rely on 
enzyme-mediated unwinding. We begin by assuming that collagen exists as an equilibrium 
distribution of states as previously outlined; that is, N corresponds to the native triple-helical 
state and V corresponds to a partially unfolded conformation (Stultz 2002; Stultz and Edelman 
2003). Our reaction scheme is based on the notion that collagenases bind and cleave vulnerable 
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conformers (Figure A1.1). Moreover, we explicitly exclude a step describing direct unfolding in 
the presence of the enzyme, 𝐶𝐶𝑁𝑁𝑁𝑁 ⇄ 𝐶𝐶𝑉𝑉𝑁𝑁 , because we wish to determine whether previous 
experimental observations can be explained without appealing to a mechanism that invokes 
collagen unfolding while bound to the enzyme; for example, enzyme-mediated unwinding.  
 
Figure A1.1. Reaction scheme used for numerical simulations. N denotes the native state of 
collagen (i.e., its triple-helical structure); E denotes full-length MMP1; CNE is the enzyme-
substrate complex; CVE denotes the complex formed between the enzyme E and the partially 
unfolded state V; and P denotes the products of collagenolysis. The model itself, as outlined 
here, makes no assumption about the form of collagen and therefore is applicable to both 
collagen in its monomeric form as well as in its fibrillar form. 
 
It is important to note that in this formalism the vulnerable state is quite distinct from the 
denatured state. We define a denatured conformation as a completely unfolded structure lacking 
triple helical structure. By contrast, vulnerable conformers have considerable native-like 
structure in which the native state and the vulnerable state differ in the local region about the 
scissile bond. Data from dynamical simulations and NMR experiments on collagen-like model 
peptides are consistent with the notion that such locally unfolded states of collagen exist (Fan, Li 
et al. 1993; Fiori, Sacca et al. 2002; Stultz 2002; Sacca, Fiori et al. 2003).  
In this reaction scheme, hydrolysis of scissile bonds in collagen occurs only when 
collagenases recognize and cleave vulnerable conformers (Figure A1.1). Under steady-state 
conditions, the experimentally observed rate of collagenolysis [𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁  in Eq. (A1.3)] is a function 
of 𝐾𝐾𝑒𝑒𝑒𝑒 = [𝑉𝑉]/[𝑁𝑁] = 𝑘𝑘1/𝑘𝑘2 (the equilibrium constant dictating the relative concentrations of 
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vulnerable and native conformers), 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 = [𝑉𝑉𝑁𝑁]/([𝑉𝑉][𝑁𝑁]) = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 /𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉  (the affinity of the 
enzyme for vulnerable states), and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 = [𝑁𝑁𝑁𝑁]/([𝑁𝑁][𝑁𝑁]) = 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 /𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁  (the affinity of the 
enzyme for native states): 
  𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 ≈ 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 𝐾𝐾𝑒𝑒𝑒𝑒𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 𝐾𝐾𝐷𝐷𝑁𝑁𝑁𝑁  (A1.4)  
 
where 𝐾𝐾𝐷𝐷𝑁𝑁𝑁𝑁 = (𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 )−1 (see Methods for derivation). When 𝐾𝐾𝑒𝑒𝑒𝑒  is low, the native state is 
preferred and consequently collagen degradation will occur slowly. Likewise, mutations in either 
the enzyme or collagen that reduce the enzyme’s affinity for vulnerable states will significantly 
lower 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 , and subsequently the rate at which collagen is degraded. Equation (A1.4) 
demonstrates that small values for 𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁  can be explained without invoking a mechanism that 
involves collagenase-mediated unwinding. 
To explore whether this reaction scheme is consistent with prior experiments, we 
numerically solve the ODEs arising from the reaction scheme shown in Figure A1.1 to obtain 
estimates of the extent of collagenolysis as a function of 𝐾𝐾𝑒𝑒𝑒𝑒 , 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 , and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 . Unlike the 
derivation of Eq. (A1.4), these calculations do not assume steady state conditions and therefore 
represent exact solutions to the chemical kinetics. Furthermore, to be consistent with prior 
experiments, we report the total fraction of collagen degraded after incubating 1 µM collagen 
with enzyme for 48h (Chung, Dinakarpandian et al. 2004).  
We first consider the case where the enzyme concentration is significantly lower than the 
total collagen concentration, as is typically done in collagen-degradation experiments that 
employ full-length enzyme. In the present study, the precise choice of enzyme concentration is 
made to be consistent with prior experiments (Chung, Dinakarpandian et al. 2004). Figure A1.2 
(A–D) depicts the fraction of collagen degraded as a function of 𝐾𝐾𝑒𝑒𝑒𝑒 , 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 , and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 . The 
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collagen degradation profiles are quite similar over a large range of 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁  values. In particular, 
for each value of 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 three distinct regimes are readily identified: 
 
1. when binding to the vulnerable state is weak or disfavored (𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 < 103M–1), little or no 
collagen degradation occurs regardless of the value of 𝐾𝐾𝑒𝑒𝑒𝑒 ; 
2. when binding is relatively strong (𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 >103M–1) and vulnerable conformations are 
sampled infrequently, 𝐾𝐾𝑒𝑒𝑒𝑒< 10–1, little to no collagen degradation occurs even after a 48h 
incubation; and 
3. when 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 >103M–1and 𝐾𝐾𝑒𝑒𝑒𝑒 >10–1 (or ~101 for 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =108M–1) significant collagen 
degradation occurs.  
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Figure A1.2. Fraction of collagen degraded at 298K after 48h with [E]/[total collagen] = 10-2, 
and A) 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =102M-1, B) 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =104M-1, C) 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =106M-1, and D) 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =108M-1 
 
These data demonstrate that collagenolysis requires vulnerable states to be sampled 
relatively frequently and relatively strong binding of collagenases to vulnerable conformers. 
Interestingly, unfolding simulations on a collagen-like peptide that models a region adjacent to 
the true collagenase cleavage site suggest that 𝐾𝐾𝑒𝑒𝑒𝑒 ≈10
0
 at 298 K, implying that the first criterion 
is met at room temperature (Stultz 2002). The fact that prior experiments have observed 
significant degradation when collagen is incubated with low enzyme concentrations at 298 K 
suggests that 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 >103M–1 (Chung, Dinakarpandian et al. 2004). In addition, if 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 = 108M-1 
B) A) 
D) C) 
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then little collagen degradation will be observed after 48h, assuming 𝐾𝐾𝑒𝑒𝑒𝑒 =100. Hence, the fact 
that significant collagenolysis does occur at room temperature suggests that 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 <108M–1. We 
note that accurate estimates for 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁  at 298K are difficult to obtain experimentally as our data 
suggest that a significant percentage of collagen molecules adopt a vulnerable conformation at 
this temperature. Nevertheless, binding constants for collagenase binding to fibrillar collagen at 
298 K are near 106M–1, and therefore well below this upper bound (Welgus, Jeffrey et al. 1980).  
While full-length enzyme can cleave collagen at relatively low enzyme concentrations, 
experiments that employ mutant forms of enzyme may require much larger enzyme 
concentrations to observe degradation. Consequently, we study how 𝐾𝐾𝑒𝑒𝑒𝑒 , 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 , and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁   affect 
the rate of collagen-degradation when a high enzyme concentration is present (Figure A1.3 A 
and B). In Figure A1.3, we have explicitly labeled the region corresponding to incubating wild-
type enzyme with collagen (i.e., 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 >103M–1 and 𝐾𝐾𝑒𝑒𝑒𝑒 >10–1). One thing is apparent from 
these data. High enzyme concentrations do not necessarily guarantee that extensive 
collagenolysis will occur even when collagen is incubated with an equimolar concentration of 
enzyme. Collagenolysis is abrogated when the mutant of interest has reduced affinity for 
vulnerable states. 
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Figure A1.3. Fraction of collagen degraded at 298K after 48h with [E]/[total collagen] = 1, and 
A) 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =102M-1, and B) 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =106M-1 
 
Prior experiments that incubated collagen with high concentrations of MMP1 mutants 
lacking a hemopexin domain did not observe any collagenolysis after 48h (Chung, 
Dinakarpandian et al. 2004). Although these results have been interpreted to mean that partially 
B) 
A) 
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unfolded states do not occur spontaneously, they can also be explained by the notion that 
removal of the hemopexin-like domain reduces the affinity of MMP1 for collagen. This is 
especially poignant given that MMP1 hemopexin-like domains contain sites that bind collagen 
(Clark and Cawston 1989; Windsor, Birkedal-Hansen et al. 1991; Bigg, Shi et al. 1997). Figure 
A1.3 demonstrates that a substantial reduction in the binding affinity for the native state (𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 ), 
which is expected for mutant enzymes lacking the hemopexin-like domain, does not noticeably 
affect the collagen degradation profile. Instead, as in the case of low enzyme concentrations, 
collagenolysis depends almost entirely on 𝐾𝐾𝑒𝑒𝑒𝑒  and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 . 
In general, mutations that destabilize the complex formed by enzyme and vulnerable 
conformations, such as the removal of collagen binding sites on the enzyme, will slow the rate of 
collagenolysis. If the destabilization is significant, little collagen degradation will be observed 
after a 48h incubation time. To quantify the amount of destabilization needed to reduce the 
fraction of collagen degraded to negligible values, we computed the destabilization energy as 
follows. Let E denote wild-type MMP1, and Em denote a mutant form of MMP1 that binds 
vulnerable states with reduced affinity such that incubating Em with collagen for 48h results in 
degradation of less than 1% of the total collagen present. The two binding reactions are given by: 
  ( )ln VEbindG RT KE V EV∆ =−+ →  (A1.5)  
  ( )minln VEmm mG RT KE V E V∆ =−+ →  (A1.6)  
 
when 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 >𝐾𝐾𝑚𝑚𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁  the destabilization energy is given by: 
  
ΔΔ𝐺𝐺 = Δ𝐺𝐺𝑚𝑚 − Δ𝐺𝐺 = 𝑅𝑅𝑅𝑅𝑅𝑅𝑏𝑏 �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁𝐾𝐾𝑚𝑚𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 � (A1.7)  
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where 𝐾𝐾𝑚𝑚𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁  is the reduced binding constant associated with Em. When 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁  falls below 𝐾𝐾𝑚𝑚𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 , 
less  than 1% of the total collagen will be degraded after 48h. We note that 𝐾𝐾𝑚𝑚𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁  is a function of 
𝐾𝐾𝑒𝑒𝑒𝑒 and therefore the destabilization energy is a function of both 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁  and 𝐾𝐾𝑒𝑒𝑒𝑒 . The main point 
here is that if MMP1 binds the vulnerable state with a binding constant of 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 , then 
destabilizing the bound state by ∆∆G kcal/mol will reduce collagenolysis such that less than 1% 
of the total collagen present will be degraded. When the enzyme binds vulnerable and native 
states with dissociation constants in the micromolar range (𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 =106 and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 =106) the 
destabilization energy is less than 7.5 kcal/mol (Figure A1.4). Moreover, when 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 >103 and 
𝐾𝐾𝑒𝑒𝑒𝑒 >10–1 (ranges suggested by low enzyme concentration simulations), the destabilization 
energy ranges from 2.5 to 12.5 kcal/mol (Figure A1.4). Therefore, modest changes in the binding 
affinity - as expected with forms of MMP1 that lack collagen binding sites in the hemopexin-like 
domain - will have important consequences on the extent of collagenolysis. 
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Figure A1.4. Destabilization energies at 298K with [E] = 1 µM and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 = 106M-1.  Energies 
plotted for 𝐾𝐾𝑒𝑒𝑒𝑒 =10-1, 100, and >101.  Because 𝐾𝐾𝑚𝑚𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁  does not vary for 𝐾𝐾𝑒𝑒𝑒𝑒 > 101 (Figure A1.3 
B), the destabilization energy curve is the same for all 𝐾𝐾𝑒𝑒𝑒𝑒 >101. Given that the lower bound for 
degradation is 𝐾𝐾𝑒𝑒𝑒𝑒 =10-1, we observe that for a given 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 , the destabilization energy does not 
differ significantly over the range of 𝐾𝐾𝑒𝑒𝑒𝑒  suggested by our simulations. 
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A1.3 Discussion 
Since the first crystallographic structures of MMPs were published, the apparent 
mismatch between the width of the MMP active site pocket (5Å) and the width of the collagen 
triple helix (15Å) has presented a formidable challenge in explaining the mechanism of collagen 
degradation (Fields 1991; Overall 2002; Stultz 2002). Previous explanations have focused on a 
hypothesis that relies on the active unwinding of the collagen triple-helix by MMPs; that is, the 
simultaneous binding of MMP domains and the coordinated motions of these domains could 
exert the necessary mechanical force to unravel the helix. Accordingly, a number of 
experimental observations have been interpreted within this paradigm. Our results, however, 
suggest that these experiments can be understood without appealing to a mechanism that requires 
MMPs to act as triple-helicases. In this regard, we note the following: 
1.  Previous experiments suggest that the catalytic domain of MMP1 alone, MMP1(∆C), 
cannot cleave collagen (Clark and Cawston 1989; Chung, Dinakarpandian et al. 2004) - a 
finding consistent with the notion that preformed partially unwound states of collagen do 
not occur spontaneously. However, our data demonstrate that the lack of collagen 
degradation by MMP1(∆C) is explained by the observation that removal of the 
hemopexin-like domain reduces the enzyme’s affinity for (and thus stabilization of) the 
vulnerable state relative to full length enzyme (Clark and Cawston 1989; Murphy, Allan 
et al. 1992; Chung, Dinakarpandian et al. 2004). As the hemopexin-like domain of 
MMP1 contains sites that bind collagen (Clark and Cawston 1989; Windsor, Birkedal-
Hansen et al. 1991; Bigg, Shi et al. 1997), it is likely that MMP1(∆C) and full-length 
enzyme have different affinities for both native and vulnerable states. However, as is 
evident from Figure A1.2 and Figure A1.3, the extent of collagenolysis is more 
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dependent on the enzyme’s affinity for vulnerable conformers. Moreover, the critical role 
of the hemopexin-like domain in stabilizing vulnerable states is further supported by the 
observation that human leukocyte elastase (HLE), an enzyme that normally does not 
cleave triple-helical collagen can hydrolyze collagen when it is combined with solutions 
containing the MMP1 hemopexin-like domain (Chung, Dinakarpandian et al. 2004). 
2.  The binding of linker and hemopexin-like domains obtained from MT1-MMP has been 
shown to significantly perturb the triple-helical structure of type I collagen as measured 
by CD spectroscopy (Tam, Moore et al. 2004). As this perturbation is similar to the 
observed change in CD spectra when collagen is thermally denatured, this observation 
has been interpreted to mean that the linker and hemopexin-like domain alone are 
functioning as triple-helicases. If, however, collagen exists as an equilibrium distribution 
of different conformational states, and binding to the vulnerable state by the enzyme 
stabilizes this conformation, then the principle of mass action dictates that the overall 
structure of collagen in solution will be shifted to vulnerable conformations, yielding a 
change in the observed CD spectrum.  
3. It has been noted that collagen can be cleaved when incubated with the catalytic domain 
of MMP1(∆C) and severed MMP1 hemopexin-like domains (HpxMMP1) (Chung, 
Dinakarpandian et al. 2004). The lack of a linker connecting MMP1(∆C) and HpxMMP1 
makes active triple-helical unwinding unlikely, as a helicase function would require 
coordinated domain movements. However, if we consider that binding of the hemopexin-
like domain stabilizes the vulnerable state, then these experimental results can be 
understood in the context of preformed native and vulnerable states. 
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4. Collagenolysis occurs when collagen is placed in solutions containing catalytically 
inactive enzyme (E200A), and other enzymes that normally do not degrade tripe-helical 
collagen; for example, full-length MMP3, catalytic domain of MMP3 alone, and HLE 
(Chung, Dinakarpandian et al. 2004). While these data have been interpreted to mean that 
E200A unwinds triple-helical collagen, they are explained by the notion that preexisting 
vulnerable states of collagen are stabilized by E200A (as noted in point 2). 
 
The observed lack of collagen degradation in the case where collagen is incubated with 
MMP1(∆C) may be further understood by considering how connected catalytic and hemopexin-
like domains affect the collagenolytic ability of MMP1. Without a connected hemopexin-like 
domain to (i) bind to the correct region of collagen, near the scissile bond; (ii) stabilize the 
vulnerable state; and (iii) ensure that the connected catalytic domain is in the vicinity of the 
scissile bond, the local concentration of catalytic domain near the collagenase cleavage site 
would be significantly smaller in experiments involving MMP1(∆C) as opposed to full-length 
enzyme. Our results demonstrate that a straightforward reaction mechanism, which assumes that 
collagen is flexible in the vicinity of the collagenase cleavage site, can explain collagenolysis 
without implying that collagenases perform the energetically costly task of actively unwinding 
triple-helical collagen. Collagen, like all other biological heteropolymers, undergoes thermal 
fluctuations that cause it to sample distinct structures in the neighborhood of the native state, 
some of which feature an ‘‘unwound’’ or vulnerable portion of the triple helix near the 
collagenase cleavage site. Collagenolysis occurs when collagenases stabilize the appropriate 
vulnerable state and, by virtue of having connected catalytic and hemopexin-like domains, 
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greatly increase the concentration of catalytic domains in the immediate vicinity of the cleavage 
site. 
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A1.4 Methods 
First, we construct a reaction scheme that describes collagenolysis without assuming that 
MMPs have any triple-helicase activity (see Figure A1.1). This reaction scheme leads to a set of 
ordinary differential equations (ODEs) as listed below: 
 
  𝑑𝑑[𝑁𝑁]
𝑑𝑑𝑑𝑑
= 𝑘𝑘2[𝑉𝑉] + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁] − 𝑘𝑘1[𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁][𝑁𝑁] (A1.8)  
  𝑑𝑑[𝑉𝑉]
𝑑𝑑𝑑𝑑
= 𝑘𝑘1[𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 [𝐶𝐶𝑉𝑉𝑁𝑁] − 𝑘𝑘1[𝑉𝑉] − 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 [𝑉𝑉][𝑁𝑁] (A1.9)  
  𝑑𝑑[𝐶𝐶𝑁𝑁𝑁𝑁]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁][𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁] (A1.10)  
  𝑑𝑑[𝐶𝐶𝑉𝑉𝑁𝑁]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑉𝑉][𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 [𝐶𝐶𝑉𝑉𝑁𝑁] − 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 [𝐶𝐶𝑉𝑉𝑁𝑁] (A1.11)  
  𝑑𝑑[𝑃𝑃]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 [𝐶𝐶𝑉𝑉𝑁𝑁] (A1.12)  
  𝑑𝑑[𝑁𝑁]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 [𝐶𝐶𝑉𝑉𝑁𝑁] + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉 [𝐶𝐶𝑉𝑉𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁][𝑁𝑁]
− 𝑘𝑘𝑜𝑜𝑏𝑏
𝑉𝑉 [𝑉𝑉][𝑁𝑁] (A1.13)  
 
To numerically solve these ODEs, we require estimates for each rate constant. As 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  
corresponds to the turnover number when the scissile bond is exposed and readily accessible, we 
assume that an upper bound for 𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  can be approximated by the catalytic rate constant of MMP-
1 on denatured collagen chains (Fields, Van Wart et al. 1987). Type I collagen contains two 
α1(I) chains and one α2(I) chain. The rate constant for denatured α1(I) chains is ~230h–1 and the 
rate constant for denatured α2(I) chain is ~750h–1. Therefore, to estimate the catalytic rate 
constant for type-I collagen, we use 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 = (1/3) × (2 × 230ℎ−1 + 750ℎ−1) ≈ 400ℎ−1. The 
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true value for the catalytic rate constant on 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  is likely significantly lower given that vulnerable 
states are not fully unfolded; that is, scissile bonds in vulnerable conformations may not be as 
exposed as scissile bonds in denatured states. Using this relatively high value for 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  in the 
numerical simulations provides a relatively stringent test of the model as we demonstrate that 
little-to-no collagenolysis occurs over 48h after exposure of the catalytic domain to collagen 
using this value. Moreover, numerical simulations with lower values of 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  produce the same 
result. 
Estimates for the remaining rate constants are determined by the equilibrium constants 
𝐾𝐾𝑒𝑒𝑒𝑒 = 𝑘𝑘1/𝑘𝑘2, 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 /𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 , and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 /𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 . The amount of collagen degraded over 
short time intervals is strongly dependent on the precise values of these rate constants. However, 
as we are interested in the fraction of collagen degraded after an extended period of time (48h), it 
is the equilibrium constants rather than the rate constants that determine the final amount of 
degradation. For example, k1 determines the rate at which native states transition to vulnerable 
states - a process driven by thermal fluctuations. If one is interested in collagen degradation after 
a long period of time, then it is the ratio of the forward rate k1 to the backward rate k2 that is most 
important. Simulations conducted using a wide range (over 10 orders of magnitude) of values for 
each rate constant verify that the precise values do not influence the results so long as the 
equilibrium constants are fixed. For each set of numerical simulations, 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁  is held at a fixed 
value, while 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑉𝑉𝑁𝑁  is allowed to vary from 10
–8
 to 1012M–1, ensuring that a wide range of 
equilibrium binding constants is simulated. Similarly, 𝐾𝐾𝑒𝑒𝑒𝑒 , the equilibrium constant for native 
and vulnerable states of collagen is also allowed to vary from 10–10 to 1010. Although we have not 
made any assumptions in our model as to whether collagen is in a soluble or fibrillar form, the 
range of equilibrium constants simulated likely includes regimes corresponding to both forms of 
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collagen. That is, it is likely that the cleavage site is not as accessible in fibrillar collagen relative 
to its state in collagen monomers. 
This effect, however, can be captured in 𝐾𝐾𝑒𝑒𝑒𝑒 , the equilibrium constant describing the 
relative amounts of native and vulnerable states. If the accessibility of the collagenase cleavage 
site is reduced in the fibrillar state, then this is effectively modeled by a low 𝐾𝐾𝑒𝑒𝑒𝑒 . As we consider 
many different values for 𝐾𝐾𝑒𝑒𝑒𝑒  in our simulations, the current set of simulations likely covers both 
scenarios, that is, cleavage of isolated collagen monomers and fibrillar collagen. Numerical 
simulations were performed in MATLAB (© Mathworks) using the ODE solver ode15s with the 
total collagen concentration set to 1µM. 
 
A1.4.1 Enzymatic cleavage with unwinding 
In this scenario, the MMP first binds to collagen, then unwinds it, and finally cleaves it.  
We assume that unwinding is a slow, but irreversible reaction. The reaction scheme is given by: 
  on
off
k
NEk
N E C→+ ←  (A1.14)  
  unwindk
NE VEC C→  (A1.15)  
  VEcatk
VEC P E→ +  (A1.16)  
where 𝑘𝑘𝑜𝑜𝑏𝑏  and 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜  are the on and off rates for the enzyme binding native collagen, respectively. 
𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑  is the rate constant for unwinding a native conformation to a vulnerable conformation, 
and 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  is the rate constant for degradation of the now-accessible scissile bond. 
To estimate the rate constant for unwinding, 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 , we first note that degradation 
experiments are typically fit with a simple Michaelis-Menten kinetics model to yield the 
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parameters 𝐾𝐾𝑚𝑚
𝑒𝑒𝑒𝑒𝑒𝑒 and 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑒𝑒𝑒𝑒𝑒𝑒 . Using parameters from the unwinding reaction scheme, the 
experimentally measured Michaelis-Menten parameters are then given by (Kuby 1990): 
  
𝐾𝐾𝑚𝑚
𝑒𝑒𝑒𝑒𝑒𝑒 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁
𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 ∙ 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑘𝑘𝑜𝑜𝑏𝑏  (A1.17)  
  
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑒𝑒𝑒𝑒𝑒𝑒 = 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁
𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  (A1.18)  
If we assume the unwinding is the rate-limiting step (i.e., 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 ≪ 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 ), we find: 
  
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑒𝑒𝑒𝑒𝑒𝑒 ≈
𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑  (A1.19)  
Thus, with Equation (A1.18) we can estimate 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑  as being equal to the experimentally 
measured catalytic rate 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑒𝑒𝑒𝑒𝑒𝑒 . We can then use the transition state theory to calculate the free 
energy barrier for unwinding as follows: 
  
𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 ≈
𝑘𝑘𝐵𝐵𝑅𝑅
ℎ
exp�−Δ𝐺𝐺+
𝑅𝑅𝑅𝑅
� = 𝜈𝜈 exp�−Δ𝐺𝐺+
𝑅𝑅𝑅𝑅
� (A1.20)  
Thus, the activation energy is given by: 
  Δ𝐺𝐺+ = −𝑅𝑅𝑅𝑅𝑅𝑅𝑜𝑜𝑅𝑅(𝜐𝜐−1𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 ) (A1.21)  
At 298 K, υ is 6.25 ps-1 (Voet, Voet et al. 2006), and with 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑒𝑒𝑒𝑒𝑒𝑒 ≈ 𝑘𝑘𝑢𝑢𝑏𝑏𝑢𝑢𝑏𝑏𝑏𝑏𝑑𝑑 ≈0.015 s-1(Welgus, Jeffrey et 
al. 1981), we find Δ𝐺𝐺+ ≈20 kcal/mol.  It is important to note that this barrier corresponds to the reaction 
when the enzyme is present. 
 
A1.4.2 Collagenolysis with preformed partially unfolded states in solution 
In this scenario, collagen can exist in either a native (folded) or vulnerable (partially 
unfolded) state. MMP can bind to either state, but cleavage will only occur when it is bound to 
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the vulnerable state. The reaction scheme is given by Figure A1.1 and the resulting ODEs are 
listed in Equations (A1.8) to (A1.13). 
We can relate the rate of cleavage of the vulnerable state of collagen (or catalytic rate) in 
this scheme to the catalytic rate, 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 , in Equation (A1.3) of the aforementioned simple 
enzymatic scheme (found in Results) by noting that the rate of product creation (𝑑𝑑𝑃𝑃/𝑑𝑑𝑑𝑑) must be 
the same for both: 
  
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁 [𝐶𝐶𝑉𝑉𝑁𝑁]𝑑𝑑 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁]𝑑𝑑 → 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁]𝑑𝑑[𝐶𝐶𝑉𝑉𝑁𝑁]𝑑𝑑  (A1.22)  
We can again gain insight by examining the steady state approximation for the 
intermediate vulnerable state-enzyme complex: 
  0 = 𝑑𝑑[𝐶𝐶𝑉𝑉𝑁𝑁]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 [𝑉𝑉][𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 [𝐶𝐶𝑉𝑉𝑁𝑁] − 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 [𝐶𝐶𝑉𝑉𝑁𝑁]= 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 [𝑉𝑉][𝑁𝑁] − (𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )[𝐶𝐶𝑉𝑉𝑁𝑁] (A1.23)  
Recombining the above equation to solve for [𝐶𝐶𝑉𝑉𝑁𝑁]yields: 
  [𝐶𝐶𝑉𝑉𝑁𝑁] = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 [𝑉𝑉][𝑁𝑁](𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 ) (A1.24)  
Similarly applying the steady state approximation to the intermediate native state-enzyme 
complex yields: 
  0 = 𝑑𝑑[𝐶𝐶𝑁𝑁𝑁𝑁]
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁][𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁] (A1.25)  
Recombining the above equation to solve for [𝐶𝐶𝑁𝑁𝑁𝑁]yields: 
  [𝐶𝐶𝑁𝑁𝑁𝑁] = 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁][𝑁𝑁]𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁  (A1.26)  
We now can calculate the ratio [𝐶𝐶𝑁𝑁𝑁𝑁]/[𝐶𝐶𝑉𝑉𝑁𝑁]and thus relate 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  and 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 : 
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𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 [𝐶𝐶𝑁𝑁𝑁𝑁]𝑑𝑑[𝐶𝐶𝑉𝑉𝑁𝑁]𝑑𝑑  
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁][𝑁𝑁]𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 (𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 +𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 [𝑉𝑉][𝑁𝑁] = 
= 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 [𝑁𝑁]𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 (𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 [𝑉𝑉]  
= 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 [𝑁𝑁][𝑉𝑉] 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁 (𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉  
=𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 �𝐾𝐾𝑒𝑒𝑒𝑒 �
−1(𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 ) (𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉 +𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉  
=𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 �𝐾𝐾𝑒𝑒𝑒𝑒 �
−1(𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 ) �(𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )−1 + 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 � 
 
(A1.27)  
If assume that 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉 >> 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  (binding is much faster than catalysis - an assumption valid for 
many enzyme-substrate complexes (Stryer 1988)), we find: 
  
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁 ≈ 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑁𝑁𝑁𝑁 �𝐾𝐾𝑒𝑒𝑒𝑒 �
−1(𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁 )(𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁 )−1 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 �𝐾𝐾𝑒𝑒𝑒𝑒 �−1 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑁𝑁𝑁𝑁𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑𝑉𝑉𝑁𝑁  (A1.28)  
Rearranging to obtain 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑𝑁𝑁𝑁𝑁 , we find: 
  
𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑁𝑁𝑁𝑁 ≈ 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑
𝑉𝑉𝑁𝑁 �𝐾𝐾𝑒𝑒𝑒𝑒 �
𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑
𝑉𝑉𝑁𝑁
𝐾𝐾𝑐𝑐𝑐𝑐𝑑𝑑
𝑁𝑁𝑁𝑁  (A1.29)  
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Appendix 2: 
Testing a Conformational Selection 
Model of Collagen Degradation  
Appendix 2 is adapted in part from: Salsas-Escat, R., Nerenberg, P.S., and C. M. Stultz (2010). 
"Cleavage Site Specificity and Conformational Selection in Type I Collagen Degradation." 
Biochemistry.
 
 Accepted. 
Acknowledgment: The Matlab simulations of the differential equations in this section were 
performed by my former labmate Paul Nerenberg   
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A2.1 Introduction 
In Chapters 1 and 2 we found that locally unfolded states exist in collagen, and 
hypothesized that they play a role in collagen degradation and collagenase cleavage site 
specificity. In Chapter 3 we have shown that these unfolded states can be cleaved by the catalytic 
domain of collagenases alone, suggesting that these unfolded states exist in the absence of 
collagenases. The results shown in Chapter 3 indicate that, while able to cleave triple helical 
collagen, CMMP1 and CMMP8 are very inefficient. This result verifies the prediction of the two 
state degradation model presented in the Introduction chapter, and explained in detail in 
Appendix 1. The failure to observe type I collagen degradation by CMMP1 and CMMP8 (Clark 
and Cawston 1989; Schnierer, Kleine et al. 1993; Chung, Dinakarpandian et al. 2004) is not due 
to the lack of locally unfolded states, but due to the low affinity of these enzymes towards these 
locally unfolded states compared to full length MMP1 and MMP8. 
Since in Chapter 3 we unequivocally show that CMMP1 and CMMP8 are to cleave type I 
collagen, in Appendix 2 we want to model this reaction using the two state degradation model 
previously presented. In particular, we wish to characterize the equilibrium existing between 
folded and locally unfolded states, as well as the interaction between CMM1/8 and these locally 
unfolded states.  
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A2.2 Results 
A2.2.1 A conformational selection model for collagenolysis  
The data presented in Chapter 3 demonstrate that type I collagen degradation at the 
unique collagenase cleavage site can occur in vitro at room temperature with only the catalytic 
domain of MMPs. Since CMMP8 and CMMP1 cleave unfolded collagen at multiple sites (Figure 
3.5 A lane 8, Figure 3.5 B lane 6), but triple-helical collagen at only one site (Figure 3.5 A lane 
7, Figure 3.5 B lane 5), we interpret our findings in light of a model where unfolding of collagen 
at the unique cleavage site enables collagenases to gain access to their corresponding scissile 
bonds (Figure A2.1) (Nerenberg, Salsas-Escat et al. 2008). In this model, collagen can exist in 
both native triple-helical (N) and vulnerable states, or locally unfolded, (V), and collagenolysis 
only occurs when the enzyme (consisting of only the catalytic domain, C) binds and cleaves the 
vulnerable state. Vulnerable states correspond to the ensemble of conformers that have the 
collagenase cleavage site in an unfolded and solvent-exposed conformation. We use N·C and V·C 
to denote complexes of the native and vulnerable states, respectively, with the mutant enzyme 
that only contains the catalytic domain, and P denotes the degradation products released by the 
enzyme after cleavage.  
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Figure A2.1. A conformational selection mechanism for collagenolysis with MMP catalytic 
domains. Collagen exists in an equilibrium between native (N) and vulnerable (V) states with the 
equilibrium determined by 𝐾𝐾𝑒𝑒𝑒𝑒 = 𝑘𝑘1𝑘𝑘2. The catalytic domain of MMPs (C) interacts in a non-
specific manner with the native state with binding constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑁𝑁𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁 , yielding the N·C 
complex. C binds to the vulnerable state, V, with binding constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 , forming the V·C 
complex. The V·C complex is then degraded with catalytic rate kcat. 
 
 
This reaction scheme naturally leads to a set of ordinary differential equations (ODEs) 
that can be solved numerically, yielding the concentration of each species as a function of time 
(see Methods). Numerical solutions of the ODEs are exact in that they do not make any 
assumptions about steady state behavior and they specifically account for the different rate 
constants associated with each of the different species in the reaction. Generating solutions for 
the model therefore requires inputs in the form of rate constants associated with each of the 
various steps in the mechanism.  
 Previous studies with a related reaction scheme demonstrated that the model is not 
sensitive to the specific choice of the individual rate constants when one is interested in the 
reactant concentrations over long times with respect to the individual rate constants themselves 
(Nerenberg, Salsas-Escat et al. 2008). In this scenario, the solutions to the ODEs depend more on 
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the ratio of the rate constants (Nerenberg, Salsas-Escat et al. 2008). Since our experiments occur 
over days and theoretical estimates for local unfolding/folding events within the collagen triple 
helix are on the order of inverse nanoseconds (Stultz 2002; Nerenberg and Stultz 2008), and rate 
constants for binding reactions in general are on the order of inverse milliseconds (Ottl, Gabriel 
et al. 2000), we explore the behavior of the system as a function of the associated equilibrium 
and binding constants, 𝐾𝐾𝑒𝑒𝑒𝑒 = 𝑘𝑘1𝑘𝑘2, 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑁𝑁𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁 , and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 . It is important to note that 
while we use these equilibrium/binding constants to describe the behavior of the model, the 
associated ODEs explicitly depend on the individual rate constants.  
As described in the Methods section we estimate 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑁𝑁𝑁𝑁  using previously determined 
collagenase binding rate constants, which were obtained under conditions when the triple-helical 
state is expected to be most stable (Ottl, Gabriel et al. 2000). We note, however, that the model is 
not sensitive to the choice of binding constant for the native state, 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑁𝑁𝑁𝑁 , see Appendix 1 for 
more details (Nerenberg, Salsas-Escat et al. 2008). The catalytic rate constant, kcat, corresponds 
to the rate of peptide bond hydrolysis after the enzyme has bound the unfolded region containing 
the cleavage site. Bounds for kcat are therefore obtained from experimentally measured rate 
constants from MMP-mediated degradation of gelatin and unfolded collagen-like peptides (see 
Methods) (Welgus, Jeffrey et al. 1982; Netzel-Arnett, Fields et al. 1991). This leaves two 
undetermined parameters for the model: 𝐾𝐾𝑒𝑒𝑒𝑒 (the equilibrium constant describing the relative 
concentration of vulnerable and native conformers) and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁  (the binding constant of the 
catalytic domain for vulnerable states). The method by which 𝐾𝐾𝑒𝑒𝑒𝑒  and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁  are converted into 
forward/backward and on/off rate constants, respectively, for the numerical simulations is 
described in the Methods section. 
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To determine estimates for the missing parameters, we fit the ODEs arising from the 
model shown in Figure A2.1 to experimental degradation data. We begin by focusing on 
previous degradation experiments that incubated CMMP8 at room temperature with a 
heterotrimeric type I collagen-like model peptide that contains the collagenase cleavage site and 
its surrounding residues (Trimer A, Figure A2.2 A) (Ottl, Gabriel et al. 2000). The melting 
temperature of this peptide is 9ºC, and experiments were performed at 25ºC; hence, the peptide is 
largely unfolded at this temperature. In our model 𝐾𝐾𝑒𝑒𝑒𝑒  represents the equilibrium constant 
between native and vulnerable states, where the vulnerable ensemble includes all conformers that 
have the collagenase cleavage site in an unfolded and solvent-exposed conformation. 
Consequently, for this system we expect 𝐾𝐾𝑒𝑒𝑒𝑒 > 1, and therefore fitting these data to the model 
shown in Figure A2.1 provides a test of the method. Using the reaction scheme outlined in 
Figure A2.1, we computed the amount of peptide that would be degraded as a function of time 
for a range of 𝐾𝐾𝑒𝑒𝑒𝑒 , �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8, and kcat values and compared these degradation profiles to the 
corresponding experimental data. For each triplet, 𝐾𝐾𝑒𝑒𝑒𝑒 , �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8, kcat, we computed the root 
mean square error (RMSE) between the degradation time course obtained with the model and the 
experimental data (see Methods). While a relatively wide range of values for 𝐾𝐾𝑒𝑒𝑒𝑒  and 
�𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝑁𝑁 �
𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 are tried (10-6 ≤ 𝐾𝐾𝑒𝑒𝑒𝑒  ≤ 106, 100 M-1 ≤ �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 ≤ 1012 M-1), the best fits are 
obtained when 𝐾𝐾𝑒𝑒𝑒𝑒 > 30 and �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 = 0.7-1.1 x 106 M-1, regardless of the value of kcat 
that was used (0.11 s-1 ≤ kcat ≤ 11.1 s-1) (Figure A2.3). Moreover, varying kcat by two orders of 
magnitude caused the minimum RMSE to vary by only 2%. As the best fits have 𝐾𝐾𝑒𝑒𝑒𝑒 > 30, 
these results suggest that the vulnerable state of the peptide dominates at room temperature - a 
finding in agreement with the experimental conditions, as discussed above. Moreover, the 
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predicted results from the model using these values show excellent agreement with experiment 
(Figure A2.2 B). 
 
Figure A2.2. Conformational selection and degradation of Trimer A by CMMP8. A) Sequence of 
the type I collagen-like model peptide Trimer A from Ottl et al. used in prior degradation 
experiments with CMMP8 (Ottl, Gabriel et al. 2000). The type I collagen sequence surrounding 
the collagenase cleavage site is shown in green, while the triplets containing the scissile bonds 
are indicated in red. The disulfide linkages of the C-terminus cystine knot region are indicated 
with the black vertical lines. B) Comparison of model and experimental degradation time courses 
over 20 h for best fit values 𝐾𝐾𝑒𝑒𝑒𝑒  = 60 , �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝑁𝑁 �
𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 = 0.7 x 106 M-1, and kcat = 1.1 s-1. 
Experimental data are indicated by the black circles; the model time course is indicated by the 
blue line. 
A) B) 
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Figure A2.3. Root mean square error (RMSE) of the conformational selection model for Trimer 
A model peptide degradation time course. For each pair of values �𝐾𝐾𝑒𝑒𝑒𝑒 ,𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �, the fraction of 
model peptide degraded by CMMP8 was computed at 1, 3.5, 6, 7.5, and 20 h.  The root mean 
square difference was then calculated using these fractions and the experimentally measured 
amount of degradation at the same time points. The lowest RMSEs (shown in dark blue) indicate 
�𝐾𝐾𝑒𝑒𝑒𝑒 ,𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 � pairs that provide good fits to the experimental degradation data. Model fitting was 
done for three values of kcat spanning two orders of magnitude: A) 0.11 s-1, B) 1.1   s-1, and C) 11 
s-1. Over this range of kcat, the best fit values of �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 range from 0.7-1.1 x 106 M-1. 
 
  
A) B) 
C) 
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A2.2.2 Determining 𝑲𝑲𝒆𝒆𝒆𝒆 for type I collagen at room temperature 
To obtain an estimate for 𝐾𝐾𝑒𝑒𝑒𝑒  at room temperature we quantified the extent of collagen 
degradation over time using the data shown in Figure 3.5 A. We then fit the reaction scheme 
shown in Figure A2.1 to these data to obtain an estimate for 𝐾𝐾𝑒𝑒𝑒𝑒 . We note that the previously 
discussed studies on a heterotrimeric type I collagen-like peptide, which contains the collagenase 
scissile bond, find that �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 = 0.7-1.1 x 106 M-1. As this peptide is a model for the 
collagenase cleavage site, we used this range of �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 in our numerical calculations of 
the model for type I collagen.  
We again compute the RMSE between the degradation time courses obtained with the 
model using many different values of 𝐾𝐾𝑒𝑒𝑒𝑒  and compare these results to the experimentally 
determined degradation time course. Varying kcat of CMMP8 over two orders of magnitude did 
not change the best fit values for 𝐾𝐾𝑒𝑒𝑒𝑒  and causes the minimum RMSE to again vary by only 2% 
(Figure A2.5). The best fits between the model and experiment are achieved when 𝐾𝐾𝑒𝑒𝑒𝑒 = 1.7-2.1 
x 10-3 (Figure A2.4 A), and the corresponding degradation plot obtained from the model agrees 
well with experiment (Figure A2.4 B). This value for 𝐾𝐾𝑒𝑒𝑒𝑒  suggests that the folded triple-helical 
native state is more favorable at room temperature. 
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Figure A2.4. Conformational selection and degradation of type I collagen by CMMP8. A) Root 
mean square error (RMSE) of the conformational selection model over the time course for 
degradation experiments utilizing type I collagen and CMMP8. For each value of 𝐾𝐾𝑒𝑒𝑒𝑒 , the 
fraction of degraded type I collagen is computed at 8, 16, 24, 32, 40, and 48 h. The root mean 
square difference is then calculated using these fractions and the experimentally measured 
fraction of degraded collagen. RMSE curves are computed using the lower (red) and upper 
(green) bounds of �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8. B) A comparison of model and experimental degradation time 
courses over 48 h for best fit values 𝐾𝐾𝑒𝑒𝑒𝑒= 2.1 x 10
-3, �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8 = 0.7 x 106 M-1, and kcat = 
1.1 s-1. Experimental data are indicated by the black circles with error bars; the model time 
course is indicated by the blue line.  
  
A) B) 
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Figure A2.5. Root mean square error (RMSE) of conformational selection model for type I 
collagen degradation time course. For each value of 𝐾𝐾𝑒𝑒𝑒𝑒 , the fraction of type I collagen degraded 
by CMMP8 is computed 8, 16, 24, 32, 40, and 48 h. The root mean square difference is then 
calculated using these fractions and the experimentally measured amount of degradation at the 
same time points. The lowest RMSEs indicate 𝐾𝐾𝑒𝑒𝑒𝑒   values that provide good fits to the 
experimental degradation data.  Model fitting is done for three values of kcat spanning two orders 
of magnitude (0.11 - 11 s-1) and for A) the lower bound (0.7 x 106 M-1) and B) the upper bound 
(1.1 x 106 M-1) of �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8. As the RMSE curves for each value of kcat have the same 
minima, this demonstrates that varying kcat does not affect the best fit values for 𝐾𝐾𝑒𝑒𝑒𝑒 . 
 
  
A) B) 
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A2.2.3 Determining 𝑲𝑲𝒃𝒃𝒃𝒃𝒃𝒃𝒃𝒃𝑽𝑽𝑽𝑽  for CMMP1 
Despite the fact that CMMP1 has a higher specific activity than CMMP8 under our 
experimental conditions (as measured against a thiopeptolide substrate, see Methods in Chapter 
3), it degrades collagen with considerably lower efficiency than CMMP8 (Figure 3.5 A and B). 
To decipher the physical basis for this reduced activity, we apply the reaction scheme shown in 
Figure A2.1 to the CMMP1 degradation experiments.  
Given that 𝐾𝐾𝑒𝑒𝑒𝑒  is an inherent property of type I collagen at a given temperature, and both 
CMMP1 and CMMP8 collagen degradation experiments were performed at room temperature, 
𝐾𝐾𝑒𝑒𝑒𝑒  is the same for both reactions. Thus, we use our degradation model to determine the range of 
�𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝑁𝑁 �
𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶1. As kcat corresponds to the catalytic rate once the protein has bound the vulnerable 
state (that is unfolded in the region of the scissile bond), it is estimated using previously 
determined kcat values for MMP1 degrading gelatin from type I collagen (Welgus, Jeffrey et al. 
1982). 
With 𝐾𝐾𝑒𝑒𝑒𝑒 = 1.7-2.1 x 10-3, the best fits are found for �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶1 = 0.9-1.3 x 104 M-1 
(Figure A2.6 A and B). These data suggest that CMMP1’s binding affinity for the vulnerable 
state of collagen is nearly two orders of magnitude lower than that of CMMP8. Expressed as a 
difference of binding free energies, ∆∆𝐺𝐺𝐵𝐵𝐵𝐵𝑁𝑁𝐵𝐵 = (∆𝐺𝐺)𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶1 − (∆𝐺𝐺)𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶8, the binding of 
CMMP1 to type I collagen is approximately 2.5 kcal/mol less favorable than the binding of 
CMMP8 to type I collagen.  
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Figure A2.6. Conformational selection and degradation of type I collagen by CMMP1. A) RMSE 
of the conformational selection model over the time course for degradation experiments utilizing 
type I collagen and CMMP1. For each value of �𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 �𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶1, the fraction of degraded type I 
collagen is computed at 24, 48, 96, and 144 h. The root mean square difference is then calculated 
using these fractions and the experimentally measured fraction of degraded collagen. RMSE 
curves are computed using the lower (red) and upper (green) bounds of 𝐾𝐾𝑒𝑒𝑒𝑒 . B) A comparison of 
model and experimental degradation time courses over 48 h for best fit values 𝐾𝐾𝑒𝑒𝑒𝑒 = 2.1 x 10-3, 
�𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝑁𝑁 �
𝑁𝑁𝐶𝐶𝐶𝐶𝐶𝐶1 = 0.9 x 104 M-1, and kcat = 0.11 s-1. Experimental data are indicated by the black 
circles with error bars; the model time course is indicated by the blue line. 
  
A) B) 
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A2.3 Discussion 
Our results in Chapter 3 unambiguously demonstrate that collagenolysis in vitro can 
occur with MMP deletion mutants that contain only the catalytic domain, and that cleavage 
occurs at the unique cleavage site recognized by full length collagenases. This indicates that the 
hemopexin-like domain is not required for peptide bond hydrolysis and enzyme specificity in 
vitro at room temperature. In light of these observations we interpret our results using a 
conformational selection model where thermal fluctuations at the unique cleavage site cause the 
protein to sample partially unfolded vulnerable states that can then be recognized and cleaved by 
collagenases (Nerenberg, Salsas-Escat et al. 2008). This formalism allows us to estimate the 
relative amounts of native and vulnerable states at room temperature from an analysis of type I 
collagen degradation data. Estimates of Keq for a small heterotrimeric peptide modeling the 
collagenase cleavage site in type I collagen suggest that the vulnerable state dominates at room 
temperature for this peptide - a finding in agreement with the measured melting temperature of 
this peptide (Ottl, Gabriel et al. 2000). For type I collagen at room temperature the calculated 
𝐾𝐾𝑒𝑒𝑒𝑒  of 1.7-2.1 x 10
-3 corresponds to a free energy difference of ~3.5 kcal/mol between the two 
states, where the folded triple-helical state is the most stable. This free energy difference 
corresponds to breaking 2-4 favorable hydrogen bonds, a finding in agreement with a previously 
proposed structure of the type I collagen vulnerable state (Nerenberg and Stultz 2008). 
Interestingly, this estimate for the relative amounts of vulnerable states for both the scissile 
bond-containing heterotrimeric peptide and type I collagen in solution are obtained from an 
analysis of the degradation data alone. That is, although the model itself does not explicitly 
contain information about the temperature at which the experiments are performed, it correctly 
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predicts that the degradation experiments are performed at a relatively high temperature for the 
heterotrimeric peptide and a relatively low temperature for collagen. 
Previous experiments that incubated type I collagen with deletion mutants corresponding 
to the catalytic domain MMPs failed to discover any degradation products, thereby suggesting 
that collagen does not adopt partially unfolded conformations at room temperature (Schnierer, 
Kleine et al. 1993; Chung, Dinakarpandian et al. 2004). However, as our work demonstrates, at 
temperatures well below collagen’s melting temperature, the relative concentration of partially 
unfolded conformers will be small, and consequently the rate of collagen degradation will be low 
(Nerenberg, Salsas-Escat et al. 2008). Under these conditions appreciable amounts of 
degradation will only be observed when relatively long incubation times and high enzyme 
concentration are used. More precisely, we find that two days of incubation time with CMMP8 
and six days with CMMP1 are required to see evidence of collagen degradation.  
Additionally, our results offer an explanation for the different type I collagen efficiencies 
of CMMP1 and CMMP8. While the catalytic rates for the two enzymes are likely different, our 
data suggest that variations in kcat are insufficient to explain the differences in the overall 
degradation rates. On the other hand, we find that the binding of CMMP1 to the vulnerable state 
of type I collagen is 2.5 kcal/mol less favorable than the binding of CMMP8. This free energy 
difference corresponds to relatively small differences in the bound structures themselves; e.g., 
breaking 1-2 favorable hydrogen bonds could easily explain a difference of this magnitude. In 
addition, the notion that CMMP1 has a weaker binding affinity for vulnerable type I collagen 
chains than CMMP8 is consistent with our observation that CMMP1 degrades denatured type I 
collagen (gelatin) less efficiently than CMMP8 (Figure 3.6 C). Together these data suggest that 
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subtle changes in binding between similar homologous enzymes can lead to significant 
differences in the overall reaction kinetics. 
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A2.4 Methods 
A2.4.1 Densitometry analysis 
Densitometry was performed with a Kodak Gel Logic 100 Imaging System. Bands are 
imaged using an automatic lane and band fitting method (Kodak Molecular Imaging Software 
v4.0.0). The percentage of type I collagen degradation by CMMP8 or CMMP1 is measured by 
dividing the sum of the net intensities of the γdeg, βdeg, ¼ and ¾ bands by the sum of the total net 
intensity of all the bands corresponding to total collagen in a given lane (γ, γdeg, β, βdeg, α1, α2, 
and the ¼ and ¾ bands). γ and β bands correspond to N-terminally crosslinked collagen 
molecules (Veis and Anesey 1965; French, Mookhtiar et al. 1987; Shigemura, Ando et al. 2004; 
Morimoto, Kawabata et al. 2009). The γ bands correspond to a trimer of chains (Shigemura, 
Ando et al. 2004; Morimoto, Kawabata et al. 2009). The β bands correspond to a dimer with two 
α1 chains (β11) or one α1 and one α2 chains (β12), with only one crosslink (French, Mookhtiar 
et al. 1987; Shigemura, Ando et al. 2004; Morimoto, Kawabata et al. 2009). These cannot be 
resolved using the 4-12% gradient gels, and are imaged together. Data are presented as the mean 
and standard deviation over three independent gels per experiment.  
 
A2.4.2 Numerical simulations using a conformational selection model 
We develop a reaction scheme based on a conformational selection model to determine 
whether our experimental observations can be explained using a formalism that assumes collagen 
can sample partially unfolded states in solution (Nerenberg, Salsas-Escat et al. 2008). In this 
scheme collagen exists in an equilibrium between native (N) and partially unfolded, or 
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vulnerable (V), states. The associated equilibrium constant is denoted by 𝐾𝐾𝑒𝑒𝑒𝑒 . The catalytic 
domain of MMPs (C) interacts in a non-specific manner with the native state with binding 
constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑁𝑁𝑁𝑁 , yielding the N·C complex and C can also bind to the vulnerable state, V, with 
binding constant 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 , forming the V·C complex. Binding of C to the native state, N, does not 
lead to collagenolysis while the V·C complex is degraded with catalytic rate kcat.  
The reaction scheme naturally leads to a set of ordinary differential equations (ODEs), 
with two rate constants corresponding to each equilibrium/binding constant (i.e., 𝐾𝐾𝑒𝑒𝑒𝑒 = 𝑘𝑘1𝑘𝑘2, 
𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑁𝑁𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁
𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜
𝑁𝑁𝑁𝑁 , and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 ). The set of ODEs that describes the time evolution of each 
species shown is given by: 
 
 𝑏𝑏[𝑁𝑁]
𝑏𝑏𝑑𝑑
= −𝑘𝑘1[𝑁𝑁] + 𝑘𝑘2[𝑉𝑉] − 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁[𝑁𝑁][𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁 [𝑁𝑁 ∙ 𝑁𝑁]  (A2.1)  
 𝑏𝑏[𝑉𝑉]
𝑏𝑏𝑑𝑑
= −𝑘𝑘2[𝑉𝑉] + 𝑘𝑘1[𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁[𝑉𝑉][𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 [𝑉𝑉 ∙ 𝑁𝑁]  (A2.2)  
 𝑏𝑏[𝑁𝑁 ∙ 𝑁𝑁]
𝑏𝑏𝑑𝑑
= −𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁 [𝑁𝑁 ∙ 𝑁𝑁]  + 𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁[𝑁𝑁][𝑁𝑁] (A2.3)  
 𝑏𝑏[𝑉𝑉 ∙ 𝑁𝑁]
𝑏𝑏𝑑𝑑
= −𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 [𝑉𝑉 ∙ 𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁[𝑉𝑉][𝑁𝑁]−𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑 [𝑉𝑉 ∙ 𝑁𝑁] (A2.4)  
  𝑏𝑏[𝐶𝐶]
𝑏𝑏𝑑𝑑
= 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑 [𝑉𝑉 ∙ 𝑁𝑁] (A2.5)  
 𝑏𝑏[𝑁𝑁]
𝑏𝑏𝑑𝑑
= −𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁[𝑁𝑁][𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁 [𝑁𝑁 ∙ 𝑁𝑁] − 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁[𝑉𝑉][𝑁𝑁] + 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁[𝑉𝑉][𝑁𝑁]+ 𝑘𝑘𝑐𝑐𝑐𝑐𝑑𝑑 [𝑉𝑉 ∙ 𝑁𝑁] (A2.6)  
    
  
where P denotes the products of collagenolysis. 
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We use previously determined rate constants for MMP1 binding to a heterotrimeric 
collagen-like peptide that contains the type I collagen collagenase cleavage site at a temperature 
substantially less than its melting temperature (i.e., we expect this peptide to be in a well-folded 
triple-helical conformation at this temperature) to estimate the native state binding rate constants, 
𝑘𝑘𝑜𝑜𝑏𝑏
𝑁𝑁𝑁𝑁  and 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁  (𝑘𝑘𝑜𝑜𝑏𝑏𝑁𝑁𝑁𝑁 =1.56 103 M-1 s-1, 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑁𝑁𝑁𝑁 =5.35 10-3 s-1) (Ottl, Gabriel et al. 2000). The 
catalytic rate constant of the vulnerable state, kcat, for CMMP1 was estimated from the 
experimentally measured catalytic rates of MMP1 degrading gelatin (Welgus, Jeffrey et al. 
1982). Because similar data does not exist for CMMP8, we set lower and upper bounds for the 
catalytic rate based on previously published data. The lower bound of kcat for CMMP8 is set 
equal to that of CMMP1, as it is known that MMP8 has a greater catalytic rate than MMP1 for 
the same substrate and at the same temperature (Welgus, Jeffrey et al. 1982; Gioia, Fasciglione et 
al. 2002). Upper bounds for the catalytic rate of CMMP8 are obtained from experimentally 
measured rate constants of FMMP8 degrading linear collagen-like peptides (Netzel-Arnett, 
Fields et al. 1991). This approach yields a range of kcat for CMMP8 spanning 0.11-11.1 s-1. 
Finding the concentration of each reactant species as function of time requires knowledge 
of each of the remaining rate constants 𝑘𝑘1,𝑘𝑘2,𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁 ,𝑐𝑐𝑏𝑏𝑏𝑏 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 . Previous studies with a related 
reaction scheme demonstrated that the model is not sensitive to the specific choice of the 
individual rate constants when one is interested in the reactant concentrations over long time 
periods (i.e., a time that is long with respect to the individual rate constants themselves, see 
Appendix 1) (Nerenberg, Salsas-Escat et al. 2008). In this case, the system behavior is dependent 
on the ratio of the rate constants, or equivalently the associated equilibrium binding constants 
𝐾𝐾𝑒𝑒𝑒𝑒  and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 . Since our experiments occur over days, which is very long with respect to the 
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folding/unfolding and binding processes of interest, we determine the behavior of the system as a 
function of 𝐾𝐾𝑒𝑒𝑒𝑒  and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 . 
To convert a given 𝐾𝐾𝑒𝑒𝑒𝑒  into the appropriate transition rate constants, 𝑘𝑘1 and 𝑘𝑘2, for the 
solution of the ODEs, we use initial rate constant values (𝑘𝑘1𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  and 𝑘𝑘2𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  , set equal to 106 s-1) that 
are consistent with the folding times for a number of small proteins; e.g., (Wittung-Stafshede, 
Lee et al. 1999; Kubelka, Chiu et al. 2006). These rate constants are then multiplied them by a 
scale factor α according to: 
 𝑘𝑘1 = 𝛼𝛼12𝑘𝑘1𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  𝑐𝑐𝑏𝑏𝑏𝑏 𝑘𝑘2 = 𝛼𝛼−12𝑘𝑘2𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  (A2.7)  
 
𝐾𝐾𝑒𝑒𝑒𝑒 = 𝑘𝑘1𝑘𝑘2 = 𝛼𝛼 𝑘𝑘1𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑘𝑘2𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  (A2.8)  
In this way, the appropriate rate constants can be determined for any value of 𝐾𝐾𝑒𝑒𝑒𝑒 . We 
use a similar approach to determine the vulnerable state binding rate constants, 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁  and 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 , 
from a given 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝑁𝑁 :  
 
 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁 = 𝛽𝛽12𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  𝑐𝑐𝑏𝑏𝑏𝑏 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 = 𝛽𝛽−12𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  (A2.9)  
 
𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝑁𝑁 = 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁
𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜
𝑉𝑉𝑁𝑁 = 𝛽𝛽 𝑘𝑘𝑜𝑜𝑏𝑏𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  (A2.10)  
 
The initial rate constants for binding the vulnerable state, 𝑘𝑘𝑜𝑜𝑏𝑏
𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  and 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑 , are set 
equal to experimentally measured rates for MMP1 binding to a heterotrimeric collagen-like 
peptide that contains the type I collagen collagenase cleavage site at a temperature substantially 
greater than its melting temperature (i.e., we expect the triple helix to be mostly unfolded and 
191 
 
thus the scissile bonds to be solvent-exposed at this temperature) (𝑘𝑘𝑜𝑜𝑏𝑏
𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑 =4.5 102 M-1 s-1, 
𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜
𝑉𝑉𝑁𝑁 ,𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑 =5.94 10-3 s-1) (Ottl, Gabriel et al. 2000). With these rate constants, Equations (A2.1)-
(A2.6) are then solved using the ode15s solver in MATLAB 2008a (© MathWorks) using the 
durations and initial concentrations of collagen and enzyme specific to the relevant degradation 
experiment(s). 
Solutions to the model yield the concentration of collagen degradation products as a 
function of time, 𝐶𝐶𝑚𝑚𝑜𝑜𝑏𝑏𝑒𝑒𝑚𝑚 (𝑑𝑑), while the degradation experiments yield the fraction of 
peptide/collagen degraded as a function of time, 𝐹𝐹𝑒𝑒𝑒𝑒𝑒𝑒 (𝑑𝑑). To relate the calculated concentrations 
to the measured degraded fractions, we normalize the concentration of degradation products to 
the initial substrate concentration: 𝐹𝐹𝑚𝑚𝑜𝑜𝑏𝑏𝑒𝑒𝑚𝑚 (𝑑𝑑) = 𝐶𝐶𝑚𝑚𝑜𝑜𝑏𝑏𝑒𝑒𝑚𝑚 (𝑑𝑑)/𝑆𝑆𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑 , where 𝑆𝑆𝑏𝑏𝑏𝑏𝑏𝑏𝑑𝑑  is the initial 
substrate concentration. We then calculate the root mean square error (RMSE) between 
experimental and model time courses according to:  
 
𝑅𝑅𝐶𝐶𝑆𝑆𝑅𝑅 = �𝑏𝑏−1 ��𝐹𝐹𝑚𝑚𝑜𝑜𝑏𝑏𝑒𝑒𝑚𝑚 (𝑑𝑑) − 𝐹𝐹𝑒𝑒𝑒𝑒𝑒𝑒 (𝑑𝑑)�2𝑏𝑏
𝑑𝑑=1  (A2.11)  
where n is the number of experimental time points. 
 
A2.4.3 Derivation of the effective equilibrium constant in the presence of full 
length enzyme 
We first assume that the full length enzyme in Figure C.1 is catalytically inactive (i.e., 
degradation does not occur from the V·F complex). In this case, the system will reach an 
equilibrium defined by: 
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 𝑏𝑏[𝑁𝑁]
𝑏𝑏𝑑𝑑
= 𝑏𝑏[𝑉𝑉]
𝑏𝑏𝑑𝑑
= 𝑏𝑏[𝑁𝑁 ∙ 𝐻𝐻]
𝑏𝑏𝑑𝑑
= 𝑏𝑏[𝑉𝑉 ∙ 𝐻𝐻]
𝑏𝑏𝑑𝑑
= 𝑏𝑏[𝑉𝑉 ∙ 𝐹𝐹]
𝑏𝑏𝑑𝑑
= 𝑏𝑏[𝑅𝑅]
𝑏𝑏𝑑𝑑
= 0 (A2.12)  
where [E] is the free enzyme concentration and the remaining variables are the species 
enumerated in Figure C.1. We wish to then calculate the equilibrium ratio of all vulnerable states 
to all native states:  
 
𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑜𝑜𝑜𝑜 = [𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻] + [𝑉𝑉 ∙ 𝐹𝐹][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻]  (A2.13)  
As an intermediate step to obtaining 𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑜𝑜𝑜𝑜 , we first note that: 
 
𝐾𝐾𝑒𝑒𝑒𝑒 = [𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] (A2.14)  
Proof: 
 
𝐾𝐾𝑒𝑒𝑒𝑒 = [𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = [𝑉𝑉][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] + [𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = 1[𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉] + 1[𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉 ∙ 𝐻𝐻]= 1[𝑁𝑁][𝑉𝑉] + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉] + 1[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻] + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉 ∙ 𝐻𝐻] 
Using the fact that 𝐾𝐾𝑒𝑒𝑒𝑒 = [𝑉𝑉][𝑁𝑁] = [𝑉𝑉∙𝐻𝐻][𝑁𝑁∙𝐻𝐻], we have: 
 [𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = 11
𝐾𝐾𝑒𝑒𝑒𝑒
+ [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉] + 1[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻] + 1𝐾𝐾𝑒𝑒𝑒𝑒 = 𝐾𝐾𝑒𝑒𝑒𝑒1 + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉] 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻]𝐾𝐾𝑒𝑒𝑒𝑒 + 1= 𝐾𝐾𝑒𝑒𝑒𝑒1 + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉] [𝑉𝑉][𝑁𝑁] + 𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻] [𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁 ∙ 𝐻𝐻] + 1 = 𝐾𝐾𝑒𝑒𝑒𝑒1 + [𝑁𝑁 ∙ 𝐻𝐻][𝑁𝑁] + 𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁][𝑁𝑁 ∙ 𝐻𝐻] + 1= 𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁][𝑁𝑁} + [𝑁𝑁 ∙ 𝐻𝐻] + 𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = 𝐾𝐾𝑒𝑒𝑒𝑒 �[𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻]� = 𝐾𝐾𝑒𝑒𝑒𝑒 
Using Equation (A2.14) and the fact that 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 = [𝑁𝑁∙𝐻𝐻][𝑁𝑁][𝑅𝑅] = [𝑉𝑉∙𝐻𝐻][𝑉𝑉][𝑅𝑅] and 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝑁𝑁 = [𝑉𝑉∙𝐹𝐹][𝑉𝑉∙𝐻𝐻] we can calculate 
𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑜𝑜𝑜𝑜  from Equation (A2.13) as follows: 
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𝐾𝐾𝑒𝑒𝑒𝑒
𝑒𝑒𝑜𝑜𝑜𝑜 = [𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻] + [𝑉𝑉 ∙ 𝐹𝐹][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = [𝑉𝑉] + [𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] + [𝑉𝑉 ∙ 𝐹𝐹][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = 𝐾𝐾𝑒𝑒𝑒𝑒 + [𝑉𝑉 ∙ 𝐹𝐹][𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻]= 𝐾𝐾𝑒𝑒𝑒𝑒 + [𝑉𝑉 ∙ 𝐻𝐻]𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝑁𝑁[𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻] = 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝑁𝑁[𝑁𝑁] + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉 ∙ 𝐻𝐻] = 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝑁𝑁[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻] + [𝑁𝑁 ∙ 𝐻𝐻][𝑉𝑉 ∙ 𝐻𝐻]= 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝑁𝑁[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻] + 1𝐾𝐾𝑒𝑒𝑒𝑒 = 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝑁𝑁𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁]𝐾𝐾𝑒𝑒𝑒𝑒[𝑉𝑉 ∙ 𝐻𝐻] + 1 = 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝑁𝑁𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁][𝑉𝑉 ∙ 𝐻𝐻][𝑉𝑉 ∙ 𝐻𝐻][𝑁𝑁 ∙ 𝐻𝐻] + 1= 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝑁𝑁𝐾𝐾𝑒𝑒𝑒𝑒[𝑁𝑁][𝑁𝑁 ∙ 𝐻𝐻] + 1 = 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝑁𝑁𝐾𝐾𝑒𝑒𝑒𝑒1
𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝐻𝐻 [𝑅𝑅] + 1 = 𝐾𝐾𝑒𝑒𝑒𝑒 + 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑉𝑉𝐻𝐻𝑁𝑁𝐾𝐾𝑒𝑒𝑒𝑒𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝐻𝐻 [𝑅𝑅]
𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
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𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝐻𝐻 [𝑅𝑅] + 1 � = 𝐾𝐾𝑒𝑒𝑒𝑒 �1 + � 𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 [𝑅𝑅]𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝐻𝐻 [𝑅𝑅] + 1�𝐾𝐾𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑉𝑉𝐻𝐻𝑁𝑁� 
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